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Resumo 
 
Staphylococcus pseudintermedius (S.pseudintermedius) é 
uma bactéria patogénica oportunista, responsável pela 
maioria das infeções cutâneas e pós-cirúrgicas em cães. O 
número de estirpes resistentes a antibióticos β-lactâmicos 
está a aumentar constituindo actualmente um dos grandes 
desafios enfrentados pela medicina veterinária. As bactérias 
mais resistentes ao tratamento são aquelas que produzem 
biofilme sendo esta capacidade considerada um fator de 
virulência. Num biofilme, as bactérias estão envoltas numa 
matriz de substâncias poliméricas extracelulares (SPE), 
algumas das quais são proteínas. 
Tendo por objectivo obter mais informação acerca do 
biofilme, foi caracterizado o proteoma da matriz do biofilme 
de uma estirpe bastante virulenta de S. pseudintermedius 
isolada de um cão com piodermite profunda. Para tal 
cultivaram-se biofilmes da estirpe de S. pseudintermedius 
5819/10 em meio apropriado, separou-se a matriz das suas 
células bacterianas e avaliou-se as proteínas presentes 
quanto ao seu conteúdo e complexidade. Posteriormente o 
proteoma foi separado por electroforese 1D, caracterizado 
por nanoLC-ESI-Q-TOF e analisado usando ferramentas 
bioinformáticas 
Constatou-se que o proteoma da matriz do biofilme da estirpe 
5819/10 de S. pseudintermedius é muito diverso e que 63% 
das proteinas podem estar relacionadas com a região 
extracelular do biofilme ou da membrana plasmática na 
forma de complexos proteicos. Verificou-se também que a 
maioria das proteínas identificadas possui funções essenciais 
para a sobrevivência da bactéria mas não foi possível 
estabelecer uma relação clara entre elas e a formação de 
biofilmes. Algumas proteínas que se sabe estarem envolvidas 
na formação de biofilmes foram identificadas, tratam-se 
principalmente de factores reguladores da formação de 
biofilme e outros factores de virulência relacionados com a 
colonização de um hospedeiro a adesão bacteriana a uma 
superfície. A prevalência de adesinas e a ausência quase total 
de proteínas envolvidas na síntese de SPEs, forneceu dados 
que apoiam a hipótese que a matriz do biofilme do S. 
pseudintermedius 5819/10 seja constituída por células 
directamente ou indirectamente unidas entre si. 
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Abstract 
 
Staphylococcus pseudintermedius is an opportunistic 
pathogenic bacterium responsible for most skin and post-
surgical infections in dogs. The number of bacterial strains 
resistant to β-lactam antibiotics is increasing and are the major 
challenges now faced by veterinary medicine. Bacteria that 
produce biofilm are more resistant to treatment and thus, the 
production of this structure is already considered a virulence 
factor. In a biofilm, bacteria are embedded in a matrix of 
extracellular polymeric substances (EPS) some of which are 
proteins.  
With the objective to know more of this array element, the 
characterization of the biofilm matrix proteome (BMP) from 
a highly virulent S. pseudintermedius strain isolated from a 
dog with severe pyoderma was performed. Biofilm was 
developed by culturing the S. pseudintermedius strain 
5819/10 in specific media. The biofilm matrix was then be 
separated from bacterial cells and evaluated for their protein 
content and complexity. Finally, the proteome was separated 
by 1D electrophoresis and characterized by nanoLC-ESI-Q-
TOF and analysed using bioinformatics tools. 
The BMP of strain S. pseudintermedius 5819/10 consisted in 
a diverse group of proteins, where 63% of the proteins could 
be related to either the extracellular region or the plasma 
membrane, as protein complexes, and most of them had 
functions essential to cell survival. However, it was not 
possible to establish a clear relation between them and biofilm 
formation. Proteins known to be involved in biofilm 
formation consisted mostly of regulator factors of biofilm 
formation as well as virulence factors of-mainly-bacterial cell 
adhesion and host colonization. The prevalence of adhesins 
and the almost total absence of proteins involved in EPS 
synthesis pointed to a biofilm matrix where cells are directly 
or indirectly closely glued together to each other. 
 
 
 
 
 1 
 
 
Index 
 
Index ............................................................................................................................................................. 1 
Figures Index ................................................................................................................................................. 2 
Tables index .................................................................................................................................................. 3 
Abbreviations ................................................................................................................................................. 4 
1.Introduction ................................................................................................................................................. 7 
1.1 Staphylococci Biofilms .................................................................................................................... 7 
1.1.1 Biofilm formation as a virulence factor of Staphylococcus infections .............................................. 8 
1.1.2 Biofilm formation and dispersion ................................................................................................. 11 
1.1.3 Constitution of the Biofilm Matrix ................................................................................................. 14 
1.2 Experimental methods for the identification of staphylococci biofilm matrix proteins ....................... 21 
1.2.1 SDS-PAGE and 2D-PAGE for protein separation ........................................................................ 21 
1.2.2 MALDI- TOF/TOF mass spectrometry for protein identification .................................................... 22 
1.2.3 GeLC-MS/MS ............................................................................................................................. 23 
1.3 Aims ............................................................................................................................................. 30 
2.Materials and Methods .............................................................................................................................. 31 
2.1 Workflow ....................................................................................................................................... 31 
2.2 Detailed Description ...................................................................................................................... 33 
2.2.1 Preparation of biofilms ................................................................................................................ 33 
2.2.2 Biofilm Matrix Extraction Protocol ................................................................................................ 33 
2.2.3 Protein Isolation from Biofilm Matrix extracts ............................................................................... 35 
2.2.4 Protein quantitation ..................................................................................................................... 35 
2.2.5 SDS-PAGE coupled with MALDI-TOF/TOF Mass Spectrometry for preliminary protein extracts 
evaluation ............................................................................................................................................ 36 
2.2.6 GeLC-MS/MS for proteome characterization ............................................................................... 38 
3.Results and Discussion ............................................................................................................................. 40 
3.1 Biofilm Formation and Growth ....................................................................................................... 40 
3.1.1 Biofilm extraction: protocol development and optimization ........................................................... 45 
3.1.2 Protein Identification ................................................................................................................... 50 
3.2 Proteomic Analysis by GeLC-MS/MS ............................................................................................ 51 
3.2.1 Protein Quantitation .................................................................................................................... 51 
3.2.2 Biofilm Matrix Proteome .............................................................................................................. 52 
3.2.2.3 Final Remarks.......................................................................................................................... 66 
4.References ............................................................................................................................................... 67 
5.Annexs ..................................................................................................................................................... 78 
5.1 Protein Quantitation Data .............................................................................................................. 78 
5.2 LC-MS/MS data from the identified proteins .................................................................................. 79 
 
2 
 
Figures Index  
 
Figure Page Number 
Figure 1: Scheme depicting biofilm formation and 
dispersion regulated by agr, sarA and sigB genes 
12 
Figure 2- Mechanisms of  mature biofilm formation 13 
Figure 3- PIA monomer 15 
Figure 4- EC-TA monomers of S. epidermidis 
RP62A (A) and S. aureus MN8m (B) 
16 
Figure 5- Main secreted and cell-wall associated 
proteins of s.pseudintermedius that may be found 
on its biofilm matrix 
20 
Figure 6- GeLC-MS/MS protocol workflow for 
protein identification and annotation of S. 
pseudintermedius 5819/10 biofilm matrix proteome 
32 
Figure 7- Stages of biofilm formation after 7 hours 
of growth 
41 
Figure 8- Stages of biofilm formation after 23 hours 
of growth 
42 
Figure 9- Closer look at darker biofilm matrix 
formed after 23 hours of growth 
43 
Figure 10- Biofilm after 31 hours of growth 44 
Figure 11- Closer look 31 hours old biofilm 44 
Figure 12- Biofilm before extraction (after 48 hours 
of growth) 
45 
Figure 13- 12% polyacrylamide SDS PAGE gel 
profile of some of the samples extracted 
47 
Figure 14- Light microscopy monitoring of the 
extraction procedures 
49 
Figure 15- Schematics of the way gel bands were 
cut in minigel used in the first stage of GeLC-
MS/MS. 
52 
Figure 16- Cellular Component GOs attributed to 
10 or more annotated proteins 
54 
Figure 17- Molecular function GOs attributed to 10 
or more annotated proteins 
55 
Figure 18- Biological processes GOs attributed to 
10 or more annotated proteins 
56 
Figure 19- Proteins involved in the biofilm life 
cycle present in the S. pseudintermdius 5819/10 
biofilm matrix 
58 
 
 
 
 
 
 
3 
 
Tables index 
 
Table 1 Secreted proteins from S.aureus (56) and S.epidermidis (83) found exclusively in their 
biofilm matrices .............................................................................................................................. 17 
Table 2- Volumes of washing and extraction buffer used for protocol development ....................... 46 
Table 3- Proteomic Data retrieved from the MALDI-TOF/TOF analysis followed by comparison 
with Uniprot/SwissProt database (release 2013_09) restricted to the bacteria taxonomy group .... 51 
Table 4- Numerical summary of LC-MS-MS analysis .................................................................... 53 
Table 5- Comparion between the number of proteins found o S. pseudintermedius 58910 and other 
bacterial strains ............................................................................................................................... 53 
Table 6-Biofilm-associated proteins present on S. pseudintermedius 5819/10 biofilm matrix 
proteome ......................................................................................................................................... 62 
Table 7- Calibration Curve Data used for the protein quantitation assay. On the left there’s 
absorbance (Abs) measured for 4 standards and a blank and on the calibration curve parameters 
follow the y=mX+b equation. .......................................................................................................... 78 
Table 8- Protein quantitation data for the replicates used in the GeLC-MS/MS analysis. The 
number in front of the replicate code (ex: PD I2 10 nº) refers to the volume of sample (µL)  that 
was pipetted onto the 96-well plate for measurement. ................................................................. 78 
Table 9-Descritpion of abbreviations, color codes and technical terminology used on table 10. ... 79 
Table 10- List of all identified proteins by GeLC-MS/MS. ................................................................ 80 
 
  
4 
 
Abbreviations 
 
agr Accessory gene regulator 
AIPs Auto-inducing peptides 
Asb-14 Amidosulfobetaine-14 
Atl Bifunctional autolysin 
B2GO BLAST2GO 
Bap Biofilm-associated protein 
Bax Apoptosis regulator Bax 
BHI Brain heart infusion 
BMP Biofilm Matrix Proteins 
CID Collision Induced Dissociation 
cidA Regulator of murein hydrolase and cell death 
CWA proteins Cell wall associated proteins 
CW-TAs Cell wall teichoic acids 
D-Ala D-alanine 
DIGE Difference gel electrophoresis 
DNase Deoxyribonuclease 
DTT Dithiothreitol 
Eap Extracellular adherence protein 
EB Extraction Buffer 
Ebp Elastin binding protein  
EC-TAs Extracellular teichoic acids 
eDNA extracellular DNA 
Efb Extracellular fibrinogen-binding protein 
Emp Extracellular matrix protein-binding protein 
ESI Electrospray  ionization  
FnBPs Fibronectin-binding proteins 
GeLC 
SDS-PAGE coupled with High Resolution Liquid Cromatography 
Glc Glucose 
Glc6Ala Glucose-6-alanine 
GlcNAc N-acetylglucosamine 
GO Gene Ontology 
Hlb β-hemolysin 
HPLC High Permormance Liquid Cromatography 
HTH Helix-turn-helix 
IAA Iodoacetamide 
icaADBC Intercellular adhesion biosynthetic genes 
icaR Intercellular adhesion regulatory gene 
ID Internal diameter 
IPG Immobilized pH gradient 
5 
 
LC Liquid chromatography  
LM Light Microscopy 
LPXTG 
Leucine-proline-any aminoacid-threonine-glycine aminoacid 
sequence 
lrg Regulator of murein hydrolase and cell death 
LS-EPS Loosely-bound EPS 
m/z Mass to charge ratio 
MALDI Matrix-Assisted Laser Desorption/Ionization 
MALDI-TOF/TOF 
Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight/Time-
Of-Flight tandem mass spectrometer 
MIC Minimal inhibitory concentration 
MLST Multi locus sequence typing 
MOWSE Molecular WEight SEarch algorithm 
MRSA Methicillin-resistant staphylococcus aureus 
MRSP Methicillin-resistant staphylococcus pseudintermedius 
MS Mass spectrometry 
MS/MS Tandem mass spectrometry 
MSCRAMMs 
Microbial surface components recognizing adhesive matrix 
molecules 
MSSA Methicillin susceptible Staphylococcus aureus 
NAc N-Acetylglucosamine 
NaCl Sodium chloride 
NCBI National Center for Biotechnology Information 
PBP Penicillin-binding protein 
pgaABCD Poly-N-acetyl glucosamine biosynthetic genes 
pI Isoelectric point 
PIA Polysaccharide intercellular adhesin 
PVL Panton–Valentine leucocidin  
Q-TOF  Quadrupole-time-of-flight mass analyser 
Rbf Protein regulator of biofilm formation 
RPLC 
Reverse Phase High Performance Liquid Cromatography 
sarA Staphylococcal accessory regulator A 
Sbi Immunoglobulin-binding protein 
SCCmec Staphylococcal chromosomal cassette mec 
SDS Sodium dodecyl sulfate 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SECcanine Canine type C enterotoxin 
SEPP1 Extracellular elastase 
6 
 
SIET Staphylococcus pseudintermedius exfoliative toxin 
sigB Alternative sigma factor B 
SpA Immunoglobulin G-binding protein A; protein A(short version) 
spp. Species 
Spx Global regulator of stress response genes 
SrrAB Respiratory response regulator 
SSI Surgical site infection 
ST Sequence type 
TAs Teichoic acids 
TB-EPS Tightly-bound EPS  
WB Washing Buffer 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
7 
 
1.Introduction 
 
1.1 Staphylococci Biofilms 
 
A biofilm is defined as a “microbial derived sessile community characterized by cells 
that are irreversibly attached to a substratum, interface or to each other, are embedded in a 
matrix of extracellular polymeric substances that they have produced and exhibit an altered 
phenotype with respect to growth rate and gene transcription” (1). Externally, a biofilm can 
look like a simple but thick aggregate of cells and polymers (2) but in some cases, pillar or 
mushroom-shaped structures can be formed (2). Inside the biofilm, bacteria live in a complex 
community, that possess primitive homeostasis, metabolic cooperativity and a primitive 
circulatory system that provide some accessibility to essential nutrients even in the deepest 
regions of the biofilm (2). 
However, not all the bacteria in the biofilm express the same phenotype (3). This is 
because there is a gradient of oxygen, nutrients and electron acceptors, which leads to 
different gene expression throughout the biofilm (3). For instance, cells in the upper and 
lower layers, respectively more exposed to oxygen and to dissolved nutrients, present a 
higher metabolic activity metabolic. Most cells though, are dormant and live in an anoxic 
environment deprived of nutrients (3). 
The phenotype that the dormant cells present is responsible for the biofilm bacterial 
resistance to antimicrobials, that their planktonic counterparts do not have (4). Dormant cells 
consist mainly in very slow growing cells with a very low metabolic activity and a small 
percentage of persister cells (3). Slow growing cells are not very susceptible to antimicrobial 
agents (5). Persister cells are in a metabolically quiescent state and as consequence, they are 
able to live without producing or consuming substances that are targets of antimicrobial 
agents (4). Therefore, they possess multidrug resistance and are able to survive the onslaught 
of bactericidal antibiotics. (4). Once these chemicals are eliminated, persister cells shift to a 
metabolic active state and continue the infection of the host by the bacterial biofilm (6). 
Bacteria living encased in an biofilm matrix, benefit from its ability to sequester and 
concentrate environmental nutrients such as carbon, nitrogen and phosphate (7). The biofilm 
matrix may also provide a diffusion barrier to slow down the infiltration of some 
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antimicrobial agents (8). It has been shown that reactive chlorine species (ex: hypochlorite) 
present in several antimicrobials may be deactivated in the surface layers of the biofilm 
before they are able to penetrate the lower layers (9). Antibiotics such as oxacillin, 
cefotaxime and vancomycin have also shown reduced penetration throughout 
Staphylococcus aureus (S. aureus) and Staphylococcus epidermidis (S. epidermidis) 
biofilms (10). This finding is not universal as an earlier penetration study of vancomycin and 
rifampin in S. epidermidis biofilms, the biofilm matrix acted as a diffusion barrier (11).  
Biofilms may also contribute to the persistence of bacteria (12). Micro-colonies may 
detach and disperse either due to mechanical shear forces provided by the fluid channels or 
through a genetically programmed response (12). The detached micro-colonies then migrate 
to uninfected regions of the host, attach and form a new biofilm (12). In the end, biofilms 
enhance bacterial growth, provide resistance against antimicrobial agents (and the host 
immune response), and provide a platform for enabling bacterial spread (13). 
1.1.1 Biofilm formation as a virulence factor of Staphylococcus infections 
 
Biofilm formation is now recognized as an important virulence factor in several 
staphylococci infections (14). One reason for it, is that the minimal inhibitory concentration 
(MIC) of several antimicrobials for sessile bacteria within biofilms can be 10 to 1000 times 
higher than for their planktonic counterparts (15). Thus, to treat them, a larger quantity of 
antibiotics is necessary and their undesirable secondary effects are more pronounced (15). 
Bacterial biofilms may be of particular concern in veterinary orthopedic surgery 
associated with implants (16) and skin infections (17, 18). For instance, following the 
placement of an implant, it can rapidly be coated with a host-derived, protein-based 
conditioning film, which contains receptors that allow for bacterial attachment, initiating the 
process for biofilm formation and beginning a surgical site infection (SSI) (19). Indeed, the 
ability of bacteria to form a biofilm has been shown to be a leading cause of persistent SSIs 
and pyoderma and thus, the presence of a biofilm can greatly impact the ability to treat them 
(19). 
Therapeutic options available to treat biofilm-associated infections are limited, 
particularly when the strain is resistant to various antibiotics (20). Removal of infected 
orthopedic devices, with the associated morbidity and treatment costs, may be the only viable 
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option (21). So, the development of alternative treatment regimens for biofilm-associated 
infections is needed. 
1.1.1.1 Staphylococcus pseudintermedius infections: emergence of methicillin 
resistance  
 
 Staphylococcus pseudintermedius is a recently described gram-positive pathogenic 
bacterium that was first isolated from the lung tissue of a cat (22). It is an opportunistic 
pathogen andinfects primarily dogs (23, 24) where it is the leading cause of pyoderma and 
surgical site infections (SSIs) (25). S. pseudintermedius can also infect humans (13, 26), 
mainly due to contact with companion animals (27). Though these infections are still rare, 
they can be problematic to treat, particularly when the strain is methicillin-resistant (28).  
S. pseudintermedius isolates used to be susceptible to β-lactam antibiotics, but 
methicillin-resistant S. pseudintermedius (MRSP) is becoming prevalent (29). In fact, MRSP 
has been isolated from dogs, cats and humans (29). In a study by multi-locus sequence typing 
(MLST) involving isolates from different countries and animal species, it has been found 
identical or closely related sequence types (ST) in several countries on different continents 
indicating broad geographic dissemination of the most successful clones (26). Also the ST’s 
of clinical human isolates were closely related to commensal canine isolates suggesting 
zoonotic transmission (26).  
Methicillin resistance is conferred by the presence of the mecA gene, which encodes 
the production of an altered penicillin-binding protein (PBP) that has a low affinity for all β-
lactam antimicrobials: penicillins, cephalosporins and carbapenems (30). The mecA gene is 
located on the chromosome of the bacterium on a mobile element called the staphylococcal 
chromosomal cassette mec (SCCmec) (31). This element can be transferred between 
staphylococci species resulting in an increased number of resistant bacteria (32).  
MRSP strains have also been shown to be resistant to a large variety of antibiotics 
besides β-lactams (29). For instance, in cats suffering from urinary tract infections, MRSP 
was found - and proved – to be resistant to not only to beta-lactams, but also to 
fluoroquinolones, tetracyclines, macrolides, lincosamides and streptogramins, 
chloramphenicol, trimethoprim, gentamicin, kanamycin, neomycin and streptomycin (29).  
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Multidrug-resistant MRSP isolates represent a challenge for antimicrobial therapy in 
veterinary medicine because of the limited treatment options (29). Based on susceptibility 
results, the most useful systemic antimicrobials may include chloramphenicol, rifampicin, 
amikacin, clindamycin or minocycline (33). Aggressive topical therapy has been effective 
as the only treatment in certain cases, but the adverse effects of some of these medications 
may limit their usefulness (33).  
While in vitro susceptibility to vancomycin and linezolid is reported by some 
laboratories, the use of these drugs in animals is strongly discouraged (33). That is because 
the pressure put on the use of antimicrobials that are important for treatment of serious 
infections in humans, raises ethical questions and creates the potential for scrutiny and 
eventually restriction of extra-label drug use in veterinary medicine (29, 33).  
Studies on the risk factors associated with MRSP infections in animals are lacking 
(29), but are urgently needed. Knowledge is key. A good place to start is by looking into 
biofilm producing strains of S. pseudintermedius. Indeed, biofilm formation in S. 
pseudintermedius has not been fully characterized (34) but has been hypothesized as one of 
the reasons for the emergence of a few successful MRSP clones (35).  
Research is under way and there are positive signs already. The experimental anti-
biofilm drug DispersinB® has already been proven to be capable of degrading the 
polysaccharide intercellular adhesin (PIA) of MRSP biofilm matrices in dogs and thus, 
destroying the biofilm (36). However, not every biofilm contain PIA (37, 38). Consequently, 
novel anti-biofilm drugs are needed. Along with PIA, the biofilm matrix of staphylococci 
biofilms contain teichoic acids, proteins and, DNA (39). Of these compounds, proteins are 
the most diverse group and may provide key targets for anti-biofilm drugs, or even a new 
drug itself. After all, DispersinB® is an N-acetylglucosaminidase found on Actinobacillus 
actinomycetemcomitans biofilms, where it is responsible for the detachment of cells from 
biofilms grown attached to a plastic surface (40).  
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1.1.2 Biofilm formation and dispersion 
 
As opportunistic pathogens, S. aureus, S. epidermidis and S. pseudintermedius, take 
advantage of a compromised immune system to infect their host (41). For S. 
pseudintermedius, skin damage (41) and immunosuppression caused by surgical procedures 
(42) are the main reasons for the pyoderma and SSIs mentioned above.  
Not much is known about S.pseudintermedius mode of biofilm formation, but S. 
pseudintermedius has biochemical pathways similar to S. aureus (22) and expresses several 
adhesins and extracellular toxins and enzymes similar to it (43). As such, the mechanism for 
biofilm formation and dispersion of S. aureus should provide a model for the yet to be 
described S. pseudintermedius biofilm formation and dispersion mechanisms (figures 1 and 
2). 
 In the planktonic mode of living, both the staphylococcal accessory regulator A 
(sarA) and the alternative sigma factor B (sigB) genes are upregulated (44-46), while the 
accessory gene regulator (agr) is dowregulated (47). This results in the inhibition of 
production of thermostable nucleases and proteases that could otherwise inhibit initial 
biofilm formation (47). sigB also inhibits protease production and additionally, stimulates 
the production of adherence factors such as the microbial surface components recognizing 
adhesive matrix molecules (MSCRAMMs), like clumping factor, fibronectin binding protein 
A (fnBPA) and coagulase, (44, 45) which covalently bind to hosts matrix proteins (48).  
Covalent attachment of bacterial surface proteins is catalyzed by a family of enzymes 
called sortases like sortase A of S. aureus (49).  This enzyme recognizes a sequence of amino 
acid residues called the LPXTG motif (Leu-Pro-X-Thr-Gly) at the C-terminus of the host 
membrane surface proteins sequences, and then cleaves it between the Gly and Thr residues 
(49). Following that, it proceeds to catalyze the formation of an amide bond between the 
carboxyl-group of threonine and the amino-group of the cell-wall peptidoglycan (49). This 
way, the bacteria becomes attached to a biological surface (49). 
The immature biofilm then increases in cell density until a mature biofilm, where 
attached cells are embedded in an extracellular polymeric matrix (50). This development 
occurs either in an extracellular DNA (eDNA) dependent (37), a PIA dependent (51) or even 
in PIA independent manner (38). Once enough bacteria are attached, transient upregulation 
12 
 
of the sarA and agr genes, downregulates the production of adhesins and upregulates the 
production of several immunoavoidance factors and toxins that cause damage to the host 
organism (52).  
When the number of cells within the biofilm reaches a certain number and the density 
throughout the bacterial community of auto-inducing peptides (AIPs) involved in cell-to-
cell communication reaches a quorum sensing threshold, expression of agr is induced (47). 
This in turn upregulates the expression of detergent-like peptides, proteases and 
thermostable nuclease leading to the release of bacterial cells from the mature biofilm in 
what is called seeding dispersal (53). 
 
Figure:1 Scheme depicting biofilm formation and dispersion regulated by the agr, sarA and sigB genes, retrieved from 
reference (54). Pointy arrows heads depicts an event or process that is promoted while hammer-like arrow heads depicts 
an event/process that is blocked or suppressed. Agr: accessory gene regulator; sarA: staphylococcal accessory regulator 
A; sigB: alternative sigma factor B. 
1.1.2.1  Mechanisms of mature biofilm formation 
  
 The development of the biofilm matrix is a key step for the biofilm formation and 
virulence (14). As mentioned above, it can occur in PIA dependent or independent manner 
or even in an eDNA dependent mechanism as illustrated in figure 2. In vitro biofilm 
production has also been triggered by the addition of glucose and NaCl to the growth media 
of S. aureus strains and they seem to be associated with different modes of biofilm formation 
(55). In methicillin-susceptible S.aureus (MSSA) isolates, biofilm development in medium 
containing NaCl was correlated with PIA-dependent biofilm production whereas in MRSA 
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isolates grown in either medium containing glucose or NaCl, it was PIA-independent and 
instead was mediated by adhesins (55), which are proteins that glue cells together and to 
surfaces (56). 
 
Figure 2- Mechanisms of mature biofilm formation adapted from reference (54). Arrow heads are the same as figure 
1.Bap:  biofilm-associated protein; cidA: regulator of murein hydrolase and cell death; Dnase:  deoxyribonuclease; eDNA: 
extracellular DNA; FnBPs: fibronectin-binding proteins; icaADBC: intercellular adhesion biosynthetic genes; icaR: 
intercellular adhesion regulatory genee; Irg: regulator of murein hydrolase and cell death; PIA: polysaccharide intercellular 
adhesin; Rbf: protein regulator of biofilm formation; SpA: immunoglobulin G-binding protein A; Spx: global regulator of 
stress response genes; SrrAB: respiratory response regulator. 
 
1.1.2.1.1 Mature Biofilm Formation in PIA-dependent manner 
 
After adhesion, bacteria may start biofilm production through the synthesis of an 
adhesive polysaccharide polymer known as PIA (51).  In S. aureus, PIA is produced in vivo 
and in vitro from UDP-N-acetylglucosamine via transcription of genes of the intercellular 
adhesion (ica) locus: the biosynthetic icaADBC operon (57). These genes are necessary for 
biofilm formation and virulence and are upregulated in response to anaerobic growth, such 
as the internal environment of the immature biofilms (58). Under anaerobic conditions, PIA 
synthesis is triggered by the staphylococcal respiratory response regulator (SrrAB) through 
the binding of a 100 bp DNA sequence upstream of the icaADBC operon (59).  
The synthesis of PIA can be repressed by the expression of transcriptional regulator 
of the teicoplanin-associated locus (tcaR), the intercellular adhesion regulator gene (icaR) 
and indirectly, the global regulator of stress response genes (spx) (60-62). icaR encodes a 
transcriptional repressor that represses PIA production by binding to the ica cluster promoter 
(60, 61) and spx modulates this action (62). However, transcription of icaR can be repressed 
by the protein regulator of biofilm formation (Rbf) (63). When this occurs or when icaR is 
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simply deleted, the expression of the icaADBC operon is enhanced, PIA production increases 
as well as the biofilm formation (60, 61, 63). 
1.1.2.1.2 Mature Biofilm Formation in PIA-independent manner 
 
Despite the importance of the ica gene locus in biofilm development, biofilms can 
occur in an ica-independent fashion (55). In ica-deletion mutants of MRSA, PIA-
independent biofilm formation can be mediated by cell-to-cell adhesion through their cell 
wall-associated proteins (55). Proteins arbitrating this type of biofilm formation include the 
S. aureus protein A (Spa) (64), fibronectin-binding proteins (FnBPs) (65) and the biofilm-
associated protein (Bap) (66). 
1.1.2.1.3 Mature Biofilm Formation in eDNA-dependent manner 
 
 Extracellular DNA (eDNA) can also induce PIA-independent biofilm formation (37, 
67). On the other hand, DNase treatment degrades eDNA and inhibits eDNa-mediated 
biofilm formation (68). Genomic DNA is the source of eDNA and its release is arbitrated 
through cell lysis and controlled by lrg and cidA genes expression (37, 67). lrg is a regulator 
of murein hydrolase and cell death (37) while cidA is an holin homolog involved in cell lysis 
and encodes an effector of murein hydrolase activity and also regulates cell death (67). 
Upregulation of the lrg, results in inhibition of cellular lysis, DNA release and biofilm 
formation (37). On the other hand, cidA gene expression enhances cellular lysis, DNA 
release and biofilm formation (67). 
1.1.3 Constitution of the Biofilm Matrix  
 
1.1.3.1  Polysaccharides 
 
In staphylococci biofilms there are two main classes of polysaccharides: the 
polysaccharide intercellular adhesin (PIA) and the extracellular teichoic acids (EC-TAs) 
(51). PIA is a linear β-(1,6)-linked N-acetylglucosaminoglycan containing about 130 N-
acetylglucosamine (GlcNAc) residues, partially substituted with O-succinyl groups and 
partially de-N-acetylated (69) and its monomeric structure is presented in figure 3. As for 
the EC-TAs, they are composed of glycerol, phosphate, glucose, and GlcNAc in S. 
epidermidis (70) and phosphate, ribitol, glycerol, GlcNAc, and D-Ala in S. aureus (71).  
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EC-TA are highly polar and hydrophilic molecules, whereas PIA is rich in relatively 
hydrophobic NAc groups (51). Both groups of molecules have positive and negative charges 
due to substitution of hydroxyl with charged groups: free amino-groups and O-succinyl 
substituents in PIA, D-alanyl esters and phosphate groups in EC-TA (51).  The amount of 
substitutions may vary and be influenced by the growth conditions (70). Also, the capacity 
to regulate the number of positive and negative charges, as well as the hydrophilic properties 
of its biofilm constituents by staphylococci, should increase its ability to form biofilm on 
surfaces with different physicochemical properties and to survive and proliferate under 
varying environmental conditions (51). 
PIA was first characterized in S. epidermidis (69) and subsequent studies in the model 
strain S. epidermidis RP62A (70) have revealed the presence of a similar polymer, where 
only the degree of N-deacetylation and O-succinylation as well as phosphorylation varied 
between them. PIA not only promotes intercellular adhesion and biofilm formation (72), it 
also contributes to the pathogenesis of biomaterial-associated infections , to the binding to 
hydrophilic surfaces and to hemagglutination (73). 
 
 
 
 
Figure 3- PIA monomer consisting of a partially de-N-acetylated β-(1,6)-linked N-acetylglucosaminoglycan. Image based 
on the data from reference (69), but retrieved from reference (72). 
PIA or similar polymers seem to be wide spread in bacterial biofilms (51). In Gram-
negative bacteria Escherichia coli, the gene locus pgaABCD is responsible for the production 
of poly-β-(1,6)-GlcNAc (PGA) (74), which is a polymer with a structure very similar to PIA 
(74). Homologues of pgaABCD were found in other Gram-negative bacteria such as, 
Actinobacillus pleuropneumoniae and Aggregatibacter actinomycetemcomitans (75, 76). 
What is remarkable is that coding genes for PIA and PGA have a low degree of homology: 
pga and ica genes do not have a great degree of homology, but the polymers they encode are 
structuraly and functionally the same. (74).  
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Teichoic acids (TAs) are an integral part of the cell wall of staphylococci bacteria 
(51). Due to their alanine content (and the charge its positively amino group brings), cell 
wall teichoic acids (CW-TAs) contribute to the formation of S. aureus biofilms and enhances 
the adhesion of S. epidermidis cells to fibronectin-coated surfaces in the early stages of 
biofilm formation (77). TAs, are also found beyond the cell wall and can be secreted to the 
biofilm matrix, EC-TAs (78). In fact, due to their cell wall origin, the composition and 
structure of both CW-TAs and EC-TAs in S. epidermidis RP62A and S. aureus MN8M are 
the same (71, 79). 
The EC-TA of S. epidermidis is composed of (1,3)-linked poly(glycerol phosphate), 
substituted at the position 2 of the glycerol residues with α-Glc, α-GlcNAc, D-Ala, or α-
Glc6Ala (79). In S. aureus however, there is also a poly(ribitol phosphate) EC-TA polymer 
(71). In the poly(ribitol phosphate) chain, nearly 100% of ribitol is substituted with β-
GlcNAc at position 4 and its structure matches the one described for S. aureus H (80). As in 
S. epidermidis polymer, the glycerol residues are (1,3)-linked, but most are not substituted: 
only about 20% are acylated with D-Ala at position 2 (71). Looking into these evidences, the 
degree of substitution in D-Ala, an important pathogenic element (51), seems different in 
both bacteria species and one could expect similar differences for the S. pseudintermedius 
biofilm matrix . 
Figure 4- EC-TA monomers of S. epidermidis RP62A (A) and S. aureus MN8m (B). Image based on the data from 
references (71, 79) but retrieved from reference (51) for the S. pseudintermedius biofilm matrix. 
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1.1.4.2 eDNA 
 
Extracellular DNA (eDNA) is considered a major structural component of the biofilm 
matrix of S. aureus, whereas it is only a minor component of biofilms formed by S. 
epidermidis (81). That is because when treated with DNase I, the formation of S. aureus 
biofilms is inhibited and detachment of pre-formed S. aureus biofilms occurs (81). The 
eDNA of S. aureus consists of small fragments of genomic DNA (11 kb) and they mediate 
intercellular adhesion (81). This genomic DNA is obtained through a phenomenon 
analogous to programmed cell death and is regulated by the cidA gene (82). This release, 
also promotes biofilm formation and growth (82), as previously described. 
1.1.4.3 Proteins 
 
There are many known proteins within the biofilm matrix (reviewed in (39)), but 
regarding staphylococci, not many of them were identified. In table 1, secreted proteins 
found on the biofilm matrix of S. epidermidis and S. aureus strains are presented (56, 83). 
They were identified in two recent studies and provide clues about which proteins might be 
present in the S. pseudintermedius biofilm matrix. The secreted proteins identified comprise 
binding proteins, enzymes, and toxins. 
Table 1 Secreted proteins from S.aureus (56) and S.epidermidis (83) found exclusively in their biofilm matrices 
Secreted 
Proteins 
Protein 
name & 
abbreviatio
n 
Acession 
Number |Entry 
Name 
Gene Extracellular function Bacteria 
Enzymes 
 
Extracellular 
elastase, 
SEPP1 
P0C0Q3|SEPA_
STAEP 
sepA 
Hydrolysis of casein and elastin 
and glucagon 
S.epider
midis 
Epidermin 
leader 
peptide 
processing 
serine 
protease 
EpiP 
P30199| 
EPIP_STAEP 
epiP Complement evasion 
Glutamyl 
endopeptidas
e 
P0C0Q2|GSEA_
STAES 
gseA 
Human fibronectin and type 1 
collagen hydrolysis 
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Thermonucle
ase 
Q5HHM4 
NUC_STAAC | 
nuc 
Biofilm dispersion: eDNA 
hydrolysis 
S.aureus 
Staphylocoa
gulase 
Q5HJE9 
|Q5HJE9_STAA
C 
SACOL0
209 
Adhesion to fibrinogen and its 
conversion into fibrin; blood 
clotting 
Bifunctional 
autolysin, 
Atl 
Q99V41| 
ATL_STAAN 
atl Biofilm formation; adhesion 
Binding 
Proteins 
Fibrinogen-
binding 
protein, Efb 
A6QG59| 
FIB_STAAE 
fib 
Biofilm formation, adhesion, 
complement evasion 
Extracellular 
adherence 
protein, Eap 
Q53599| 
MAP1_STAAU 
map 
Biofilm formation, cell-to-cell 
adhesion 
Immunoglob
ulin-binding 
protein, Sbi 
Q99RL2| 
SBI_STAAN 
sbi Complement evasion 
Immunoglob
ulin G-
binding 
protein A, 
SpA 
A6QD95| 
A6QD95_STAA
E 
spa 
Biofilm formation, complement 
evasion 
Extracellular 
matrix 
protein 
binding 
protein, Emp 
Q99VJ2| 
EMP_STAAM 
emp 
Biofilm formation, adhesion, 
abscess formation 
Toxins 
β-hemolysin, 
Hlb 
Q931I6| 
Q931I6_STAA
M 
truncate
d-hlb 
Biofilm formation, 
sphingomyelinase activity 
Uncharacteri
zed 
leukocidin-
like protein 2 
Q5HEH9| 
LUKL2_STAAC 
SACOL2
006 
Bax-independent apoptosis of 
human neutrophils 
 
 The binding proteins were identified in the S. aureus biofilms (56). Some of them 
are immunoglobulin binding proteins: Protein A (SpA) and Sbi (56). These proteins bind to 
human IgG - inactivating it - and thus evading the complement system, “an elaborate 
network of cascades for dealing with microbial intruders” (84). Moreover, SpA has a pivotal 
role in PIA-independent biofilm formation by inducing bacterial cell aggregation and thus 
acting as an adhesin (64).  
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The other binding proteins found were the adhesins Eap, Efb and Emp (56). Eap was 
shown to stimulate cell aggregation and biofilm formation and also strongly bound itself to 
the S. aureus cell surface (56). It was also able to form biofilm matrix architecture and 
contribute to biofilm development through the formation of a structural framework in the 
biofilm matrix (56). Efb promotes biofilm formation and complement system evasion 
through the stimulation of fibrinogen binding to ADP-activated platelets and inhibition of 
platelet aggregation, respectively (85). At last, Emp adheres to the host fibronectin, 
fibrinogen, and vitronectin (86), plays an important role in low-iron-induced biofilm 
formation of S. aureus (87) and is necessary for abscess formation (88). 
Enzymes secreted by S. aureus onto its biofilm matrix were autolysin, coagulase and 
thermonuclease (56). Autolysin is required for both FnBP- and PIA-mediated biofilm 
development on hydrophobic polystyrene and to the attachment to hydrophilic polystyrene 
(65). Coagulase adheres to fibrinogen and catalyzes its conversion into fibrin, leading to the 
formation of blood clots while thermonuclease has been implicated in bacterial cell 
detachment, through the hydrolysis of eDNA (37). 
Enzymes secreted onto S. epidermidis biofilm matrix on the other hand, were the 
tissue-damaging proteases serine protease EpiP, glutamyl endopeptidase and extracellular 
elastase (83). These enzymes play a key role in the inactivation of the host defense 
mechanisms and thus in the persistence of S. epidermidis biofilms and infections (83). Serine 
protease EpiP is involved in complement evasion through the processing of epidermin, a 
lantibiotic that helps to exclude competing organisms that are sensitive to its bactericidal 
activit (89). Glutamyl endopeptidase, also known as serine proteinase, hydrolyses human 
fibronectin and type 1 collagen (90). Finally, extracellular elastase is a metalloprotease that 
has a low substrate specificity and hydrolyzes casein, elastin and glucagon (91). 
A couple of toxins were also found on the biofilm matrix of S. aureus, namely a 
hemolysin and a leukotoxin. β-hemolysin has sphingomyelinase activity with a high affinity 
for sphingomyelin (92). This toxin is also capable of forming covalent cross-links to itself 
in the presence of eDNA producing an insoluble nucleoprotein matrix in vitro and, thus 
forming a biofilm. The leukocidin has a molecular mass close to 40 kDa, it may be one of 
the two proteins that constitute the S. aureus Panton-Valentine leukocidin (93) that directly 
targets mitochondria and induces Bax-independent apoptosis of human neutrophils (94). 
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 In spite of large variety of secreted proteins in both biofilm matrixes, the overall 
number of those only present in this proteome was very low (56, 83). The biofilm matrix 
proteome (BMP) of S. aureus was comprised of only 14% secreted proteins but more than 
50% were already known as cytoplasmatic proteins (56). Among these, there were homologs 
of enzymes with functionality related to protein synthesis and carbohydrate metabolism also 
found on E. coli biofilm matrix, such as ribosomal proteins (30S and 50S) and 
glyceraldehyde-3 phosphate dehydrogenase, respectively (95). In the S. epidermidis BMP, 
the secreted proteins only accounted for 16% of BMP, with the rest being cell wall associated 
proteins (CWA proteins) (83).  
All of this evidence provides valuable information that gives some clues to predict 
which proteins might be found on the biofilm matrix of S. pseudintermedius (figure 5). 
Similar to S. aureus, S. pseudintermedius produces a variety of virulence factors, including 
enzymes such as coagulase, thermonuclease and various proteases, surface proteins like 
clumping factor and protein A, and toxins such as cytotoxins, exfoliative toxins and 
enterotoxins (reviewed in (96)) which could also be found on the biofilm matrix . Of note 
are the canine type C enterotoxin (SECcanine), a superantigen, and the S. pseudintermedius 
exfoliative toxin (SIET), as both have been associated with canine pyoderma infections (97, 
98).  
Figure 5- Main secreted and cell-wall associated proteins of s.pseudintermedius that may be found on its biofilm matrix. 
Image retrieved from reference (96). 
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1.2 Experimental methods for the identification of staphylococci biofilm 
matrix proteins 
 
In order to characterize biofilm matrix proteins, several steps must be accomplished: 
biofilm formation, biofilm matrix and protein extraction protein separation and 
identification. In vitro biofilm formation is performed by cultivating staphylococci in tryptic 
soy broth (TSB) and brain heart infusion (BHI), supplemented with either glucose of NaCl 
within plastic flasks with a large surface area to maximize the adhesion (99). Then, the 
biofilm matrix is extracted using a cation exchange resin (83, 100) or concentrated NaCl 
(56). Proteins are then isolated through trichloroacetic acid precipitation (101) and then 
ressolubilized in an electrophoresis running buffer, in order to get simplified protein fraction 
to proceed with the proteomic analysis. 
Proteins are usually then separated by polyacrylamide gel electrophoresis, namely 
two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) (102). There is also an 
alternative procedure to 2-DE-PAGE, where sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) is combined with High Performance Liquid Cromatography 
after tryptic digestion of each band and it is called GeLC-MS. 
1.2.1 SDS-PAGE and 2D-PAGE for protein separation 
 
The SDS-PAGE is a separation method where proteins are separated according to 
their molecular mass (103). Protein samples are denatured with SDS in order to obtain their 
linear primary amino acid structure (104, 105). After that, they are transferred to a porous 
polyacrylamide gel and subjected to an electric current (104, 105). SDS gives proteins an 
even negative charge and so, they will move towards the positive pole at velocity dependent 
on their molecular mass (105). Those with higher mass are the slowest and also the most 
difficult to migrate through the gel (105).   
The pore size in the gel is crucial for a good separation (105). The smaller the pore, 
the harder it will be for bigger proteins to penetrate and move through the gel (105). On the 
other hand, if the pore size is too large, proteins with a similar mass may migrate at the same 
time and will not separate themselves (105). The key to regulate the pore size is the 
acrylamide percentage on the gel, as the pore size is inversely proportional to the amount of 
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acrylamide used (105). As a reference point, in the S. epidermidis proteomic study 
mentioned in 1.1.4.3, a 12% polyacrylamide gel was used (83).  
Proteins separated by SDS-PAGE subsequently rely on mass spectrometry (MS) 
techniques for identification and further characterization (104). Protein in-gel are excised 
and then in gel digested with a specific protease, namely trypsin (104). The mass of the 
resulting tryptic peptides and of their fragments is determined using a mass spectrometer. 
These results are combined in order to obtain protein identifications (104). 
1.2.2 MALDI- TOF/TOF mass spectrometry for protein identification 
 
Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight/Time-Of-Flight 
tandem mass spectrometer (MALDI-TOF/TOF) is an instrument with the advantages of high 
sensitivity for peptide analysis and comprehensive fragmentation information provided by 
high-energy collision-induced dissociation (CID) (106). MALDI ionizers create mainly 
single charged ions (107). Samples are incorporated into the crystalline structure of small 
UV radiation absorbing molecules, that provide a vehicle for ions to be created from polar 
or charged biomolecules (108). When laser radiation strikes the matrix crystals, the energy 
deposition is thought to cause rapid heating of the crystals brought about by matrix 
molecules emitting absorbed energy in the form of heat (108). The rapid heating causes 
sublimation of the matrix crystals and expansion of the matrix and sample into the gas phase 
(109). Ions may be formed through gas phase proton-transfer reactions in the expanding gas 
phase plume with photo-ionized matrix molecules (109).  
MALDI ionizers are usually coupled to TOF analyzers (110). Within this device, 
mass-to-charge ratios are determined by measuring the time it takes for ions to move through 
a field-free region (110). Given a constant accelerating voltage, the flight time for an ion will 
be related to its mass to charge ratio (m/z) (110).  
The flight path for an ion can be increased, without increasing the size of the flight 
tube through the incorporation of an ion mirror or reflectron at the end of the tube (110). 
With this device in place, ion direction is reversed to send the ions back down the same 
vacuum chamber at a slightly different angle so the flight path of the reflected ions does not 
cross with the ions entering the reflectron (110). The reflectron can also correct minor kinetic 
energy differences among ions of the same m/z value and so minimize variations in their 
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fight times (110). Ions with higher kinetic energy arrive earlier at the reflectron but also 
penetrate deeper before reflection than the less energetic ions (110). Thanks to that, ions with 
the same m/z ratio but different initial energies are capable of meeting at the detector at about 
the same time (110). 
Structural information is deduced from ion fragmentation (110). This is because there 
can be peptides with the same mass but different composition and amino acid sequence. 
Thus, incorporating a collision cell and a second TOF to the equipment will allow this type 
of analysis (106). A precursor ion is fragmented inside the collision chamber and the mass 
of the fragment ions is determined in the second TOF. The analysis of the generated MS/MS 
spectrum enable to deduce the peptide amino acid sequence (106). 
The MS/MS peak mass values of each ion fragment are then compared with the 
theoretically expected tryptic peptide masses in databases such as the SWISSPROT or the 
NCBI non-redundant (111), with the help of a search engine such as Mascot (112),  which 
uses a development of the MOWSE algorithm (112, 113). The program gives to each ion 
fragment a score based on the probability of the matching between the experimental data and 
the sequence databases being chance events (112). The identification match with the lowest 
probability will be the best match, and it will be significant if it has a probability of occurring 
inferior to 0.05 (112).  
1.2.3 GeLC-MS/MS 
 
GeLC-MS is generally considered to be the technique that provides the highest 
number of protein identifications of the standard proteomics workflows (114). In this 
technique, proteins are first separated by 1DE (SDS-PAGE) and then each lane of the gel is 
excised into multiple gel slices (114). Each of these slices is then in-gel trypsin digested and 
provides the peptide samples for a distinct LC-MS analysis (114). This allows overcoming 
the ion suppression effect common in MS analysis, and increases the number of proteins 
identified in a complex sample.  
Performing an initial 1DE has other advantages. Firstly, the proteins can be 
solubilized with SDS, assuring maximum solublization compared to other protein separation 
methods (114). And secondly, the first dimension gel gives insight on the initial apparent 
molecular mass of the protein identified from its migration on SDS-PAGE (114) and this 
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can provide insight into protein processing or modification (115). On the other hand, the 
main problem with this approach is that is very time consuming (114). 
1.2.3.1 High resolution liquid chromatographic techniques: HPLC and nano HPLC 
 
Liquid chromatography (LC) can be regarded as the separation of components of a 
mixture based upon the rates at which they elute from a stationary phase typically over a 
mobile phase gradient (116). Differing affinities of the mixtures components for the 
stationary and mobile phase’s leads to their separation, since certain components will be 
more attracted to the mobile phase and will elute quickly whilst others will be retained by 
the stationary phase for longer and therefore will elute more slowly, i.e. have a larger 
retention time (RT) (116). HPLC on the other hand is an evolution, where high-pressure 
pumps and strengthened packed columns are combined to improve separations.  
The HPLC device consists of solvent reservoirs, one for each of the mobile phase 
eluents (solvent A and B), as well as further reservoirs for autosampler syringe and line 
washes. A high-pressure pump forms the solvent delivery system, which generates and 
meters a specified flow rate (typically millimeters per minute). A solvent partitioning valve 
allows the mixing of solvents A and B at specified ratios and time gaps, thus permitting the 
operator to programme the HPLC to perform gradient elution steps (117).  
To commence the HPLC cycle sample analysis, an autosampler injector system 
introduces the sample to the mobile phase stream and is carried to the HPLC column (116). 
In the case of reverse phase HPLC (RPLC) for peptide separation, the column is packed 
typically with silica–C18H37 particles to act as a non-polar retaining stationary phase (116). 
At an appropriate time point during the HPLC separation (which is sample matrix-dependent 
and must be optimized to allow for the elution of the maximum number of polar sample 
components), is introduced to the mobile phase in increasing ratios in an incremental 
manner, thus the increasing organic content of the solvent leads to the elution of the retained 
non-polar compounds from the stationary phase. (116). Throughout the chromatographic run 
a mass spectrometer is recording the signal of the eluted sample components, the signal is 
amplified and delivered to a computer where it is processed and displayed as a chromatogram 
(116).  
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Factors influencing the performance of the HPLC system are the polarity of the 
sample compounds that are being analyzed; the composition of the mobile phase; and the 
chemical properties of the stationary phase (116). However, there are several, other which 
influence the efficiency of HPLC separations and were utilized in the development of nano 
HPLC such as column length and internal diameter and particle size (116).  
Here enters nano-LC that offers higher efficiency, shorter analysis time and better 
compatibility with MS, due to the relatively low flow-rates (40-600 nL min-1) that allow the 
transfer of the entire effluent from the column into the MS (118). Nano-LC uses capillary 
columns of 10-100 μm internal diameter (ID) packed with the same type of stationary phase 
as used in regular HPLC. In nano-LC the use of pre-columns is recommended, since 
capillaries can be easily blocked at the inlet, when real samples are injected. Pre-columns 
can also be used for sample clean up and pre-concentration. (119). 
 Providing that a column bed is uniformly packed and stable, the chromatographic 
separation efficiency is determined by the particle size and column length (120). Longer 
lengths of column enhance chromatographic separation, though at the expense of increased 
analysis times and system back pressure (120). Smaller particle sizes lead to an increased 
surface area improving compound retention and providing improved chromatographic 
separation at the expense of an increased pressure being required to drive the mobile phase 
(121). Unfortunately, decreases in column particle size result in greater system back 
pressures, as does increases in column length along with increased solvent consumption and 
sample analysis times (120). 
In modern HPLC and nano-LC, particles in the µm range are commonly employed 
to maximize the chromatographic resolution power along with short column lengths to 
reduce sample analysis times, backpressure, and solvent consumption (121). The column’s 
ID influences the selectivity of separation and detection sensitivity in gradient elution as well 
as determining the volume of sample that can be loaded. Narrow-bore columns are 
commonly used in LC-MS applications since they offer greater sensitivity than the larger-
ID columns, although they restrict the volume of sample that can be loaded (117). Finally, a 
nanospray ionization source is coupled to the nanoLC cromotograph. 
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1.2.3.2 ESI-MS/MS 
 
1.2.3.2.1 Ionization Source 
 
In the electrospray ionization (ESI) of peptides, an acidic, aqueous peptidic solution 
is sprayed through a small-diameter needle (122). A high, positive voltage is applied to this 
needle to produce a Taylor cone from which droplets of the solution are sputtered (122). The 
positive charged droplets then move from the needle towards the more negatively charged 
instrument (122). During the course of this movement, evaporation of the droplets occurs, 
reducing their size (122). This leads to split of the droplets into smaller ones due to high 
number of positively charged particles (122). The evaporation and droplet-splitting cycle 
repeats until the small size and charging of the droplet desorbs protonated peptides into the 
gas-phase, where they can be directed into the mass spectrometer by appropriate electric 
fields (122). 
ESI tends to protonate all available basic sites in analyte molecules (122). In peptides, 
they are the N-terminal amine moiety and the basic side groups of the lysine, arginine, and 
histidine residues (122). As a result, multiply protonated peptide ions are observed whenever 
a lysine, arginine,  or histidine  residue is present in a peptide (122).  Doubly charged peptides 
tend to predominate in tryptic digests of proteins because of the proteolytic specificity of 
trypsin (122). This enzyme cleaves amide bonds at the C-terminal side of each  lysine  and  
arginine  residue (122). In general, the peptides produced have only two basic sites - the N-
terminus and the side chain of the C-terminal lysine or arginine residue (122). Consequently, 
ionization takes place by protonation of those two sites (122). More, highly charged tryptic 
peptides nearly always contain internal histidine, lysine-proline bonds, arginine-proline 
bonds, or missed cleavage sites (122). As a result, the maximum charge state of a peptide in 
a tryptic digest can provide some information about its structure (122).  
ESI is a very efficient process for whom the efficiency of protonation of amino acid 
residues basic sites in acidic environments plays a major role (122). To add to its 
atratitiveness to proteomic studys, ESI is compatible with reversed-phase high-performance 
liquid chromatography (RPLC) solvent systems (122). Water/solvent mixtures have 
excellent spray properties and, although methanol might be preferred, acetonitrile is an 
acceptable solvent for electrospray (122).  
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Nanospray is a low-flow spray-ionization technique used in the mass spectrometric 
analysis of protein digests (122). The fundamental ionization mechanism is same but 
distinguished by extremely low flow rates from the spray needle (122). The dimensions of 
the Taylor cone and the sputtered droplets produce the sensitivity enhancement seen with 
nanospray (123). As the flow rate is lowered, and as the size of the electrospray needle is 
reduced, the dimensions of the Taylor cone and of the droplets that are produced are also 
reduced (123). The efficiency of desorption of analytic peptide ions from the electrosprayed 
droplet increases as the size of the droplets decreases because of the larger surface area of 
the droplet relative to its total volume (123).  As a result, a greater proportion of analyte is 
desorbed from the droplets and is transmitted from the spray needle to the entrance aperture 
of the mass spectrometer and detectable signals can be observed with attomole amounts of 
peptides (123). The result of this sensitivity enhancement is that nanospray ionization 
extends the sequencing of proteins in electrophoretic gels down to the silver stain-detectable 
level, which is equivalent to as little as 10 to 100 fmol of protein in the gel (123).  
A practical effect of nanospray is that the microliter volumes of sample produced by 
a protein digest can be sprayed for extended periods (122). Because ions are generated for a 
longer period, more sophisticated experiments can be performed, such as MS-MS 
experiments to investigate  structure of product ions, or optimization of collision conditions 
by using a variety of energies, or simply acquiring more product ion  spectra than could be 
acquired when operating on the chromatographic time scale (122). The primary 
disadvantages of nanospray ionization relate to inherent difficulties of miniaturization; 
namely the need for microscopes to manipulate and place the needle, obstruction of the 
needle, and, in particular, the practical problems related to executing in-line HPLC 
separations at low nanoliter-per-minute flow rates (122). These difficulties, although 
generally manageable, have been the driving force behind the development of microspray 
ionization as a compromise between the flow conditions of electrospray ionization and 
nanospray ionization (122). 
Ionization suppression by trifluoroacetic acid is most easily solved by replacing the 
trifluoroacetic acid in the HPLC buffer systems with acetic acid (122). This step is important 
to maximize the sensitivity of electrospray ionization because the ion-pairing activity of 
trifluoroacetic acid tends to disrupt the protonation reaction, which suppresses positive ion 
generation (122). Trifluoroacetic acid is a standard ion-pairing agent in reversed-phase 
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HPLC analysis of peptides (122). Although the choice of ion pairing agent can have dramatic 
effects of the quality of separation in complex mixtures, it is important to remember that 
good chromatographic separation of peptides can also be accomplished with acetic acid, and 
the high UV cut-off that makes its use impractical for typical HPLC analyses is irrelevant 
with mass (122).  
The problems associated with the changing proportions of solvent and water in the 
column effluent are minimized by post-column mixing of the column flow with a sheath 
liquid designed to optimize analyte signal generation and removed altogether when using 
nanospray, which does not use them (122). This so-called “sheath-flow” is provided coaxial 
to the column and is typically a mixture of methanol, water, and acetic acid (122). The 
function of the sheath liquid is to dampen any effect of the gradient on the characteristics of 
the spray (122). As a result, conditions in the ion source can be adjusted or tuned for optimum 
sensitivity, and that sensitivity is maintained throughout the elution gradient (122).  
SDS remnants from the electrophoresis run may also cause problems to the GeLC-
MS system (122). They can reduce the sensitivity of the experiment either by competing in 
some way for the ionization of peptides or by disrupting the spray/evaporation process. SDS 
in the polyacrylamide gel electrophoresis gives proteins an uniform negative charge which 
would then neutralize the positive charge given by ESI, making impossible for the peptides 
to move into the mass analyzer (122). SDS is also a surfactant and thus will affect the surface 
tension of the solvent droplets containing the peptides inside the ESI device, disrupting the 
spatial details of the evaporation process established in optimizing the tuning of the ion 
source (122). The net effect is that the presence of SDS in a sample dramatically reduces the 
sensitivity of the analysis (122). Fortunately, any trace of SDS or other ionic species that 
might otherwise interfere with the ionization are removed through the use of the reversed-
phase HPLC inlet (122). 
1.2.3.2.2 Mass Analyzer 
 
One of the analyzes that is usually coupled to the ESI or Nanospray ionization source 
used in GeLC-MS/MS experiments is a quadrupole-time-of-flight tandem mass analyser 
(122). It uses a quadrupole mass filter for the first mass analyzer and an orthogonal time-of-
flight mass analyzer for the second mass analyzer (122). The collision cell is a hexapole lens 
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system that contains and transmits all the ions within the selected m/z range (122). For 
peptide mass measurements, the first quadrupole is used in an rf-only mode to transmit all 
ions and the time-of-flight mass analyzer carries out the mass analysis (122). The key 
distinction in a quadrupole-time-of-flight instrument is that mass spectra and product ion 
spectra are both recorded by the time-of-flight mass analyzer with all of the advantages of 
time-of-flight analysis previously described in 1.2.2 (122). 
1.2.3.2.3 Data Interpretation 
 
The specificity and sensitivity of LC–MS/MS enable simultaneous analysis of 
multiple components from complex biological mixtures (124). LC is the first dimension of 
the analysis during which a complex biological extract is chromatographically separated into 
either individual or overlapping bands of compounds (124). In a LC–MS/ MS method, 
compounds elute off a LC column into a mass spectrometer which performs as a mass filter 
(124). The mass filtering provides high selectivity to differentiate among ions formed from 
different co-eluting analyses (124). 
The structural elucidation (amino acid sequence) is performed using data system 
software to compare the nominal masses of the product ions with the theoretical masses of 
ions from compounds in a mass spectral library (124), as reviewed in the MALDI- TOF/TOF 
proteomic analysis (section 1.2.2). Also, in order to identify proteins, bioinformatics tools 
such as ProteinScape (Bruker) using the MASCOT search engine, identifies proteins on the 
basis of peptide mass spectra (125). With MASCOT, peptide mass spectra from protein 
digests are analyzed, assigned a sequence, and protein databases are searched for the 
presence of the peptide sequences (125).The higher the scores of the peptide sequences 
identified in the candidate protein, the higher the confidence in the identification (125). The 
identified proteins can then annotated using gene ontology categories - either manually or 
using software such as Blast2GO (BioBam) or ProteinScape (Bruker) in order to better 
understand its biological significance. 
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1.3 Aims 
 
The objectives of this study are the characterization of the BMP of a highly virulent S. 
pseudintermedius strain isolated from a dog with severe pyoderma (5819/10), previously 
characterized by MLST as belonging to ST71, the highly spread European-clone (126). 
Biofilm was developed by culturing the S. pseudintermedius strain 5819/10 in specific 
media. The biofilm matrix was then separated from bacterial cells and evaluated for its 
protein content and complexity. Finally, the proteome was separated by 1D-electrophoresis 
and characterized by nanoLC-ESI-Q-TOF and analysed using bioinformatics tools.  
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2.Materials and Methods 
 
2.1 Workflow 
 
Biofilm from S. pseudintermedius strain 5819/10 was grown in TSB enriched with 
4% (w/v) of NaCl at 37ºC during 48 hours in a 6-well culture plate using a protocol adapted 
from the literature (127). Pieces of biofilm matter were taken for light microscopy inspection 
at several time-points of the growth process. After 48 hours of growth, the biofilm matrix 
was extracted using a version of a recently published extraction protocol (56), where the 
amounts of washing buffer and extraction buffer were optimized. The extraction was 
monitored at several time-points by light microscopy, for which a known staining protocol 
was first tested and then used (128). 
In order to choose the optimal extraction conditions, 5 biofilms grown in wells of a 
6-well culture plate, were washed with 330, 660 or 1000 µL of washing buffer and the 
biofilm matrix was extracted using 100 or 200 µL of extraction buffer- the procedure was 
monitored by LM. The extracted protein matrix from biofilm samples obtained after different 
extraction protocols were then run in an SDS-PAGE minigel and stained with Coomassie 
Brilliant Blue in order to access their profiles and thus select the extraction conditions.  
The more intense gel bands were excised, digested with trypsin, and identified using 
MALDI-TOF/TOF mass spectrometry analysis with the goal of doing a preliminary analisis 
of the biofilm matrix proteome The protein identification was performed using GPS 
Explorer™  software (Applied Biosystems) with MASCOT (version 2.2) search engine and 
the Uniprot/SwissProt database (release 2013_09) restricted to the Staphylococcus 
taxonomy group for protein identification and an initial assessment of the matrix protein 
extracts was made, to check the enrichment in extracellular proteins. 
For GeLC-MS/MS, biofilm from 6 inoculates was grown in petri dishes as well as in 
wells of 6-well culture plates, aiming to generate higher amounts of protein from biofilm 
samples, it was necessary to grow the.The quantities of extraction reagents were adjusted for 
the petri dishes (by a factor ± 6) taking into account the surface area of the vessels. This was 
essential for complete biofilm extraction.  
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After extraction, the total protein of  all replicates was quantified. The  replicates with 
the biggest protein quantity were selected for GeLC-MS/MS analysis- the biological 
replicates PD I1 100, PD I3 10 and PD I2 10, as well as the thecnical replicate PD I2 100. 
About 20 µg of protein from the selected samples were partially run in an SDS-PAGE 
minigel and stained with Coomassie Brilliant Blue. After that, each lane was cut in 4 bands 
and the 16 bands were destained, reduced and alkylated and then digested with trypsin.  
High Resolution LC-MS/MS analysis was performed for protein identification using 
Data Analysis 4.2 software (Bruker) to interpret LC-MS/MS and ProteinScape 3.1 (Bruker) 
using MASCOT search engine (version 2.2) and the Uniprot/SwissProt database (release 
2014_05) restricted to the Staphylococcus taxonomy group for protein identification. The 
protein identification data was subjected to protein-protein BLAST (BLASTp) search with 
BLAST2GO (B2GO) software (BioBam) in order to perform gene onthology (GO) 
annotation to the identified proteins and better characterize them. A general overview of the 
GOs from the proteome was performed before proteins related to biofilm formation; cell 
adhesion, host colonization and pathogenesis were singled out. A comparison between the 
obtained proteome and already published ones was also undertaken. 
Figure 6- GeLC-MS/MS protocol workflow for protein identification and annotation of S. pseudintermedius 5819/10 biofilm 
matrix proteome. Biofim matrix protein isolation procedures was optimized by changing the volumes of washing and extraction 
buffers used and comparing the 1D electrophoresis gel profile of each combination of buffers; a preliminary protein identification 
of BMP was performed with the optimization protein extracts using MALDI-TOF/TOF.  Biofilm formation and biofilm matrix 
proteins isolation steps were monitored by light microscopy during the optimization procedure 
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2.2 Detailed Description 
 
2.2.1 Preparation of biofilms 
 
Prior to inoculation and close to a flame, a small amount of stock culture from S. 
pseudintermedius strain 5819/10 was transferred to blood agar and incubated 24 h 
aerobically at 37ºC. Then, 5819/10 inoculates were prepared by transfer of 3-4 colonies into 
test tubes containing 5 ml of trypitic soy broth (TSB) – near a flame - and incubated 
aerobically overnight (ON) at 37ºC. The used strain was first isolated in the Laboratory of 
Antimicrobial and Biocide Resistance of  Faculty of Veterinary Medicine of Lisbon 
University from a severe case of dog pyoderma (126) and chosen for its virulence (129).The 
inoculates where then diluted 1:100 the  into TSB enriched with 4% (w/v) sodium chloride 
(NaCl) inside a plastic container, be it the wells of 6 well cell culture plate or 90-mm 
diameter sterilized dishes, again near a flame. The decision to grow biofilm in TSB enriched 
with NaCl instead of glucose was made based on previous but still unpublished biofilm 
growth studies with the straina . Finally, biofilm development occurred throughout 48 hours 
incubation at 37ºC under static conditions. In the biofilm growth optimization assay, pieces 
of the growing biofilm were taken after 7, 23, 31 and 48 hours of growth.  
For the GeLC-MS/MS assay in particular three inoculates were grown in TSB - as 
described- and then diluted 1:10 as well as 1:100 as described above. Biofilm from this 6 
diferent cultures were grown inside petri dishes and wells in 6-well culture plates. In the end, 
protein extracts. 
2.2.2 Biofilm Matrix Extraction Protocol 
 
This extraction protocol was adapted from a previous protocol (56). First, planktonic 
cells and the remaining growth medium were decanted and the biofilm matrix was inspected 
through Light Microscopy (LM), either directly or through a smear on a slide. Then, biofilms 
of S. pseudintermedius formed in the plastic containers were detached by mixing it with a 
washing buffer (WB) composed of 10 mM Tris-HCl (pH 8.0) and a protease inhibitor 
cocktail (Sigma-Aldrich). They were then mechanically peeled away from the adherent 
surface using a cell scrapper and  transferred into a test tube. 
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The yielded biofilm was vortexed and centrifuged at 5,000 x g for 10 min. Between 
the vortex and centrifugation steps, a piece of biofilm was taken for inspection through LM. 
The supernatant containing reminiscent growth medium and planktonic bacteria was 
transferred into a new test tube and placed in storage at -80ºC. On the other hand, to the 
pellet containing the biofilm matrix, a matrix extraction buffer (EB) composed of 10 mM 
Tris-HCl (pH 8.0), 1 M NaCl, and protease inhibitor cocktail (Sigma-Aldrich) was added. 
The mixture was then incubated at 25°C for 30 min with gentle rotation. Here, a new 
inspection by LM was taken. After the incubation, the mixture was centrifuged at 5,000 x g 
for 10 min and the supernatant (the biofilm matrix suspension) was transferred into a new 
test tube and its contents again inspected using LM. The supernatant comprising the biofilm 
matrix fraction was then stored at – 20º C, while the pellet containing the removed biofilm 
bacterial cells was stored at -80ºC. 
2.2.2.1 Light Microscopy Protocol 
 
The light microscopy inspection was only performed during the biofilm growth trial 
the biofilm matrix extraction trial. Biofilm formation was monitored in the former in order 
to confirm the presence of cell aggregates embedded in matrix of extracellular polymeric 
substances. During the extraction procedure, light microscopy was used to see the effect that 
both the washing and extraction buffers had on the biofilm matrix, in terms of removal of 
planktonic cells in the former and biofilm embedded cells in the latter and to evaluate the 
removal of planktonic cells during the entire extraction procedure. 
After selecting the optimal extraction conditions of biofilms grown in 6-well culture 
plate wells (as explained in section 3.1.1), buffer volumes were scaled up in order to apply 
the extraction protocol to biofilms grown on 90 mm petri dishes. The surface area of the 
culture plate wells and the petri dish were used as references for the scaling calculation, since 
bacteria adhesion and then biofilm growth is dependent on the surface area of the material 
(1, 130). The surface area of the petri dishes used was about 6 times the one from a well in 
6–well culture plate. Therefore, biofilms grown in petri dishes were washed with 4029 µL 
of WB and extracted 611 µL of EB.   
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The staining protocol was adapted from the literature (128, 131, 132). In it, it is stated 
that biofilm EPS (polysaccharides mostly) generally stains orange/pink with Congo Red 
solution, whilst Ziehl carbol fuchsin stains bacterial cells purple/red (132). 
Biofilm samples were smeared onto glass slides and were covered with 10 mM 
cetylpyridinium chloride. The slides were allowed to air dry for 20–30 min and then fixed 
by gentle heating by transient passage over a Bunsen burner flame and allowed to cool. After 
that, the slides were then stained for 15 min with a 2:1 mixture of saturated Congo Red 
solution and 10% (v/v) Tween 80, and rinsed in distilled H2O. Slides were then counter-
stained with Ziehl carbol fuchsin 10% (v/v) for 6 min, rinsed in distilled H2O and dried at 
37oC prior to visualization by light microscopy. After around 30 minutes, the slides were 
ready to be observed in a LM equipped with the Olympus D-10 digital camera. 
2.2.3 Protein Isolation from Biofilm Matrix extracts 
 
Proteins were precipitated using a protocol adapted from the literature (101). Proteins 
were isolated through precipitation, using 20% (w/v) trichloroacetic acid at 4ºC until 
achieving a final concentration of 10%. Following 30 min of incubation, the samples were 
centrifuged 16,000 x g for 30 min at 4ºC. The supernatant was discarded and the precipitates 
were washed twice with cold acetone and the pellet recovered after a centrifugation step at 
16,000 x g at 4ºC. The pellets were dried at room temperature and stored at -20ºC until 
further use. 
2.2.4 Protein quantitation 
 
Proteins pellets were first ressolubilized in the DIGE buffer (urea 7M, thiourea 2M, 
Triton X-100 2 % (v/v), Asb-14 0.5 % (m/m), DTT 50mM). Then they were quantified using 
the 2D QuantKit (GE Healthcare). 
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2.2.5 SDS-PAGE coupled with MALDI-TOF/TOF Mass Spectrometry for 
preliminary protein extracts evaluation 
 
2.2.5.1 SDS-PAGE 
 
Proteins were concentrated in a 5% (w/v) acrylamide 7-cm stacking gel and separated 
in a 12.5% (w/v) acrylamide resolving gel. To the protein samples previously solubilized 
with solubization buffer, 5% of 1DE sample buffer (62.5 mM Tris-HCl pH 6.8, 20% 
glycerol, 2% SDS, 5% β-mercaptoethanol e bromophenol blue powder) was added. The 
electrophoretic separation was performed at 50V for 15 min and then 150V for 1 h. 
PageRuler Unstained Protein Ladder (Thermo Scientific) molecular mass standard was run 
along with the samples. After the run, the gel was stained with Coomassie Brilliant Blue and 
photographed. 
 
2.2.5.2 Protein reduction and alkylation 
 
Gel bands of interest were excised and transferred to different tubes. Then 100 µL of 
acetonitrile (ACN) was added to each tube and incubated for 15 min. The ACN was 
removed, 50 µL of 10mM dithiothreitol (DTT) in 100 mM NH4HCO3 was added, followed 
by 45 min incubation at 56ºC, in order to reduce disulphide bridges. Next, the liquid was 
discarded and 50 µL of 55 mM iodoacetamide (IAA) in 100 mM NH4HCO3 was added. This 
was followed by 30 min incubation in the dark at room temperature in order to alkylate the 
previously reduced dissulphide bridges. 
2.2.5.3 In gel digestion of proteins 
 
The gel bands were dehydrated with 100 µL ACN for 15 min. This step was repeated 
until the gel bands were white and then the bands dried in a sample vacuum concentration 
system (SpeedVac) for about 10 min. The gel bands were rehydrated in a digestion buffer 
(6.7 µg/ml trypsin in 50 mM NH4HCO3) and incubated for 15 min at 4ºC. More digestion 
buffer was added when needed to completely cover the gel bands. Following an incubation 
period of 45 min at 4ºC, the remaining buffer was removed and 50 mM NH4HCO3 was added 
to cover the gel bands. The digestion step took 14h at 37ºC. Formic acid was added, up to a 
final concentration of 5%, in order to stop the reaction. Finally, after an incubation period of 
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15 min under agitation, the supernatants containing the peptide digests were transferred to 
new tubes and both bands and digested peptides were stored at -20ºC until further use.  
2.2.5.4 MALDI-TOF/TOF 
 
2.2.5.4.1 Sample preparation 
 
The tryptic peptides were acidified with 5% (v/v) formic acid, concentrated with 
POROS R2 microcolumns (GELoader tip, Eppendorf) and co-crystallised in MALDI-
TOF/TOF sample plates using the matrix α-cyano-4-hydroxycinnamic acid (Sigma).  
 
2.2.5.4.2 MALDI-TOF/TOF data acquisition and protein identification 
 
Tandem mass spectrometry was performed using a MALDI-TOF/TOF 4800 plus 
mass spectrometer (Applied Biosystems). The mass spectrometer was externally calibrated 
using des-Arg-Bradykinin (904.468 Da), angiotensin 1 (1296.685 Da), Glu-Fibrinopeptide 
B (1570.677 Da), ACTH (1-17) (2093.087 Da), and ACTH (18-39) (2465.199) (4700 
Calibration Mix, Applied Biosystems). Each reflector MS spectrum was collected in a result-
independent acquisition mode, typically using 1000 laser shots per spectra and a fixed laser 
intensity of 3500V. The fifteen strongest precursors were selected for MS/MS, the weakest 
precursors being fragmented first. MS/MS analyses were performed using CID (Collision 
Induced Dissociation) assisted with air, with collision energy of 1 kV and gas pressure of 1 
x 10 -6 torr. Two thousand laser shots were collected for each MS/MS spectrum using a fixed 
laser intensity of 4500V. 
Proteins were identified using GPS Explorer™  software (Applied Biosystems) with 
MASCOT (version 2.2) search engine and the Uniprot/SwissProt database (release 2013_09) 
restricted to the Staphylococcus taxonomy group. Searches were performed in the MS/MS 
ion search mode and the parameters were set as follows: minimum mass accuracy of 30 ppm 
for the parent ions, an error of 0.3 Da for the fragments, one missed cleavage in peptide 
masses, and Cys carbamidomethylation and Met oxidation as fixed and variable amino acid 
modifications, respectively. Peptides were only considered if the ion score indicated 
extensive homology (p<0.05). 
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2.2.6 GeLC-MS/MS for proteome characterization 
 
2.2.6.1 Gel Electrophoresis 
 
Four proteins was subjected to partial 1D-electrophoresis and protein digestion steps as in 
sections 2.2.6.1-3 but with some differences. The SDS-PAGE run was stopped at 2/3s of the 
run and each lane was cut in 4 bands. In-gel digestion trypsin digestion was performed at a 
5:1 ratio of protein: trypsin (w/w). After digestion, the supernatants were transferred to new 
tubes and then lyophilized and stored at -20oC in preparation to the LC-MS/MS analysis. 
 
2.2.6.2 LC-MS/MS 
 
The samples were analyzed on a Maxis Impact Q-TOF spectrometer (Bruker, 
Bremen), coupled to a nano-HPLC system (Proxeon, Denmark). The samples, dissolved in 
5% acetonitrile, 0.1% formic acid in water, were first concentrated on a 100 µm ID, 2cm 
Proxeon nanotrapping column and then loaded onto a 75 µm ID, 25 cm Acclaim PepMap 
nanoseparation column (Thermo). The chromatography was runned using a 0.1% formic 
acid - acetonitrile gradient (2-30% in 120 min for total lysates digests at a flow rate 300 
nL/min). The column was coupled to the mass spectrometer inlet through a Captive Spray 
(Bruker) ionization source. MS acquisition was set to cycles of MS (2Hz), followed by 3 
second cycles of MS/MS (4-16Hz, intensity depending) of a variable number of the most 
intense precursor ions, with an intensity threshold for fragmentation of 2000 counts, and 
using a dynamic exclusion time of 2 min, with an automated precursor re-selection when a 
3 fold increase in intensity was observed. All spectra were acquired on the range 150-2200 
Da. LC-MS/MS data was analyzed using the Data Analysis 4.2 software (Bruker).  
Proteins were identified using the Data Analysis 4.2 software (Bruker) to interpret 
LC-MS/MS and ProteinScape 3.1 (Bruker) using MASCOT search engine (version 2.2) and 
the Uniprot/SwissProt database (release 2014_05) restricted to the Staphyloccocus 
taxonomy group. MS/MS spectra were searched with a precursor mass tolerance of 10 ppm, 
fragment tolerance of 0.05 Da, trypsin specificity with a maximum of 2 missed cleavages, 
cysteine carbamidomethylation set as fixed modification and methionine oxidation as 
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variable modification. Significance threshold for the identifications was set to p<0.05, 
minimum MASCOT ions score of 20.  
 
2.2.6.3 Protein identification criteria, BLASTp searches and gene ontology annotation  
  
Protein identification reports were generated containing the information of all the 
matched peptides and proteins. Protein identifications were considered if the protein score 
indicates significant statistical confidence (p<0.05). Protein identifications with only one 
peptide with 95% confidence were done using two additional quality criteria:  sequence 
coverage of ≥ 10% and a deviation of predicted mass, RMS90 of ≤ 50 ppm. 
A BLASTp search was performed through BLAST2GO (BioBam) java application 
(http://www.blast2go.de). This enabled to perform GO annotation of the identified proteins 
by using GO categories of the best hit derived from the BLASTp results (BLASTp minimal 
Expectation value set to < 1x10-3).  
Non-caractherized proteins were excluded from further data treatment while the rest 
were characterized by their cellular component, molecular function and biological process 
GO terms. The annotated proteins were also compared to known biofilm cells and matrix 
homologous proteins from bacterial strains of E. coli, Pseudomonas auruginosa and S. 
aureus in order to highlight biofilm matrix related proteins and other virulent proteins. 
Known proteins associated to biofilm formation, cell adhesion, host colonization and 
pathogenesis were singled out. 
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3.Results and Discussion 
 
3.1 Biofilm Formation and Growth 
 
Biofilm formation and growth was monitored using light microscopy (figures 7-12). 
Samples of a biofilm grown in one plate of a 6-well culture plate were taken after 7, 23, 31 
and 48 hours after which they were fixed and stained using a protocol previously described 
(128, 131) but not previously used in Staphylococcus spp. The figures show that it provided 
enough contrast between cells, biofilm matrix nearly stripped of bacteria and denser biofilm 
matrix full of bacteria.  
After 7 hours of growth (fig. 7), it was possible to observe the formation of globular-like 
aggregates of EPS of diferent size and color in what appears to be different stages of 
development (fig. 7-A). Some of them even have an interior darker than others, which are 
only formed by a brighter matrix substances. The bright tissue might be the beginning of 
what is called the loosely-bound EPS (LS-EPS), which is a type of biofilm matrix gluing 
clusters to form microcolonies and flocs (133). The dark tissue on the other hand might be 
the tightly-bound EPS (TB-EPS), which is found on the cell wall, which links cells  together 
in clusters, and are generally cell wall associated proteins (133). Also observed, are 
membrane-like tissues composed of the darker material surrounding a sea of the lighter 
material with embedded bacteria, which fits the description of a biofilm matrix (fig 7-B). 
The growing biofilm does not appear to be formed homogeneously. Not only matrix-like 
structures and globules so thick that resemble a fully-formed biofilm (figure 7-A) are 
observed, bacteria surrounded by a thin coating of EPS (in fig 7-C) and circular structures 
interconnected by a matrix (fig. 7-D) are also present after 7 hours of growth. The EPS 
connected circular structures may point towards a biofilm that is first formed in small patches 
and then form the connecting tissue between themselves and finally, to close the net they 
produce a polymer rich structure so that appears to be a differentiated type of biofilm matrix. 
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On the other hand, the differences observed could be related to biofilm formation through 
different means: PIA-dependent or -independent and eDNA-dependent biofilm formation. 
However, the data presented cannot prove this hypothesis and no proteomic analyses was 
performed at this stage. The clearest evidence these micrographs provide is that first, the 
staining protocol provides the distinction between cells and different types of EPS and 
second, that biofilm growth and maturation is not uniform. 
 
 
 
 
After 23 hours the biofilm seems generally denser, though different stages of 
development are still observed (fig. 8). Notably it became apparent the development of 
canals throughout the denser structures (fig 8-C and D) and the opening of pockets in both 
types of EPS (fig 8-B and D). 
Figure 7- Different stages of biofilm formation after 7 hours of growth. In A there’s a circular structures 
composed of dark matrix surrounded by light matrix. In B, small cocci are embedded in semi-transparent 
light purple matrix. C shows a section of darker but still light purple matrix that separates the interior of 
the matrix from the exterior and is full of embedded cocci. D, on the other hand, shows the interior of a 
section of matrix where large round structures of slightly darker purple matrix are interconnected by 
bridges in the same color and a thinner matrix.  
 
Figure 6- Stages of biofilm formation after 7 hours of growth 
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The darker matrix seems to be a very differentiated and dense structure (figs 9-C and and 
9-A, respectively). Congo red stains polysaccharides reddish and carbol fuchsin, the bacteria 
blue/pink (128, 131). Both of these hues are prevalent here, but some globules, canals, and 
pockets are clearly visible still (figs 9-B and 9-D). There also seems to be bacteria traveling 
through the channels in fig 8-A, though one has to keep in mind that LM provides 2D images 
and does not guarantee that both channels and bacteria are in the same plane or just 
superimposed. 
 
 
 
 
Figure 8- Stages of biofilm formation after 23 hours of growth. A shows a portion of dense biofilm matrix surrounded by 
thinner matrix. B highlights the thickening of lighter-colored biofilm matrix as the biofilms developed while C shows that 
denser biofilm matrix had already developed as well as internal channel. D shows a frontier region between region 
between different types of EPS where the thinner matrix merges with the denser one. The thinner part of the matrix seems 
to become darker and thicker as it gets closer to the denser part possibly indicating an area of intermediate matrix density.  
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After 31 hours of growth, there was evidence of a more mature and differentiated 
biofilm (Fig 10-B), but also one very fragmented (fig 10-A,10-D 11-B and C for ex.). It was 
possible to observe bacteria glued by a purple matrix (fig 11-B and C). In other micrographs 
(fig 10-A and D) a lack of a lot matrix is observed as if the biofilm was ripped apart. It was 
not expected, but it might just show that the biofilm matrix sample observed in these pictures 
did not possess a highly mature biofilm or simply the biofilm was not sufficiently fixed 
during the staining procedure and washed away when rinsing the slides between changing 
dyes.  
 
 
 
 
 
 
Figure 9- Closer look at darker biofilm matrix formed after 23 hours of growth. A highlights a channel within a 
very dark purple portion of matrix with what appears to be cocci aggregates traveling through it. B shows a 
slightly pinkish matrix containing some pockets and darker globules while C shows a different part of same 
section of the matrix where channels coming from said part of the matrix. D highlights the existence of channels 
and pockets throughout this denser part of the matrix. 
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In the last stage of the growth period (fig 12), the biofilm matrix looked like a mixture 
of the one pictured after 27 and 31 hours (figures 8-11), but with some differences. There 
was a bluish biofilm matrix (fig 12-A, B and C) as well as a thick purplish biofilm matrix 
full of channels (fig 12-E). This highlighted the existence of both polysaccharide rich matrix 
and bacteria rich biofilm matrix. Figures 12-B and C shows large aggregates of cocci on a 
Figure 11- Closer look 31 hours old biofilm. A shows an evolution of the previous stage while B and C highlights a less darker and 
presumably mature biofilm. The arrows in B and C point towards the matrix that surrounds and supports the bacteria. 
Figure 10- Biofilm after 31 hours of growth. A very fragment biofilm with small pieces 
close to a very fragment bulk is observed (A). In stark contrast, an integral matrix where 
dense section of matrix are interconnected by a large thinner section (B) is also present. 
Around the globule in B there’s also a hallow of intermediate density matrix similar to 
the matrix in fig.7-D. C shows a piece of thinner matrix embedding a small amount of 
bacteria while D shows mostly cocci aggregates neighboring a near existent matrix.  
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matrix support and in figures 11-A and C it was possible to see blue cocci aggregates and 
light purple matrix with or without bacteria directly connected to a dark purple biofilm 
containing a large amount of bacteria embedded in EPS. This evidence were in agreement 
with scanning electron microscopy studies on S. pseudintermedius biofilms that have shown 
that the biofilm matrix consists in bacteria embedded in EPS with large aggregates of cocci 
on the surface (34).  
 
 
 
 
 
 
 
 
 
 
 
3.1.1 Biofilm extraction: protocol development and optimization 
 
The monitoring of the extraction procedure was done immediately following the 
biofilm formation and growth experiment, using the remaining 5 biofilms cultivated 
alongside the one sampled for the growth monitoring. Five different conditions (table 2) 
were experimented based on the data provided by the literature protocol: three different 
volumes of washing buffer (WB) were tested and coupled with two different volumes of 
extraction buffer (EB). 
 
 
Figure 12- Biofilm before extraction (after 48 hours of growth). Different types of matrix are present. A shows a matrix 
consisting of denser matrix attached to thinner one in which some cocci are embedded. In B, embedded in light purple 
matrix there’s a large amount of cocci which are further highlighted in C. D is a close up. D shows in more detail an 
area of the same matrix depicted in A where the dark matrix merges with the lighter one and where cocci aggregates 
are present. E shows a purplish matrix full of channels and bacteria. 
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Table 2- Volumes of washing and extraction buffer used for protocol development 
Sample 
Code 
Volume (µL) 
Washing buffer 
(10 mM Tris-HCl (pH 8.0) & protease inhibitor 
cocktail) 
Extraction buffer 
(10 mM Tris-HCl (pH 8.0), 1 M NaCl & protease 
inhibitor cocktail) 
E32 330 200 
E61 660 100 
E11 1000 100 
E12 1000 200 
 
 In order to find the most appropriate extraction procedure, the extraction was 
monitored by light microscopy and by 1DE coupled with MALDI-TOF/TOF. The protein 
extracts were solubilized in 1DE sample buffer and 20 µL of dissolved samples were loaded 
into a SDS-PAGE mini-gel. Along with most samples from the biofilm matrix extraction 
assay, a sample obtained using another extraction run using j the most extreme version of 
the extraction protocol (the same as sample E12)) was loaded into the gel (sample TBM 2nd 
Exp).  
 On the gel profile is shown in figure 13, nine bands with similar profiles were 
detected on most of the lanes. This indicates that the different extraction procedures did not 
induce differences on the bulk of the protein extracted. Differences in protein band density 
were observed between lanes and they do not follow a pattern that clearly established a 
proportion between band densities with the amount of extraction buffer added. Most glaring, 
the bands in sample E12 were denser than E11, but this sample has bands more intense than 
TBM 2º E, which is a sample extracted the same way as E12. The differences in band density 
were mostly attributed to the different amount of protein in the loaded samples, since at this 
stage the samples were not quantified. Yet, the extraction procedure using 660 µL of WB 
and 100 µL of EB, provided the gel profile with the denser bands. Attending that the same 
volume of protein extract was loaded in each well, it can be assumed that sample E61 had 
the higher protein concentration. Having also provided a similar gel profile as the rest, this 
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extraction procedure was then selected for the remaining extractions and basis for the biofilm 
production scaling-up by 6 fold from the 6-well culture plate to the 90-mm petri dishes. 
  
 The extraction procedure was monitored by light microscopy at 3 time points (fig 
14):  
1. After the addition of the washing buffer followed by quick vortexing; 
2. After the addition of extraction buffer followed by 30 minutes of incubation under 
mild agitation; 
3. After the extraction: sampling of the resulting suspension. 
 
Figure 13- 12% polyacrylamide SDS PAGE gel profile of some of the samples extracted. Samples are the same as 
described in the table 2 with the addition of the TBM 2º Exp that is similar to the E12 sample, but was extracted 
separately The protein marker is the PageRuler Unstained Protein Ladder from Thermo Scientific. 4 proteins were 
identified and their position along the gel is shown based on their MW- more information is presented on table 3 in the 
next section.  
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The addition of washing buffer (figs. 14-1A and 14-1B) removed the majority of 
planktonic coccus when compared to pre-extraction biofilm shown in figures 13A. There 
was still big and opaque/dense dark purple circular structures and inside the “membranes” 
of the biofilm, a wide open space. This showed that the washing buffer actually removed a 
large amount of biofilm matter by itself. However looks can be deceiving because in later 
extraction stages (figs 14-2B and 14-3A), they were present as well as in every test condition 
monitored (including the presented one but in too blurred images). Interesting, the hollow 
space of figures 14-1A and 14-1B was filled with filaments of biofilm matter that demark 
what appeared to be sheets of biofilm matter and some coccus aggregates. The retention of 
this material could be evidence that the biofilm was not homogenous and that some parts 
were denser or more resistant than others.   
The addition of the extraction buffer did not change the appearance of the biofilm too 
much. Comparing figures 14-1A and 14-1B with 14-2A, there was still an outer biofilm 
membrane with a dense aggregate and coccus. The major difference was the larger amount 
of coccus in the latter image. This could be either the result of a release of bacteria from 
large cocci aggregates inside the matrix or from denser biofilm material. There was also a 
smoothing of the biofilm “membranes” which could offer support to the latter hypothesis.  
Neither washing nor extraction buffers destroyed the complex biofilm structure with all 
its different densities in biofilm matrix and channels within as well as cocci aggregates 
(figure 14-2B). However, after centrifugation the state of the biofilm became different. At 
the end of the extraction procedure, there was still both denser and lighter types of biofilm 
matrix (together or not) and a few cocci (figs. 14-3A and 14-3B). Figure 14-3A shows a 
biofilm with more holes, less denser material and no visible cocci compared to figure 14-
2B. On the other hand, figure 14-3B shows a biofilm similar to 14-2A but much hollower 
and fragmented, though still some cocci are observed. It seems as if the extraction buffer 
loosened the biofilm matrix and centrifugation removed the loosened material. Supporting 
this hypothesis, a S. aureus biofilm subjected to a similar treatment lost its surface-adherent 
materials and the internal structure of the biofilm was exposed (56).  
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Figure 14- Light microscopy monitoring of the extraction procedures. Images 1A and 1B shows the state of the 
biofilm after addition of washing buffer. The matrix is mainly clean of cocci aggregates both inside and outside 
the matrix, while denser parts of matrix are visible. 2A and 2B shows the state of the matrix after the addition 
of the extraction buffer. In 2A a cleaner version of 1A and 1B is present where the border the matrix and its 
inner structures are thinner while a dark globule was not removed. 2B confirms shows that denser sections of 
biofilm matrix still remain after washing and addition of extraction buffer. Persistent. However, after been 
shaken and centrifuged, the matrix was ripped apart with large holes forming in denser matrix (3A) as well as 
in the lighter matrix (3B). In the latter, a darker section of matrix similar to a peninsula looks like a globule 
similar to the one in 1A that was shredded to pieces. 
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3.1.2 Protein Identification 
 
To evaluate the optimized matrix and protein extraction protocols, the more intense 
1DE gel bands of the total protein extracts were submitted for protein identification using 
MALDI-TOF/TOF data. The more intense gel bands from samples E61 and E12 were 
excised, digested with trypsin and analyzed by MALDI-TOF/TOF. The combined 
(MS+MS/MS) data obtained were then matched with the Uniprot/SwissProt database 
(release 2013_09) restricted to the Staphylococcus taxonomy group the S. pseudintermedius 
protein database through MASCOT (version 2.2) on the GPS Explorer™ (Applied 
Biosystems) software. 
Four staphylococcal proteins were identified with 3 of them being extracellular ones. 
The main evidences obtained from this preliminary study are that most proteins have a rather 
small molecular mass and are similar to those found in both S. aureus and S. epidermidis 
studies, notably Atl and Eap. The former is usually a CW-protein, but it can be found on the 
biofilm matrix. As for the latter, it obtained the biggest protein score here and was also one 
of the most expressed proteins in a S. aureus study in which a similar extraction protocol 
was used. 
The preliminary protein identification assays by MALDI-TOF/TOF were used to 
check if the main protein bands belonged to biofilm matrix proteins. For the proteome 
characterization the proteomic procedure was changed to GeLC-MS/MS. and due to the high 
complexity of protein extracts and to remove any contaminant that co-precipated with the 
proteic matter when the biofilm matrix extracts were previously subjected to trichloroacetic 
acid precipitation. This method allowed an initial fractionation of the protein extracts and 
the removal of impurities in the first-dimension PAGE run, while high resolution liquid 
chromatography provided a powerful separation and high confidence in protein 
identification. 
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Table 3- Proteomic Data retrieved from the MALDI-TOF/TOF analysis followed by comparison with Uniprot/SwissProt 
database (release 2013_09) restricted to the bacteria taxonomy group 
Protein 
Name 
Accession 
Number|E
ntry Name 
Gene 
Location 
in figure 
12 
(number) 
Protein MW 
(kDa) 
Prote
in 
Scor
e 
Tot
al 
Ion 
Sco
re 
Pep. 
Cou
nt 
Intens
ity 
Match
ed 
Location 
Relevant 
Functions 
Bifunctio
nal 
autolysin 
Atl 
E8SEU0|
E8SEU0_ 
STAPH 
SPSINT_
0746 
1 150.67 107 107 2 7,019 
cell wall 
protein 
involved 
in 
peptidogl
ycan 
catabolic 
process 
N-
acetylmuramoyl
-L-alanine 
amidase activity 
Elongatio
n factor 
Tu 
E8SJ27|E
8SJ27_ST
APH 
tuf 3 43.19 232 221 4 
11,01
1 
cytoplasm 
 
Promotion of 
the GTP-
dependent 
binding of 
aminoacyl-
tRNA to the A-
site of 
ribosomes 
during protein 
biosynthesis 
Enolase 
E8SKF4|E
8SKF4_ 
STAPH 
eno 2 47.00 432 404 7 
15,15
6 
 
 
Cytoplas
m, Cell 
surface, 
and cell 
exterior 
(is a 
secreted 
protein) 
Catalysis of 
reversible 
conversion of 2-
phosphoglycerat
e into 
phosphoenolpyr
uvate. Essential 
for the 
degradation of 
carbohydrates 
via glycolysis 
Extracell
ular 
adherenc
e protein 
of broad 
specificit
y 
Eap/Map 
E8SIY6|E
8SIY6_S 
TAPH 
SPSINT_
1487 
4 27.42 1050 966 17 
38,96
4 
 
Extracellu
lar region 
Pathogenesis 
  
3.2 Proteomic Analysis by GeLC-MS/MS 
 
3.2.1 Protein Quantitation 
 
For this analysis, biofilms of six inoculates (biological replicates) were grown in petri 
dishes as well as in a 6-plate culture plate. The buffers’ quantities used in the scale-up 
extraction protocol in the petri dishes were proportional to the surface area (for bacteria 
adhesion) of plates of culture plate (about 6 times more). All the samples were quantified 
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using 2D-Quantkit followed by a 1D SDS-PAGE of 5 µg of total protein to visually confirm 
the quantification and estimate a concentration to use in the proteomic assay (5.1 Annex).  
Four biological replicates with similar gel profiles and a protein concentration 
(around 2 µg/µL) were selected for the proteomic assay. About 20 µg of each were loaded 
into a SDS-PAGE gel, and the electrophoresis was interrupted when the fringe beacon 
reached 2/3 of the cassette. After that, the gels were stained with Coomassie Blue and then 
destained, the gel profile was analyzed and it was decided to cut each lane into four bands 
and digest them with trypsin. The supernatant was removed, dried and stored at -20ºC until 
performing the LC-MS/MS assays. 
 
Figure 15- Schematics of the way gel bands were cut in minigel used in the first stage of GeLC-MS/MS. The dark lines 
indicate the cutting positions of the several gel bands used for tryptic digestion before the GeLC-MS/MS assays.The sample 
codes refers to the actual biofilm samples. PD refers to the plastic 90 mm petri dishes, the support material where the 
biofilms were grown. The “Is” refers to the different inoculates and the “10s and 100s” are references to the dilution 
factors of the inoculates prior to biofilm grown: 1:10 and 1:100 respectively. 
3.2.2 Biofilm Matrix Proteome 
 
3.2.2.1 Gene Ontology Overview 
 
A total of 746 unique proteins were identified from the LC-MS/MS analysis (Section 
5.2, Annex) when the results from all replicates were combined. Proteins where then mapped 
and annotated with Blast2GO (BioBam). Of these, 655 proteins had GO terms assigned to 
them, with 584 being directly identified proteins from the database, while 71 were identified 
from homology. The identified and annotated proteins were then compared with BMPs from 
E. coli MG1655, P. aeruginosa and S. aureus MR23 (56, 95, 134). Additionally the 
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published cellular proteomes of S. aureus COL and N315 were also included in the 
comparison (135). From the 655 identified and annotated proteins, 126 homologous proteins 
were found in the published strains (table 5), with 24 proteins being previously described in 
the biofilm cells of S. aureus COL and N315. Percentage wise, most proteins had homologs 
in the E. coli matrix proteome while in absolute terms, with the three S. aureus strains matrix 
and cellular proteomes.   
Several S. pseudintermedius proteins had homologs with P. aeruginosa PAO1 but 
percentage wise they were relatively few. These differences can be explained when one takes 
into account that most of P. aeruginosa biofilm matrix proteins were found on outer 
membrane vesicles present in the biofilm matrix (134). The proteins found within them were 
significantly different from the ones of P. aeruginosa planktonic outer membrane vesicles 
(134), which points to specialization of the P. aeruginosa biofilm. However, these structures 
are yet to be described in the S. pseudintermedius biofilms and are not likely to, since they 
are only produced by Gram-negative bacteria (136).   
Table 4- Numerical summary of LC-MS-MS analysis 
Type of identification nº of proteins 
Directly identified Proteins with GOs 584 
Blasted Proteins with GOs 71 
Total identified and annotated Proteins 655 
Total Proteins without GOs 91 
Total Proteins 746 
 
Table 5- Comparion between the number of proteins found o S. pseudintermedius 58910 and other bacterial strains 
Bacteria 
Nº of identified 
proteins 
Nº of homologous 
proteins 
% homologous 
proteins 
P. aeruginosa PAO1 178 26 14,6 
E.coli MG1655 40 32 80,0 
S. aureus 
(COL, MR23 & 
N315) 
130 68 52,3 
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Blast2Go (BioBam) allowed the attribution of cellular components, molecular and 
biological functions to the identified proteins using their GOs. A threshold of 10 protein 
sequences allocated to the same GO term were selected for further analysis. (about 1,5 % of 
proteins with GOs coverage). Also, it is important to know that not every annotated protein 
has a GO for each class but some have more than one GO for each class. This meant that the 
number of GOs in each graphic do not correspond to the number of annotated proteins (655). 
Following the established criteria and regarding the cellular component attributed to 
each protein sequence, the data shows that 242 assignments were done, of which 63% could 
be related to either the extracellular region or the plasma membrane, such as protein 
complexes (fig. 16). On the other hand, cell-wall associated proteins did not make the 
selected sequence coverage cut-off and so, do not appear in the GO pie-chart (fig 16). Also, 
a relevant number of proteins were attributed to ribosomes and a few to cytosol, which was 
also observed in the BMPs of E. coli, P. aeruginosa and S. aureus (56, 95, 134). For instance, 
ribosomal proteins associated with metabolic processes were found on the upper layers of 
the P. aeruginosa biofilms (137).  
 
The annotated proteins had GOs terms for molecular functions mainly related to 
binding and enzymatic activity (fig 17). Less prominent functions identified were structural 
Figure 16- Cellular Component GOs attributed to 10 or more annotated proteins. 
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molecule (of the ribosome) activity and transmembrane transporter activity. Protein binding 
transcription factor and enzyme regulator activities were also identified but were less 
common. The highest number of annotated proteins were ion binding proteins, while nucleic 
acid binding (DNA and rRNA) proteins were less prominent.  
As for enzymatic activity GO terms, proteins with oxidoreductase activity were the 
more common ones followed by transferases, hydrolases, ligases, lyases and isomerases. The 
annotated hydrolases identified had either ATPase, GTPase, nuclease or carbon-nitrogen 
(peptide bonds and others) hydrolase activities. On the other hand, the anotated transferases 
were involved in the transport of acyl, methyl, glycosyl and phosphorous-containing groups 
(kinases and nucleotidyltransferases).  
Most annotated proteins had cell related GOs biological processes such as the cell 
cycle, cellular division, cell morphogenesis, stress response, cellular component 
organization and biogenesis (including the cell wall), transmembrane transport, but most 
notoriously, the cellular metabolic processes, with cellular aminoacid metabolic processes 
being the most abundant GO (fig 18). Another significant metabolic processes identified 
were related to protein synthesis, such as ribosome biogenesis and gene translation. Other 
than this, carbohydrate, lipid and nucleic acid metabolic processes (both DNA and tRNA) 
also made the threshold.  
All of these functions are essential to cell survival and to be expected on a bacterial 
cell proteome. Although most of these activities are well known intracellular activities, it is 
not possible to exclude their extracellular presence and their involvement in biofilm 
Figure 17- Molecular function GOs attributed to 10 or more annotated proteins. 
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production and maintenance. Indeed, most cellular component GOs are for proteins that are 
part of protein complexes, but the location of this complexes is not specified. Even if most 
proteins were of intracellular origin, with the current data it would not be possible to 
ascertain whether they were normally secreted by biofilm-embedded bacteria or the by-
product of cell lysis, either as a regular biofilm function or the result of experimental 
handling-but that was not the objective of this study.  
 
3.2.2.2 Biofilm-associated proteins: Regulators and Virulence Factors 
 
Planktonic S. aureus strains express both sarA and sigB genes in order to inhibit 
protease and thermonuclease production that could hinder biofilm production (44-46). 
Additionally sigB stimulates the production of adhesins for the initial covalent attachment 
of bacteria to a host matrix proteins (48). In the S. pseudintermedius 5819/10 biofilm matrix, 
the presence of the SarA protein was confirmed together with the membrane protein SaeR 
(fig. 19 and table 6). In S. aureus, response regulators SaeR and SaeS act synergistically with 
SarA to repress extracellular protease production that would otherwise limit accumulation 
of critical proteins (such as adhesins) that contribute to biofilm formation (138). Sae is 
required for the induced expression of the important virulence factors IsdA and IsdB in low 
iron conditions (139). Although these factors were not detected, Clp protease required for 
isdB gene transcription (140) was identified.  
Figure 18- Biological processes GOs attributed to 10 or more annotated proteins. 
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Furthermore, SaeR/SaeS activates the expression of exoproteins involved in adhesion 
and invasion of mammalian host cells, including coagulase, Spa, hemolysins (Hla and Hlb), 
DNase, and cell wall-associated proteins (Emp, Eap/Map, FnbA) (141-145) as well as the 
Iron-regulated surface determinant proteins A and B under low iron conditions (139) in order 
to obtain iron from hemoglobin and other iron-rich host proteins from mammalian host cells 
(146). Of all of these proteins, only Eap and β-hemolysin (Hlb) were present on the S. 
pseudintermedius 5819/10 biofilm matrix.  
SarA and SaeR were not the only DNA-binding proteins responsible for the 
expression of virulence factors found among the biofilm matrix proteins. The HTH-type 
transcriptional regulator MgrA, the transcriptional regulatory protein SrrA and the response 
regulator VraR were also present. In S. aureus MgrA, is a repressor of alpha-toxin, 
coagulase, protease, and protein A as well as an activator of capsular polyssacharide 8 (CP8) 
and thermonuclease (147). CP8 enhances the antiphagocytic activity of S. aureus (148) while 
thermonuclease is involved in biofilm seeding dispersal (53). The latter was indeed present 
on the S. pseudintermedius 5819/10 biofilm matrix, even with concurrent SarA activity, 
while the other repressed proteins were not.  
SrrA is part of the two-component regulatory system SrrA/SrrB (149), which is 
involved in the global regulation of staphylococcal virulence factors in response to 
environmental oxygen levels (59). SrrAB induces icaADBC gene transcription and 
polysaccharide intercellular adhesin expression, protecting S. aureus from neutrophil killing 
under anaerobic growth condition (59). SrrA in itself binds to the Agr, Spa and Toxic shock 
toxin promoters repressing their transcription under anaerobic conditions but also promotes 
it under aerobic conditions (149, 150).  
 VraR, or vancomycin resistance associated regulator is part of the two-component 
system VraSR, that positively modulates the regulation of cell-wall biosynthesis pathway 
(in S. aureus) (151). Part of the genes regulated by VraSR system are associated with cell-
wall biosynthesis, such as PBP2, SgtB and MurZ (152). The sensor kinase VraS has been 
shown to respond to the damage of cell-wall structure or inhibition of cell-wall biosynthesis 
by the antimicrobials bacitracin, fosfomycin, teicoplanin, vancomycin and β-lactams, 
leading to overexpression of VraR and reducing the susceptibility to the said antimicrobials, 
inhibitors of cell-wall synthesis (151, 152).  
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RNA polymerase sigma factor SigB was not present in the S. pseudintermedius 
5819/10 biofilm matrix, nor adherence factors known to be associated with it: clumping 
factor, fibronectin binding protein A (FnBPA) and coagulase (44, 45). Such proteins bind to 
human platelets (153) and a serine-rich adhesin for platelets that mediate direct binding to 
human platelets by S. aureus (153) was also present on the S. pseudintermedius 5819/10 
biofilm matrix. This protein, Serine-rich adhesin for platelets,  has been shown to mediate 
the direct binding of S. aureus to human platelets leading to endovascular infection (154). 
Eap/Map as well as an autolysin (Atl) were identified. In S. aureus MR23 biofilm 
matrix, Eap/Map was the most abundant protein and was responsible for cell-to-cell 
aggregation between the bacteria (56). Finding this protein was expected since, both SaeR 
and a transcriptional regulator from the Fur family were detected. Fur, together with SaeRS 
are also required for full induction of the oxidative stress response - which is necessary for 
intracellular survival in neutrophils- and expression of non-covalently bound surface 
proteins (such as Eap/Map and Emp) in low-iron growth conditions (139).  
Figure 19- - Proteins involved in the biofilm life cycle present in the S. pseudintermdius 5819/10 biofilm matrix. In bold 
are proteins that were present in S.pseudintermedius 5819/10 biofilm matrix and in underlined bold are key stages of 
the biofilm life cycle. Ponty arrows (bar the vertical thin ones close to “O2” and “cell density” describes the expression 
of proteins or genes or the ocurrence of an event. T-headed arrows describes the inhibiton of protein or gene 
expression, the stopaged of cell lysis by Irg gene products as well as zinc-binding by EpbS which prevents SasG-
dependent biofilm formation.Two way arrows linked to another describe an action that two proteins execute together; 
SarA and SaeR also work together to repress extracellular protease production. 
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Regarding the autolysin, the one identified by LC-MS/MS belongs to a different 
strain of S. pseudintermedius but has a 99% similarity to the one from the preliminary assay.  
In S. aureus, this autolysin is a secreted protein required for both FnBP- and PIA-mediated 
biofilm development on hydrophobic polystyrene and to the attachment to hydrophilic 
polystyrene (65). Since S. pseudintermedius biofilms were grown in polysterene dishes in 
this experiment, its presence was not unexpected.  
Another adhesin associated with biofilm formation found was Elastin binding protein 
EbpS. It is a weak adhesin though, as inactivation of ebpS has a minimal effect on the binding 
of S. aureus to elastin peptides, which in fact is mediated by fibronectin-binding proteins 
(155). More relevant is its role in the regulation of biofilm formation mechanisms that are 
zinc concentration dependent (156). In its absence, the addition of Zinc2+ ions increases 
biofilm formation in S. aureus (156). Zinc ions are essential for the dimerization of the cell-
wall-anchored protein SasG leading to cell-to-cell adhesion (157). It binds to Zinc2+ ions, 
undergoing conformational changes that leads to the formation of aggregates (157). By 
binding to Zinc2+, Ebps regulates the transfer of zinc ions to SasG through competitive 
binding and thus, also regulates zinc-dependent biofilm formation (156). A homolog of SasG 
was not found in the S. pseudintermedius 5819/10 biofilm matrix though, so there was not 
enough evidence to support the theory that EpbS regulates Zinc-dependent biofilm formation 
on this strain.  
After adhering to a surface, bacteria start forming EPS either producing 
polysaccharide intercellular adhesin, teichoic acids, releasing DNA or adhesins. Cell-wall 
associated adhesins might even work in conjuction with the polyssacarides or DNA, by 
binding the cells to them such as the autolysin AtlAEfm of Enterococcus faecium (158). 
Adhesins can also bind cells together directly such as the above SasG and Eap. Autolysins 
also have a role in cell lysis and consequent DNA release (158). In S. epidermidis, evidence 
shows that AtlE mediates cell lysis and thus contributes to biofilm formation (73). However, 
there was no evidence that the autolysin found on S. pseudintermedius 5819/10 biofilm 
matrix nor its S. aureus homolog played a role in eDNA-dependent biofilm formation 
through cell lysis. The only known protein found to be involved with it, was the 
thermonuclease mentioned above.  
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Moreover, despite the presence of SrrA, none of the Ica proteins responsible for PIA 
synthesis were identified. Indeed, the only proteins associated with PIA synthesis were 
repressors: the HTH-type transcriptional regulator TcaR and the Regulatory protein Spx that 
promotes the expression of icaR gene and thus the IcaR protein that represses PIA synthesis 
when binding to the icaADBC gene cluster (60). Regarding teichoic acid synthesis, only a 
glycerol phosphate lipoteichoic acid synthase was identified. This protein synthetizes 
membrane theicoic acids and thus has a role in  bacterial growth and cell division (159) but 
no evidence supporting a role in biofilm formation was found yet. 
Another regulator that is noted for its absence is the accessory gene regulator (agr) 
protein Agr. Agr expression induces the production of nucleases, membrane and cell-wall 
degrading surfactant-like peptides and proteases that degrade the biofilm matrix and promote 
seeding dispersion of bacteria (52). Looking at the presented evidence, that was not a 
surprise. The only protein that could be up-regulated by Agr is thermonuclease. The other 
proteins identified were associated with biofilm formation and not with bacterial dispersion. 
SarA, in particular, inhibits the synthesis of said biofilm-associated bacteria dispersion 
proteins (52).  
Finally, as mentioned in section 1.1.3, transient up-regulation of sarA and agr genes, 
leads to the production of several immunoavoidance factors and toxins that cause damage to 
the host organism (52). Though so far associated with those genes, some proteins of this type 
were indeed found on the S. pseudintermedius biofilm matrix. The most infamous protein 
was the S.pseudintermedius exfoliative toxin coded by the siet gene as it has been already 
associated with canine pyoderma (98). Another one found was the synergohymenotropic 
toxin, which is coded by the luk-I family of genes. Luk-I, which is very similar to Panton–
Valentine leucocidin (PVL) from S. aureus, shows strong leucotoxicity towards various 
polymorphonuclear cells.  
Although immunoglobulin binding protein A (SpA) was not identified, 
Immunoglobulin-binding protein Sbi was detected. By binding to IgG-and inactivating it, it 
allows the bacteria to evade the hosts’ immune system (56). There were not tissue damaging 
proteases apart from Clp in S. pseudintermedius biofilm matrix, but a potentially important 
protease was present: Do-like Serine protease, DegP/HtrA. Its Streptococcus pyogenes 
homolog is involved in the folding and maturation of secreted proteins, as well as in the 
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degradation of proteins that misfold during secretion (160). Like S. pseudintermedius, 
Streptococcus pyogenes is a Gram-positive bacteria and the presence of this protease here, 
supports the theory that it plays an important role in the biogenesis of secreted proteins in 
Gram-positive bacteria.
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Table 6-Biofilm-associated proteins present on S. pseudintermedius 5819/10 biofilm matrix proteome 
Accession Number Protein Name Gene Name 
Gene Ontology 
Componen
t 
Function Process 
tr|E8SKE3|E8SKE3_STA
PH 
ATP-dependent Clp protease proteolytic subunit clpP cytoplasm 
hydrolase activity; 
peptidase activity; 
serine-type 
endopeptidase 
activity; serine-type 
peptidase activity 
 
 
proteolysis 
tr|F0P7U5|F0P7U5_STA
PE 
Autolysin spsC - 
amidase activity; 
hydrolase activity; 
hydrolase activity, 
acting on glycosyl 
bonds; mannosyl-
glycoprotein endo-
beta-N-
acetylglucosaminid
ase activity; N-
acetylmuramoyl-L-
alanine amidase 
activity 
metabolic 
process; 
peptidoglycan 
catabolic process 
tr|E8SER2|E8SER2_STA
PH 
Do-like Serine protease, DegP/HtrA 
SPSINT_07
18 
 
catalytic activity; 
peptidase activity; 
serine-type 
endopeptidase 
activity 
proteolysis 
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tr|E8SHG6|E8SHG6_ST
APH 
Elastin binding protein EbpS 
SPSINT_11
81 
Cellular 
componen
t; 
plasma 
membrane 
- 
catabolic process; 
cell wall 
organization or 
biogenesis 
tr|F0P3J0|F0P3J0_STAPE Exfoliative toxin siet - peptidase activity 
proteolysis 
 
tr|E8SIY6|E8SIY6_STAP
H 
Extracellular adherence protein of broad specificity 
Eap/Map 
SPSINT_14
87 
extracellul
ar region 
- pathogenesis 
tr|F0P8S4|F0P8S4_STAP
E 
Glycerol phosphate lipoteichoic acid synthase ltaS - 
catalytic activity; 
sulfuric ester 
hydrolase activity; 
transferase activity 
metabolic process 
tr|F0P8V5|F0P8V5_STA
PE 
HTH-type transcriptional regulator MgrA mgrA 
intracellul
ar 
DNA binding; 
sequence-specific 
DNA binding 
transcription factor 
activity 
regulation of 
transcription, 
DNA-templated; 
transcription, 
DNA-templated 
tr|F0P5W3|F0P5W3_STA
PE 
HTH-type transcriptional regulator TcaR tcaR 
intracellul
ar 
sequence-specific 
DNA binding 
transcription factor 
activity 
regulation of 
transcription, 
DNA-templated 
tr|E8SHU1|E8SHU1_ST
APH 
IgG-binding protein Sbi 
SPSINT_00
32 
- 
immunoglobulin 
binding 
pathogenesis 
tr|F0P8I4|F0P8I4_STAPE Regulatory protein Spx spxA cytoplasm - 
negative 
regulation of 
transcription, 
DNA-
templated;regulati
on of 
transcription, 
DNA-templated; 
transcription, 
DNA-templated 
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tr|E8SGR9|E8SGR9_STA
PH 
Response regulator SaeR 
SPSINT_22
75 
- DNA binding 
phosphorelay 
signal 
transduction 
system; 
regulation of 
transcription, 
DNA-templated; 
transcription, 
DNA-templated 
tr|F0P9I8|F0P9I8_STAPE Staphylococcal accessory regulator A sarA 
Cytoplasm
; 
intracellul
ar 
DNA binding; 
sequence-specific 
DNA binding 
transcription factor 
activity 
regulation of 
transcription, 
DNA-templated; 
transcription, 
DNA-templated 
sp|Q5HCP3|SRAP_STAA
C 
Serine-rich adhesin for platelets sraP 
extracellul
ar region; 
cell wall; 
membrane 
calcium ion binding pathogenesis 
tr|F0P6U1|F0P6U1_STA
PE 
Synergohymenotropic toxin lukF-I 
extracellul
ar region 
- 
cytolysis in other 
organism; 
pathogenesis 
tr|F0P6Z1|F0P6Z1_STAP
E 
Thermonuclease nucB - 
hydrolase activity; 
hydrolase activity, 
acting on ester 
bonds; nucleic acid 
binding 
metabolic process 
tr|F0P5I0|F0P5I0_STAPE Transcriptional regulator, Fur family SPSE_1301 - 
DNA binding; 
sequence-specific 
DNA binding 
transcription factor 
activity 
regulation of 
transcription, 
DNA-templated 
tr|F0P5I7|F0P5I7_STAPE Transcriptional regulatory protein SrrA srrA - DNA binding 
phosphorelay 
signal 
transduction 
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system; 
regulation of 
transcription, 
DNA-templated ; 
transcription, 
DNA-templated 
tr|F0P648|F0P648_STAP
E 
Two-component response regulator VraR vraR - 
DNA binding; 
sequence-specific 
DNA binding 
transcription factor 
activity 
phosphorelay 
signal 
transduction 
system; 
regulation of 
transcription, 
DNA-templated; 
phosphorelay 
signal 
transduction 
system 
tr|E8SJ39|E8SJ39_STAP
H 
β-hemolysin 
SPSINT_02
34 
extracellul
ar region 
phosphoric diester 
hydrolase activity 
metabolic process 
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3.2.2.3 Final Remarks 
 
The work developed in this Master Thesis Project showed that the biofilm matrix 
proteome of a highly virulent S. pseudintermedius strain comprised a diverse group of 
proteins and confirmed the expression of several genome predicted proteins on the biofilm 
matrix. As in other bacterial BMPs, most of them were related to cellular metabolism. 
Several were also involved in the metabolism of known components of the cell wall, PIA 
and teichoic acids such as acetyl-glucosamine, glycerol or phosphate groups. However, it 
was not possible to establish a clear relation between them and biofilm formation. That was 
due to the lack of information since the large majority of known S. pseudintermedius have 
been inferred from homology or are just predicted proteins from gene sequences that don’t 
have sufficient information on the database. It would be helpful to perform a detailed 
function and localization analysis of these proteins in order to better describe the BMP of S. 
pseudintermedius and ascertain the importance of the proteins found on this study. 
Proteins known to be involved in biofilm formation consisted mostly of regulator 
factors of biofilm formation as well as virulence factors of-mainly-bacterial cell adhesion 
and host colonization. On the other hand, proteins related to PIA-dependent biofilm 
formation and bacterial seed dispersion were mostly absent. The prevalence of adhesins 
points to a PIA-independent biofilm where cells are directly or indirectly closely glued 
together to each other.  
In another continuation study, it would be interesting to characterize the composition 
of all polymers of the biofilm-matrix, particularly regarding its polyssacharides and eDNA 
composition in order to better understand and evaluate the hypothesis that S. 
pseudintermedius 5819/10 biofilm matrix is mainly constituted by bacteria connected by 
adhesins and/or eDNA. Additionally, it would be important to find out which virulence 
factors are more pronounced and their relevance to biofilm formation in order to disrupt 
them in the future. That way, more information is needed for discovery of anti-biofilm drugs, 
which is the main goal of the project where this Master Thesis was inserted. 
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5.Annexs 
 
5.1 Protein Quantitation Data 
 
Table 7- Calibration Curve Data used for the protein quantitation assay. On the left there’s absorbance (Abs) measured for 4 standards and a blank and on the calibration curve parameters follow the y=mX+b equation. 
Calibration Curve 
Quantitation Data Calibration Curve Parameters 
Standards 
Mass 
(µg) 
Abs. m b R2 
P1 0 0,886 
-0,00738 0,8732 0,994034113 
P2 10 0,786 
P3 20 0,721 
P4 30 0,650 
P5 40 0,585 
 
Table 8- Protein quantitation data for the replicates used in the GeLC-MS/MS analysis. The number in front of the replicate code (ex: PD I2 10 nº) refers to the volume of sample (µL)  that was pipetted onto the 96-well plate for measurement. 
 Quantitation 
Sample Code Abs 
 Mass 
(µg) 
V  
(µL) 
[Protein]  
(µg/µL) 
[Protein]avg (µg/µL) 
PD I2 10 5 0,771  13,8 5 2,8 
1,9 
PD I2 10 10 0,809  8,7 10 0,9 
PD I3 10 5 0,799  10,0 5 2,0 
1,8 
PD I3 10 10 0,756  15,9 10 1,6 
PD I1 100 5 0,723  20,4 5 4,1 
2,8 
PD I1 100 10 0,762  15,1 10 1,5 
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PD I2 100 5 0,777  13,0 5 2,6 
2.1 
PD I2 100 10 0,764  14,8 10 1,5 
 
 
5.2 LC-MS/MS data from the identified proteins 
 
Table 9-Descritpion of abbreviations, color codes and technical terminology used on table 10. 
Color code 
  Directly Identified and annotated proteins 
  Blasted and successfully annotated proteins 
  Proteins without annotation or identifcation 
Abbreviations used (data from ProteinScape 3.1 User Manual and Uniprot Fasta Headers webpage) 
Accession Database accession name 
pI Isoelectric point of protein 
#Alt. 
Proteins 
Number of similar proteins  
Scores Protein score in the format score (M: Mascot score) 
#Peptides Number of peptides identified 
SC [%] Sequence coverage (%) 
RMS90 
[ppm] 
Deviation from predicted mass (root mean square with 90% confidence value) 
OS Scientific name of the organism of the UniProtKB entry 
GN Gene Name is the first of the UniprotKB entry 
PE Protein Existence gives a numerical value describing the evidence for the existence of the protein 
SV Sequence Version is the version number of the sequence 
MW (kDa) Molecular weight of protein in kilodaltons 
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Table 10- List of all identified proteins by GeLC-MS/MS. 
Accession Protein 
MW 
[kDa] 
pI 
#Alt. 
Proteins 
Scores 
#Pepti
des 
SC 
[%] 
RMS90 
[ppm] 
tr|F0P720|F0P720_S
TAPE 
(Dimethylallyl)adenosine tRNA methylthiotransferase MiaB OS=Staphylococcus pseudintermedius (strain ED99) GN=miaB PE=3 SV=1 58,5 
5,
9 
1 
77.1 
(M:77.1) 
2 2,7 4,09 
tr|F0P591|F0P591_S
TAPE 
10 kDa chaperonin OS=Staphylococcus pseudintermedius (strain ED99) GN=groS PE=3 SV=1 10,6 
5,
2 
3 
344.6 
(M:344.6) 
5 47,4 4,54 
tr|F0P8X4|F0P8X4_
STAPE 
16s rRNA methyltransferase 22,4 
6,
9 
1 
61.7 
(M:61.7) 
2 16,3 394,47 
tr|F0P795|F0P795_S
TAPE 
1-acyl-sn-glycerol-3-phosphate acyltransferase, putative OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1065 PE=4 SV=1 23,2 
9,
8 
2 
497.4 
(M:497.4) 
11 51,7 2,66 
tr|F0P7D8|F0P7D8_
STAPE 
1-deoxy-D-xylulose 5-phosphate reductoisomerase OS=Staphylococcus pseudintermedius (strain ED99) GN=dxr PE=3 SV=1 42,1 5 2 
267.4 
(M:267.4) 
6 17,3 3,27 
tr|F0P5F8|F0P5F8_
STAPE 
1-deoxy-D-xylulose-5-phosphate synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=dxs PE=3 SV=1 68,4 
5,
8 
2 
298.0 
(M:298.0) 
7 12,1 5,46 
tr|F0P8L5|F0P8L5_S
TAPE 
1-pyrroline-5-carboxylate dehydrogenase 56,8 
5,
3 
2 
224.6 
(M:224.6) 
5 10,7 402,73 
tr|F0P6E0|F0P6E0_
STAPE 
2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=dapD PE=3 SV=1 25,3 
4,
7 
2 
115.3 
(M:115.3) 
2 15,5 272,14 
tr|F0P8C3|F0P8C3_
STAPE 
2,3-bisphosphoglycerate-dependent phosphoglycerate mutase OS=Staphylococcus pseudintermedius (strain ED99) GN=gpmA PE=3 SV=1 26,4 
5,
6 
3 
731.0 
(M:731.0) 
12 63,6 2,47 
tr|F0P852|F0P852_S
TAPE 
2,3-bisphosphoglycerate-independent phosphoglycerate mutase OS=Staphylococcus pseudintermedius (strain ED99) GN=gpmI PE=3 SV=1 56,5 
4,
8 
2 
817.6 
(M:817.6) 
15 32,1 3,88 
tr|F0P8W4|F0P8W4
_STAPE 
2-amino-3-ketobutyrate coenzyme A ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=kbl PE=3 SV=1 43,7 
5,
2 
2 
891.8 
(M:891.8) 
18 46,8 120,91 
tr|F0P369|F0P369_S
TAPE 
2-dehydropantoate 2-reductase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0212 PE=3 SV=1 34,5 
5,
3 
1 
287.6 
(M:287.6) 
6 23,5 1,83 
tr|F0P6C2|F0P6C2_
STAPE 
2-oxoglutarate dehydrogenase E1 component OS=Staphylococcus pseudintermedius (strain ED99) GN=sucA PE=3 SV=1 104,5 
5,
2 
3 
298.4 
(M:298.4) 
9 12,1 167,93 
tr|F0P6C3|F0P6C3_
STAPE 
2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=sucB PE=3 SV=1 46,4 5 3 
298.1 
(M:298.1) 
7 18,8 7 
 81 
 
tr|F0P5G5|F0P5G5_
STAPE 
2-oxoisovalerate dehydrogenase subunit beta OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1284 PE=4 SV=1 35,6 5 1 
167.8 
(M:167.8) 
3 10,7 2,36 
tr|F0P6L8|F0P6L8_S
TAPE 
30S ribosomal protein S10 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsJ PE=3 SV=1 11,6 
9,
7 
2 
260.3 
(M:260.3) 
5 33,3 4,64 
sp|Q5HDY3|RS11_S
TAAC 
30S ribosomal protein S11 OS=Staphylococcus aureus (strain COL) GN=rpsK PE=3 SV=1 13,9 
11
,2 
2 
465.5 
(M:465.5) 
6 26,4 2,6 
tr|F0P4L1|F0P4L1_S
TAPE 
30S ribosomal protein S12 methylthiotransferase 50,8 
5,
4 
2 
64.2 
(M:64.2) 
2 5,1 4,58 
tr|F0P8X0|F0P8X0_
STAPE 
30S ribosomal protein S12 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsL PE=3 SV=1 15,3 
11
,4 
2 
152.9 
(M:152.9) 
4 23,4 6,54 
tr|F0P3C0|F0P3C0_
STAPE 
30S ribosomal protein S13 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsM PE=3 SV=1 13,7 
10
,3 
2 
672.9 
(M:672.9) 
12 59,5 6,24 
sp|Q5HDX1|RS14Z_
STAAC 
30S ribosomal protein S14 type Z OS=Staphylococcus aureus (strain COL) GN=rpsZ PE=3 SV=1 7,3 
10
,4 
2 
31.7 
(M:31.7) 
1 11,5 3,4 
sp|Q5HGF8|RS15_S
TAAC 
30S ribosomal protein S15 OS=Staphylococcus aureus (strain COL) GN=rpsO PE=3 SV=1 10,6 
10
,5 
2 
50.5 
(M:50.5) 
2 14,6 5,81 
tr|F0P7G8|F0P7G8_
STAPE 
30S ribosomal protein S16 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsP PE=3 SV=1 10,2 10 2 
381.6 
(M:381.6) 
6 60,4 4,11 
tr|F0P6M8|F0P6M8
_STAPE 
30S ribosomal protein S17 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsQ PE=3 SV=1 10,2 
9,
8 
2 
77.8 
(M:77.8) 
2 20,7 6,78 
tr|F0P994|F0P994_S
TAPE 
30S ribosomal protein S18 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsR PE=3 SV=1 9,2 
11
,2 
2 
36.1 
(M:36.1) 
1 10 9,9 
tr|F0P6M3|F0P6M3
_STAPE 
30S ribosomal protein S19 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsS PE=3 SV=1 10,6 10 2 
215.9 
(M:215.9) 
5 35,9 346,75 
tr|F0P7E4|F0P7E4_
STAPE 
30S ribosomal protein S2 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsB PE=3 SV=1 29,9 
5,
2 
2 
940.6 
(M:940.6) 
18 46,8 3,7 
tr|F0P6M5|F0P6M5
_STAPE 
30S ribosomal protein S3 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsC PE=3 SV=1 24,1 
9,
8 
2 
590.1 
(M:590.1) 
11 52,5 2,63 
tr|F0P3I3|F0P3I3_S
TAPE 
30S ribosomal protein S4 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsD PE=3 SV=1 22,9 
9,
9 
2 
777.2 
(M:777.2) 
14 52,5 3,72 
tr|F0P3B3|F0P3B3_
STAPE 
30S ribosomal protein S5 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsE PE=3 SV=1 17,7 
10
,2 
2 
1033.2 
(M:1033.2) 
17 69,3 4,72 
tr|F0P996|F0P996_S
TAPE 
30S ribosomal protein S6 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsF PE=3 SV=1 11,7 5 2 
474.0 
(M:474.0) 
8 65,3 3,29 
tr|F0P8W9|F0P8W9
_STAPE 
30S ribosomal protein S7 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsG PE=3 SV=1 17,8 10 2 
613.9 
(M:613.9) 
11 50,6 4,76 
tr|F0P6N3|F0P6N3_
STAPE 
30S ribosomal protein S8 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsH PE=3 SV=1 14,8 
9,
5 
2 
1102.3 
(M:1102.3) 
17 67,4 3,63 
tr|F0P3C9|F0P3C9_
STAPE 
30S ribosomal protein S9 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsI PE=3 SV=1 14,9 
10
,5 
2 
89.9 
(M:89.9) 
2 14,4 5,05 
tr|F0P916|F0P916_S
TAPE 
33 kDa chaperonin OS=Staphylococcus pseudintermedius (strain ED99) GN=hslO PE=3 SV=1 31,8 
4,
8 
1 
230.8 
(M:230.8) 
6 27,6 2,92 
tr|F0P6S1|F0P6S1_S
TAPE 
3'-5' exoribonuclease YhaM OS=Staphylococcus pseudintermedius (strain ED99) GN=cbf1 PE=4 SV=1 35,9 6 2 
334.1 
(M:334.1) 
8 20,1 5,86 
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tr|F0P680|F0P680_S
TAPE 
3-dehydroquinate synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=aroB PE=3 SV=1 40,6 
6,
3 
2 
54.5 
(M:54.5) 
2 5,6 517,49 
tr|F0P7L1|F0P7L1_S
TAPE 
3-demethylubiquinone-9 3-methyltransferase domain protein 15,6 
4,
7 
2 
107.1 
(M:107.1) 
3 19,7 5,02 
tr|F0P786|F0P786_S
TAPE 
3-deoxy-7-phosphoheptulonate synthase/chorismate mutase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1056 PE=4 SV=1 40,9 
5,
8 
5 
488.1 
(M:488.1) 
11 23,4 5,37 
tr|F0P8D5|F0P8D5_
STAPE 
3-hexulose-6-phosphate synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=hxlA PE=4 SV=1 22,7 
4,
6 
2 
328.0 
(M:328.0) 
6 34,9 1,63 
tr|F0P4D8|F0P4D8_
STAPE 
3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ OS=Staphylococcus pseudintermedius (strain ED99) GN=fabZ PE=3 SV=1 16 
5,
7 
2 
208.2 
(M:208.2) 
5 29,3 4,08 
tr|E8SFB9|E8SFB9_
STAPH 
3-hydroxyacyl-CoA dehydrogenase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2020 PE=4 SV=1 18,8 
6,
1 
2 
130.8 
(M:130.8) 
4 27,2 5,81 
tr|E8SI87|E8SI87_ST
APH 
3-methyl-2-oxobutanoate hydroxymethyltransferase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=panB PE=3 SV=1 29,3 
5,
1 
2 
207.0 
(M:207.0) 
4 14,8 1,06 
tr|F0P5Y6|F0P5Y6_S
TAPE 
3-methyladenine dna glycosylase 22,8 
9,
5 
2 
73.9 
(M:73.9) 
2 9,9 927,33 
tr|F0P7I6|F0P7I6_S
TAPE 
3-oxoacyl-[acyl-carrier-protein] reductase OS=Staphylococcus pseudintermedius (strain ED99) GN=fabG PE=3 SV=1 26,2 
6,
1 
2 
678.4 
(M:678.4) 
12 55,5 151,5 
tr|F0P8J2|F0P8J2_S
TAPE 
3-oxoacyl-[acyl-carrier-protein] synthase 2 OS=Staphylococcus pseudintermedius (strain ED99) GN=fabF PE=3 SV=1 43,5 5 2 
640.2 
(M:640.2) 
10 41,8 255,37 
tr|F0P8J3|F0P8J3_S
TAPE 
3-oxoacyl-[acyl-carrier-protein] synthase 3 OS=Staphylococcus pseudintermedius (strain ED99) GN=fabH PE=3 SV=1 34,2 
4,
8 
1 
225.9 
(M:225.9) 
3 13,1 3,07 
tr|E8SHF2|E8SHF2_
STAPH 
3-phosphoshikimate 1-carboxyvinyltransferase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=aroA PE=3 SV=1 46,2 
5,
4 
2 
89.1 
(M:89.1) 
3 6,3 4,21 
tr|F0P9J3|F0P9J3_S
TAPE 
4-diphosphocytidyl-2-C-methyl-D-erythritol kinase OS=Staphylococcus pseudintermedius (strain ED99) GN=ispE PE=3 SV=1 30,9 
5,
2 
1 
102.6 
(M:102.6) 
3 13,1 468,52 
tr|F0P4N6|F0P4N6_
STAPE 
4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=ispG PE=3 SV=1 39,6 
5,
6 
1 
265.3 
(M:265.3) 
8 26,4 4,61 
tr|F0P4N0|F0P4N0_
STAPE 
4-hydroxy-3-methylbut-2-enyl diphosphate reductase OS=Staphylococcus pseudintermedius (strain ED99) GN=ispH PE=3 SV=1 35,6 
5,
4 
2 
113.6 
(M:113.6) 
3 7,8 5,2 
tr|E8SH09|E8SH09_
STAPH 
4-hydroxy-tetrahydrodipicolinate reductase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=dapB PE=3 SV=1 26,4 
5,
5 
2 
122.2 
(M:122.2) 
3 12,5 5,29 
tr|F0P6E2|F0P6E2_
STAPE 
4-hydroxy-tetrahydrodipicolinate synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=dapA PE=3 SV=1 32,4 
4,
8 
1 
167.9 
(M:167.9) 
3 14,4 1,24 
tr|F0P8R7|F0P8R7_
STAPE 
5 (3 )-deoxyribonucleotidase 20,4 
4,
9 
1 
180.9 
(M:180.9) 
3 21,3 1,5 
tr|F0P7Y7|F0P7Y7_S
TAPE 
5' nucleotidase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1807 PE=4 SV=1 58,6 
5,
5 
2 
61.6 
(M:61.6) 
2 3 6,41 
tr|F0P8X7|F0P8X7_
STAPE 
50S ribosomal protein L1 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplA PE=3 SV=1 25 
9,
3 
2 
1141.0 
(M:1141.0) 
19 55,8 3,15 
tr|F0P8X6|F0P8X6_
STAPE 
50S ribosomal protein L10 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplJ PE=3 SV=1 17,9 
5,
2 
2 
796.8 
(M:796.8) 
11 60,2 3,69 
tr|F0P8X8|F0P8X8_
STAPE 
50S ribosomal protein L11 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplK PE=3 SV=1 15 
9,
2 
2 
440.5 
(M:440.5) 
8 39,3 3,46 
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tr|F0P3C8|F0P3C8_
STAPE 
50S ribosomal protein L13 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplM PE=3 SV=1 16,2 
9,
3 
2 
1206.0 
(M:1206.0) 
19 82,8 4,34 
tr|F0P6M9|F0P6M9
_STAPE 
50S ribosomal protein L14 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplN PE=3 SV=1 13,1 
10
,2 
2 
523.7 
(M:523.7) 
9 50,8 3,96 
tr|F0P3B5|F0P3B5_
STAPE 
50S ribosomal protein L15 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplO PE=3 SV=1 15,6 
10
,4 
2 
411.0 
(M:411.0) 
8 33,6 7,18 
tr|F0P6M6|F0P6M6
_STAPE 
50S ribosomal protein L16 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplP PE=3 SV=1 16,2 
10
,5 
2 
292.6 
(M:292.6) 
5 43,8 5,88 
tr|F0P3C3|F0P3C3_
STAPE 
50S ribosomal protein L17 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplQ PE=3 SV=1 13,7 10 1 
269.7 
(M:269.7) 
4 34,4 2,35 
tr|F0P3B2|F0P3B2_
STAPE 
50S ribosomal protein L18 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplR PE=3 SV=1 13,2 10 1 
601.9 
(M:601.9) 
9 53,8 4,41 
tr|F0P6M2|F0P6M2
_STAPE 
50S ribosomal protein L2 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplB PE=3 SV=1 30,3 
10
,7 
1 
46.9 
(M:46.9) 
2 7,2 4,31 
tr|F0P3M6|F0P3M6
_STAPE 
50S ribosomal protein L20 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplT PE=3 SV=1 13,6 
11
,2 
2 
252.7 
(M:252.7) 
6 41,5 3,83 
tr|F0P3P6|F0P3P6_
STAPE 
50S ribosomal protein L21 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplU PE=3 SV=1 11,4 
9,
8 
2 
647.9 
(M:647.9) 
10 76,5 1,74 
tr|F0P6M4|F0P6M4
_STAPE 
50S ribosomal protein L22 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplV PE=3 SV=1 12,9 
10
,1 
2 
458.1 
(M:458.1) 
8 70,1 5,15 
tr|F0P6M1|F0P6M1
_STAPE 
50S ribosomal protein L23 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplW PE=3 SV=1 10,6 
9,
8 
2 
431.6 
(M:431.6) 
8 61,5 4,33 
tr|F0P6N0|F0P6N0_
STAPE 
50S ribosomal protein L24 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplX PE=3 SV=1 11,4 
9,
9 
1 
246.7 
(M:246.7) 
4 23,1 5,5 
tr|F0P927|F0P927_S
TAPE 
50S ribosomal protein L25 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplY PE=3 SV=1 23,6 
4,
3 
2 
479.3 
(M:479.3) 
7 28,7 1,33 
tr|F0P3P8|F0P3P8_
STAPE 
50S ribosomal protein L27 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpmA PE=3 SV=1 10,3 
10
,2 
2 
219.0 
(M:219.0) 
4 39,4 3,43 
tr|F0P7J5|F0P7J5_S
TAPE 
50S ribosomal protein L28 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpmB PE=3 SV=1 7 12 2 
64.7 
(M:64.7) 
2 27,4 9,16 
tr|F0P6M7|F0P6M7
_STAPE 
50S ribosomal protein L29 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpmC PE=3 SV=1 8 
9,
5 
2 
275.9 
(M:275.9) 
4 55,1 1,33 
tr|F0P6L9|F0P6L9_S
TAPE 
50S ribosomal protein L3 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplC PE=3 SV=1 23,7 
9,
7 
2 
682.3 
(M:682.3) 
14 45,7 112,52 
tr|F0P3B4|F0P3B4_
STAPE 
50S ribosomal protein L30 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpmD PE=3 SV=1 6,4 
10
,1 
2 
329.9 
(M:329.9) 
6 74,6 5,11 
tr|F0P4B6|F0P4B6_
STAPE 
50S ribosomal protein L31 type B OS=Staphylococcus pseudintermedius (strain ED99) GN=rpmE PE=3 SV=1 9,8 
6,
7 
2 
835.8 
(M:835.8) 
13 86,9 5,71 
tr|F0P3B9|F0P3B9_
STAPE 
50S ribosomal protein L36 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpmJ PE=3 SV=1 4,3 
11
,4 
2 
60.7 
(M:60.7) 
2 54,1 636,92 
tr|F0P6M0|F0P6M0
_STAPE 
50S ribosomal protein L4 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplD PE=3 SV=1 22,7 
9,
9 
2 
440.3 
(M:440.3) 
8 27,1 2,69 
tr|F0P6N1|F0P6N1_
STAPE 
50S ribosomal protein L5 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplE PE=3 SV=1 20,2 
9,
5 
2 
1611.8 
(M:1611.8) 
24 83,8 2,86 
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tr|F0P6N4|F0P6N4_
STAPE 
50S ribosomal protein L6 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplF PE=3 SV=1 19,6 
9,
1 
1 
985.1 
(M:985.1) 
15 51,1 3,34 
tr|F0P8X5|F0P8X5_
STAPE 
50S ribosomal protein L7/L12 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplL PE=3 SV=1 12,5 
4,
5 
2 
638.3 
(M:638.3) 
12 92,6 4,74 
tr|F0P4P7|F0P4P7_
STAPE 
50S ribosomal protein L9 OS=Staphylococcus pseudintermedius (strain ED99) GN=rplI PE=3 SV=1 16,4 
9,
4 
2 
388.4 
(M:388.4) 
7 42,6 4,25 
tr|E8SJB3|E8SJB3_S
TAPH 
6,7-dimethyl-8-ribityllumazine synthase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=ribH PE=3 SV=1 16,4 
6,
1 
2 
410.3 
(M:410.3) 
7 44,5 2,38 
tr|F0P592|F0P592_S
TAPE 
60 kDa chaperonin OS=Staphylococcus pseudintermedius (strain ED99) GN=groL PE=3 SV=1 57,6 
4,
5 
24 
2265.3 
(M:2265.3) 
37 65,1 5,4 
tr|E8SIY2|E8SIY2_ST
APH 
6'-aminoglycoside N-acetyltransferase (AAC(6')) / 2''-aminoglycoside phosphotransferase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1483 PE=4 
SV=1 
56,8 
4,
6 
1 
179.9 
(M:179.9) 
6 9,2 6,2 
tr|F0P8D4|F0P8D4_
STAPE 
6-phospho 3-hexuloisomerase OS=Staphylococcus pseudintermedius (strain ED99) GN=hxlB PE=4 SV=1 19,5 
4,
8 
2 
117.3 
(M:117.3) 
2 12,1 7,27 
tr|F0P3K7|F0P3K7_
STAPE 
6-phosphofructokinase OS=Staphylococcus pseudintermedius (strain ED99) GN=pfkA PE=3 SV=1 34,9 
5,
4 
2 
736.3 
(M:736.3) 
13 34,8 3,24 
tr|F0P5H0|F0P5H0_
STAPE 
6-phosphogluconate dehydrogenase, decarboxylating OS=Staphylococcus pseudintermedius (strain ED99) GN=gnd PE=3 SV=1 51,7 
4,
9 
2 
1372.4 
(M:1372.4) 
26 57,8 76,68 
tr|E8SK67|E8SK67_S
TAPH 
6-phosphogluconolactonase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1674 PE=4 SV=1 39 5 3 
479.1 
(M:479.1) 
11 31,8 163,38 
tr|F0P9D0|F0P9D0_
STAPE 
ABC transporter ATP-binding protein VraD OS=Staphylococcus pseudintermedius (strain ED99) GN=vraD PE=4 SV=1 28,1 
8,
9 
1 
90.2 
(M:90.2) 
3 18,6 269,29 
tr|F0P5V9|F0P5V9_
STAPE 
ABC transporter, permease protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0448 PE=4 SV=1 39 
5,
8 
1 
72.6 
(M:72.6) 
3 9,3 3,43 
tr|F0P418|F0P418_S
TAPE 
ABC transporter, substrate-binding protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0275 PE=4 SV=1 55,5 
5,
1 
2 
169.0 
(M:169.0) 
4 10,6 312,69 
tr|E8SIW7|E8SIW7_S
TAPH 
Acetate kinase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=ackA PE=3 SV=1 44,1 
5,
3 
4 
1375.4 
(M:1375.4) 
22 59 5,3 
tr|F0P4I5|F0P4I5_S
TAPE 
acetyl- biotin carboxyl carrier protein 16,8 
4,
6 
1 
114.6 
(M:114.6) 
2 20,3 2,72 
tr|F0P5F2|F0P5F2_
STAPE 
Acetyl-CoA carboxylase, biotin carboxylase subunit OS=Staphylococcus pseudintermedius (strain ED99) GN=accC PE=4 SV=1 50,4 
5,
1 
2 
168.8 
(M:168.8) 
5 10,6 435,57 
tr|E8SIV5|E8SIV5_S
TAPH 
Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=accA PE=3 SV=1 35,2 
5,
3 
3 
181.8 
(M:181.8) 
4 14,6 4,78 
tr|F0P3K5|F0P3K5_
STAPE 
Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta OS=Staphylococcus pseudintermedius (strain ED99) GN=accD PE=3 SV=1 31,9 6 2 
388.6 
(M:388.6) 
10 31,8 4,69 
tr|F0P9S4|F0P9S4_S
TAPE 
acetyltransferase 9,9 6 2 
97.2 
(M:97.2) 
2 18,7 5,25 
tr|F0P520|F0P520_S
TAPE 
Acetyltransferase, GNAT family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0392 PE=4 SV=1 21,1 
4,
7 
1 
125.9 
(M:125.9) 
4 22,7 5,05 
tr|F0P8J5|F0P8J5_S
TAPE 
Acid phosphatase 5'-nucleotidase, lipoprotein e(P4) family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1859 PE=4 SV=1 34,1 
8,
9 
1 
161.6 
(M:161.6) 
3 10 2,96 
tr|F0P6W1|F0P6W1
_STAPE 
Aconitate hydratase 1 OS=Staphylococcus pseudintermedius (strain ED99) GN=acnA PE=4 SV=1 98,4 
4,
7 
3 
1201.0 
(M:1201.0) 
27 31,5 5,54 
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tr|F0P7I5|F0P7I5_S
TAPE 
Acyl carrier protein OS=Staphylococcus pseudintermedius (strain ED99) GN=acpP PE=3 SV=1 8,5 
3,
8 
2 
69.3 
(M:69.3) 
2 31,2 4,46 
tr|B1GVE3|B1GVE3
_9STAP 
acyl dehydratase 16,1 
5,
4 
1 
67.4 
(M:67.4) 
2 19,7 1,67 
tr|F0P6D2|F0P6D2_
STAPE 
Acylphosphatase OS=Staphylococcus pseudintermedius (strain ED99) GN=acyP PE=3 SV=1 10,3 
5,
6 
2 
130.1 
(M:130.1) 
3 36,7 6,89 
tr|F0P3Q8|F0P3Q8_
STAPE 
Adenine phosphoribosyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=apt PE=3 SV=1 19 
4,
8 
1 
80.1 
(M:80.1) 
2 12,8 1,21 
tr|F0P3B7|F0P3B7_
STAPE 
Adenylate kinase OS=Staphylococcus pseudintermedius (strain ED99) GN=adk PE=3 SV=1 24,2 
4,
9 
2 
784.4 
(M:784.4) 
15 54,4 3,82 
tr|F0P616|F0P616_S
TAPE 
Adenylosuccinate lyase OS=Staphylococcus pseudintermedius (strain ED99) GN=purB PE=4 SV=1 49,6 
5,
8 
1 
153.8 
(M:153.8) 
4 8,8 466,55 
tr|E8SHP3|E8SHP3_
STAPH 
Adenylosuccinate synthetase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=purA PE=3 SV=1 47,4 
5,
2 
4 
468.8 
(M:468.8) 
9 20,6 4,53 
tr|F0P5H9|F0P5H9_
STAPE 
ADP-ribose pyrophosphatase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1300 PE=3 SV=1 20,5 
5,
4 
1 
378.2 
(M:378.2) 
7 37,8 384,96 
tr|E8SGK6|E8SGK6_
STAPH 
Aerobic glycerol-3-phosphate dehydrogenase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1034 PE=3 SV=1 62 
7,
7 
3 
1009.9 
(M:1009.9) 
18 33,5 4,82 
tr|T2I4H1|T2I4H1_9
STAP 
Alanine dehydrogenase OS=Staphylococcus pseudintermedius GN=ald1 PE=4 SV=1 39,8 
5,
4 
2 
654.4 
(M:654.4) 
11 28,6 4,24 
tr|F0P549|F0P549_S
TAPE 
Alanine racemase OS=Staphylococcus pseudintermedius (strain ED99) GN=alrA PE=3 SV=1 42,7 
5,
2 
2 
170.8 
(M:170.8) 
4 13,1 259,15 
tr|E8SIG8|E8SIG8_S
TAPH 
Alanine--tRNA ligase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=alaS PE=3 SV=1 98,4 
5,
1 
3 
818.5 
(M:818.5) 
19 21,9 232,16 
tr|E8SFE2|E8SFE2_
STAPH 
Alcohol dehydrogenase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2043 PE=4 SV=1 36 
6,
3 
2 
411.4 
(M:411.4) 
7 27,2 3,78 
tr|F0P4B3|F0P4B3_
STAPE 
aldehyde dehydrogenase 52 5 2 
1650.6 
(M:1650.6) 
25 69,2 63,36 
tr|F0P5Z1|F0P5Z1_S
TAPE 
aldose 1-epimerase 38,5 
4,
9 
1 
166.6 
(M:166.6) 
4 9,7 7,03 
tr|F0P3L2|F0P3L2_S
TAPE 
Alkaline phosphatase synthesis transcriptional regulatory protein OS=Staphylococcus pseudintermedius (strain ED99) GN=phoP PE=4 SV=1 27,2 
5,
1 
2 
147.0 
(M:147.0) 
3 17,9 490,69 
tr|F0P3F3|F0P3F3_
STAPE 
Alkaline shock protein 23 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0630 PE=4 SV=1 18,3 
5,
2 
2 
927.4 
(M:927.4) 
15 81,6 5,3 
tr|F0P984|F0P984_S
TAPE 
Alkyl hydroperoxide reductase subunit C OS=Staphylococcus pseudintermedius (strain ED99) GN=ahpC PE=4 SV=1 21 
4,
6 
2 
774.9 
(M:774.9) 
11 66,1 4,35 
tr|F0P985|F0P985_S
TAPE 
alkyl hydroperoxide reductase subunit f 54,5 
4,
7 
2 
304.0 
(M:304.0) 
7 23,7 140,73 
tr|E8SGB7|E8SGB7_
STAPH 
Alkylphosphonate utilization operon protein PhnA OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2205 PE=4 SV=1 12,7 
4,
8 
2 
134.3 
(M:134.3) 
3 34,5 321,22 
tr|F0P4I4|F0P4I4_S
TAPE 
Allophanate hydrolase subunit 2 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1185 PE=4 SV=1 38 9 1 
53.5 
(M:53.5) 
2 5,9 8,19 
tr|F0P703|F0P703_S
TAPE 
Aluminum resistance protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1465 PE=4 SV=1 45,8 
5,
1 
2 
96.2 
(M:96.2) 
2 4,6 4,45 
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tr|F0P601|F0P601_S
TAPE 
Amidohydrolase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0490 PE=4 SV=1 42,4 5 1 
117.2 
(M:117.2) 
3 6,6 4,24 
tr|F0P3Y0|F0P3Y0_S
TAPE 
Amidophosphoribosyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=purF PE=3 SV=1 52,2 
5,
8 
1 
47.0 
(M:47.0) 
2 5,5 4,68 
tr|F0P6F0|F0P6F0_
STAPE 
Aminoacyltransferase FemA OS=Staphylococcus pseudintermedius (strain ED99) GN=femA PE=4 SV=1 49,5 
6,
8 
2 
165.6 
(M:165.6) 
5 11,6 393,95 
tr|F0P6E9|F0P6E9_
STAPE 
Aminoacyltransferase FemB OS=Staphylococcus pseudintermedius (strain ED99) GN=femB PE=4 SV=1 49,3 
5,
9 
2 
281.1 
(M:281.1) 
7 16,9 2,49 
tr|G4XUK6|G4XUK6
_9STAP 
Aminoglycoside 3-phosphotransferase OS=Staphylococcus pseudintermedius GN=aphA-3 PE=4 SV=1 30,6 
4,
5 
2 
332.1 
(M:332.1) 
8 26,1 4,95 
tr|F0P654|F0P654_S
TAPE 
Aminopeptidase Peps OS=Staphylococcus pseudintermedius (strain ED99) GN=pepS PE=4 SV=1 45,9 
4,
7 
2 
320.4 
(M:320.4) 
7 21,2 3,71 
tr|F0P357|F0P357_S
TAPE 
Anaerobic ribonucleoside-triphosphate reductase OS=Staphylococcus pseudintermedius (strain ED99) GN=nrdD PE=4 SV=1 70,4 
5,
5 
1 
90.5 
(M:90.5) 
2 3,2 4,63 
tr|F0P554|F0P554_S
TAPE 
Anti-sigma B factor OS=Staphylococcus pseudintermedius (strain ED99) GN=rsbW PE=4 SV=1 18,2 
4,
8 
2 
265.1 
(M:265.1) 
4 30,6 2,36 
tr|F0P553|F0P553_S
TAPE 
Anti-sigma factor antagonist OS=Staphylococcus pseudintermedius (strain ED99) GN=rsbV PE=3 SV=1 12,2 
4,
8 
1 
128.0 
(M:128.0) 
3 21,3 5 
tr|E8SE31|E8SE31_S
TAPH 
Arginase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1826 PE=3 SV=1 33 
4,
9 
2 
152.0 
(M:152.0) 
4 14 6,13 
tr|F0P5F9|F0P5F9_
STAPE 
Arginine repressor OS=Staphylococcus pseudintermedius (strain ED99) GN=argR PE=3 SV=1 17,2 
5,
2 
2 
387.4 
(M:387.4) 
6 48 2,73 
tr|F0P879|F0P879_S
TAPE 
Arginine--tRNA ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=argS PE=3 SV=1 62,6 
5,
3 
3 
563.2 
(M:563.2) 
15 31 215,12 
tr|F0P829|F0P829_S
TAPE 
arsenate reductase 13,7 
6,
1 
1 
441.7 
(M:441.7) 
10 62,2 5,69 
tr|F0P691|F0P691_S
TAPE 
Asparagine--tRNA ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=asnS PE=3 SV=1 49,3 
5,
2 
2 
634.0 
(M:634.0) 
14 32,1 4,53 
tr|E8SK80|E8SK80_S
TAPH 
Aspartate aminotransferase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1687 PE=4 SV=1 48,1 
4,
9 
2 
102.1 
(M:102.1) 
2 4,7 7,45 
tr|F0P7L9|F0P7L9_S
TAPE 
Aspartate carbamoyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=pyrB PE=3 SV=1 33,1 
5,
2 
1 
103.1 
(M:103.1) 
2 7,2 5,03 
tr|F0P6E3|F0P6E3_
STAPE 
Aspartate-semialdehyde dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=asd PE=3 SV=1 35,8 5 2 
100.0 
(M:100.0) 
2 6,4 4,09 
tr|F0P4G2|F0P4G2_
STAPE 
Aspartate--tRNA ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=aspS PE=3 SV=1 66,3 
4,
9 
2 
1110.4 
(M:1110.4) 
21 33,8 4,79 
tr|F0P6Y3|F0P6Y3_S
TAPE 
Aspartokinase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1444 PE=3 SV=1 50,5 
6,
1 
2 
151.7 
(M:151.7) 
5 11,1 283,96 
tr|F0P626|F0P626_S
TAPE 
Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B OS=Staphylococcus pseudintermedius (strain ED99) GN=gatB PE=3 SV=1 53,3 5 2 
837.6 
(M:837.6) 
19 40,4 5 
tr|F0P4D4|F0P4D4_
STAPE 
ATP synthase epsilon chain OS=Staphylococcus pseudintermedius (strain ED99) GN=atpC PE=3 SV=1 15 
5,
6 
1 
274.7 
(M:274.7) 
4 35,8 1,56 
tr|F0P4D2|F0P4D2_
STAPE 
ATP synthase gamma chain OS=Staphylococcus pseudintermedius (strain ED99) GN=atpG PE=3 SV=1 32,3 
8,
5 
2 
710.1 
(M:710.1) 
13 50,5 3,01 
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tr|F0P4D1|F0P4D1_
STAPE 
ATP synthase subunit alpha OS=Staphylococcus pseudintermedius (strain ED99) GN=atpA PE=3 SV=1 54,7 
4,
9 
2 
1249.7 
(M:1249.7) 
21 43,7 3,1 
tr|F0P4C9|F0P4C9_
STAPE 
ATP synthase subunit b OS=Staphylococcus pseudintermedius (strain ED99) GN=atpF PE=3 SV=1 19,4 
5,
4 
2 
262.0 
(M:262.0) 
5 25,6 5,51 
tr|F0P4D3|F0P4D3_
STAPE 
ATP synthase subunit beta OS=Staphylococcus pseudintermedius (strain ED99) GN=atpD PE=3 SV=1 51,2 
4,
7 
2 
2044.8 
(M:2044.8) 
34 79,4 99,84 
tr|E8SKP1|E8SKP1_
STAPH 
ATP synthase subunit delta OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=atpH PE=3 SV=1 20,2 
5,
4 
2 
151.7 
(M:151.7) 
3 17,9 704,77 
tr|F0P900|F0P900_S
TAPE 
atp:guanido phosphotransferase 38,1 
5,
1 
2 
428.2 
(M:428.2) 
7 21,6 4,22 
tr|F0P3H1|F0P3H1_
STAPE 
ATP-binding protein, Mrp/Nbp35 family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0648 PE=4 SV=1 38,5 
5,
3 
3 
127.1 
(M:127.1) 
3 9 322,51 
tr|F0P8J6|F0P8J6_S
TAPE 
ATP-dependent chaperone protein ClpB OS=Staphylococcus pseudintermedius (strain ED99) GN=clpB PE=3 SV=1 98,7 
5,
2 
2 
395.2 
(M:395.2) 
10 12,3 5,62 
tr|F0P8Z9|F0P8Z9_S
TAPE 
ATP-dependent Clp protease ATP-binding subunit ClpC OS=Staphylococcus pseudintermedius (strain ED99) GN=clpC PE=3 SV=1 91,2 
5,
4 
2 
630.8 
(M:630.8) 
13 19,5 4,92 
tr|F0P3N0|F0P3N0_
STAPE 
ATP-dependent Clp protease ATP-binding subunit ClpX OS=Staphylococcus pseudintermedius (strain ED99) GN=clpX PE=3 SV=1 46,2 
4,
5 
2 
477.0 
(M:477.0) 
8 28,6 265,02 
tr|E8SKE3|E8SKE3_
STAPH 
ATP-dependent Clp protease proteolytic subunit OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=clpP PE=3 SV=1 21,4 5 2 
492.7 
(M:492.7) 
9 26,2 1,74 
tr|E8SK52|E8SK52_S
TAPH 
ATP-dependent DNA helicase UvrD/PcrA OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1659 PE=4 SV=1 83,9 
5,
5 
3 
134.7 
(M:134.7) 
3 5,2 4,19 
tr|F0P7E6|F0P7E6_
STAPE 
ATP-dependent protease ATPase subunit HslU OS=Staphylococcus pseudintermedius (strain ED99) GN=hslU PE=3 SV=1 53 
5,
3 
2 
689.5 
(M:689.5) 
15 35,2 148,51 
tr|E8SIP7|E8SIP7_S
TAPH 
ATP-dependent zinc metalloprotease FtsH OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=ftsH PE=3 SV=1 78 
5,
2 
3 
509.6 
(M:509.6) 
11 15,5 5,37 
tr|F0P7U5|F0P7U5_
STAPE 
Autolysin OS=Staphylococcus pseudintermedius (strain ED99) GN=spsC PE=4 SV=1 150,5 
9,
3 
2 
1953.5 
(M:1953.5) 
42 33,4 5,2 
tr|F0P8E1|F0P8E1_
STAPE 
bacillithiol biosynthesis deacetylase 2 25,3 
4,
7 
2 
236.0 
(M:236.0) 
5 20,3 3,54 
tr|F0P4G8|F0P4G8_
STAPE 
Bacterial luciferase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1169 PE=4 SV=1 38 
5,
8 
2 
163.3 
(M:163.3) 
3 9,5 1,18 
tr|F0P396|F0P396_S
TAPE 
Betaine aldehyde dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=betB PE=3 SV=1 54,8 5 3 
814.3 
(M:814.3) 
18 50,1 91,18 
tr|F0P9Q8|F0P9Q8_
STAPE 
Beta-lactamase OS=Staphylococcus pseudintermedius (strain ED99) GN=blaZ-2 PE=4 SV=1 31,3 
9,
6 
2 
172.1 
(M:172.1) 
4 19,2 2,58 
tr|F0P3Y7|F0P3Y7_S
TAPE 
Bifunctional protein FolD OS=Staphylococcus pseudintermedius (strain ED99) GN=folD PE=3 SV=1 30,9 
5,
1 
2 
489.2 
(M:489.2) 
8 29,8 5,64 
tr|F0P929|F0P929_S
TAPE 
Bifunctional protein GlmU OS=Staphylococcus pseudintermedius (strain ED99) GN=glmU PE=3 SV=1 48,5 
5,
8 
3 
443.7 
(M:443.7) 
8 30,4 257,44 
tr|F0P7M1|F0P7M1
_STAPE 
Bifunctional protein PyrR OS=Staphylococcus pseudintermedius (strain ED99) GN=pyR PE=3 SV=1 19,6 
5,
2 
2 
134.0 
(M:134.0) 
3 16,7 5,12 
tr|F0P3X7|F0P3X7_
STAPE 
Bifunctional purine biosynthesis protein PurH OS=Staphylococcus pseudintermedius (strain ED99) GN=purH PE=3 SV=1 53,8 
5,
3 
2 
880.0 
(M:880.0) 
14 38 166,46 
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tr|F0P8F1|F0P8F1_
STAPE 
Branched-chain-amino-acid aminotransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=ilvE PE=3 SV=1 40,2 
4,
9 
3 
223.1 
(M:223.1) 
5 15,8 5,81 
tr|E8SEX0|E8SEX0_
STAPH 
Butyryl-CoA dehydrogenase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1953 PE=4 SV=1 43 
5,
5 
2 
211.8 
(M:211.8) 
5 15,3 370,73 
tr|F0P727|F0P727_S
TAPE 
Cadmium efflux system accessory protein OS=Staphylococcus pseudintermedius (strain ED99) GN=cadC PE=4 SV=1 14,4 
6,
3 
1 
73.4 
(M:73.4) 
2 11,1 4,78 
tr|F0P7L6|F0P7L6_S
TAPE 
Carbamoyl-phosphate synthase large chain OS=Staphylococcus pseudintermedius (strain ED99) GN=carB PE=3 SV=1 116,6 5 2 
1156.5 
(M:1156.5) 
25 20,9 6,33 
tr|F0P7L7|F0P7L7_S
TAPE 
Carbamoyl-phosphate synthase small chain OS=Staphylococcus pseudintermedius (strain ED99) GN=carA PE=3 SV=1 40,1 
5,
6 
1 
449.7 
(M:449.7) 
9 29,5 3,62 
tr|F0P649|F0P649_S
TAPE 
carbonic anhydrase 21,5 5 2 
95.5 
(M:95.5) 
3 17,6 372,36 
tr|F0P848|F0P848_S
TAPE 
Carboxylesterase OS=Staphylococcus pseudintermedius (strain ED99) GN=est PE=4 SV=1 28,1 
4,
7 
1 
70.6 
(M:70.6) 
2 8,9 598,53 
tr|F0P787|F0P787_S
TAPE 
Catabolite control protein A OS=Staphylococcus pseudintermedius (strain ED99) GN=ccpA PE=4 SV=1 36,5 
5,
7 
2 
637.5 
(M:637.5) 
14 38 3,75 
tr|F0P5Q2|F0P5Q2_
STAPE 
Catalase OS=Staphylococcus pseudintermedius (strain ED99) GN=katA PE=3 SV=1 57 
5,
6 
2 
1390.1 
(M:1390.1) 
24 58,3 99,03 
tr|E8SIB7|E8SIB7_S
TAPH 
CBS domain protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1332 PE=4 SV=1 18,4 
8,
5 
3 
72.5 
(M:72.5) 
2 11,7 3,58 
tr|F0P7M5|F0P7M5
_STAPE 
cell division protein DivIVA 23,1 
4,
9 
2 
458.4 
(M:458.4) 
9 39,7 2,94 
tr|F0P7P0|F0P7P0_
STAPE 
Cell division protein ftsA OS=Staphylococcus pseudintermedius (strain ED99) GN=ftsA PE=3 SV=1 52,1 
4,
5 
1 
688.3 
(M:688.3) 
14 33,3 166,05 
tr|E8SJ87|E8SJ87_S
TAPH 
Cell division protein FtsK OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1508 PE=4 SV=1 122,6 
5,
2 
3 
93.5 
(M:93.5) 
2 2,7 7,39 
tr|F0P7P6|F0P7P6_
STAPE 
Cell division protein FtsL OS=Staphylococcus pseudintermedius (strain ED99) GN=ftsL PE=3 SV=1 14,9 
9,
6 
1 
65.4 
(M:65.4) 
1 10,2 4,15 
tr|F0P7N9|F0P7N9_
STAPE 
Cell division protein FtsZ OS=Staphylococcus pseudintermedius (strain ED99) GN=ftsZ PE=3 SV=1 40,9 
4,
9 
3 
1503.7 
(M:1503.7) 
18 50 4,48 
sp|Q5HGP2|SEPF_S
TAAC 
Cell division protein SepF OS=Staphylococcus aureus (strain COL) GN=sepF PE=3 SV=1 21 
4,
9 
2 
124.5 
(M:124.5) 
3 15 2,7 
tr|E8SIR2|E8SIR2_S
TAPH 
Cell shape-determining protein MreC OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1413 PE=3 SV=1 31 
7,
2 
1 
142.7 
(M:142.7) 
4 20,5 319,32 
tr|F0P4Y8|F0P4Y8_S
TAPE 
Cell wall biosynthesis protein ScdA OS=Staphylococcus pseudintermedius (strain ED99) GN=scdA PE=3 SV=1 25,3 
5,
3 
1 
285.7 
(M:285.7) 
6 32,1 2,41 
tr|E8SK62|E8SK62_S
TAPH 
Cell wall surface anchor family protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1669 PE=4 SV=1 40,9 
6,
5 
2 
115.3 
(M:115.3) 
3 6,8 5,69 
tr|E8SID3|E8SID3_S
TAPH 
Chaperone protein DnaJ OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=dnaJ PE=3 SV=1 41,6 
6,
4 
3 
218.9 
(M:218.9) 
6 21,5 4,25 
tr|F0P4K7|F0P4K7_
STAPE 
Chaperone protein DnaK OS=Staphylococcus pseudintermedius (strain ED99) GN=dnaK PE=3 SV=1 66 
4,
6 
3 
2327.1 
(M:2327.1) 
38 63,8 75,52 
tr|F0P3Y9|F0P3Y9_S
TAPE 
Chitinase-related protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1733 PE=4 SV=1 11,8 
4,
4 
1 
108.3 
(M:108.3) 
3 28,8 2 
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tr|F0P679|F0P679_S
TAPE 
Chorismate synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=aroC PE=3 SV=1 42,8 
5,
9 
2 
290.5 
(M:290.5) 
6 17,2 3,31 
tr|E8SHQ9|E8SHQ9
_STAPH 
Chromosomal replication initiator protein DnaA OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=dnaA PE=3 SV=1 51,1 
5,
3 
3 
224.5 
(M:224.5) 
6 10,5 6,33 
tr|F0P9T3|F0P9T3_S
TAPE 
Chromosome partioning protein, ParB family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2499 PE=4 SV=1 32,6 
5,
4 
1 
210.8 
(M:210.8) 
5 18,4 273,74 
tr|F0P3K9|F0P3K9_
STAPE 
Citrate synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=gltA PE=3 SV=1 42 
5,
3 
2 
229.7 
(M:229.7) 
6 16,4 5,56 
tr|F0P8K1|F0P8K1_
STAPE 
Coenzyme A disulfide reductase OS=Staphylococcus pseudintermedius (strain ED99) GN=cdr PE=4 SV=1 49,6 
5,
9 
2 
361.7 
(M:361.7) 
8 17 4,35 
tr|F0P8E5|F0P8E5_
STAPE 
Cof-like hydrolase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2223 PE=4 SV=1 31,7 5 2 
364.3 
(M:364.3) 
6 28,8 4,28 
tr|F0P8L8|F0P8L8_S
TAPE 
Cold shock protein B OS=Staphylococcus pseudintermedius (strain ED99) GN=cspB PE=3 SV=1 7,3 
4,
5 
2 
251.4 
(M:251.4) 
4 60,6 3,81 
tr|F0P6D4|F0P6D4_
STAPE 
Cold shock protein OS=Staphylococcus pseudintermedius (strain ED99) GN=cspA PE=3 SV=1 7,3 
4,
5 
3 
257.0 
(M:257.0) 
5 50 237,65 
tr|F0P6E5|F0P6E5_
STAPE 
Conserved virulence factor B OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1398 PE=4 SV=1 34,9 
5,
1 
1 
124.0 
(M:124.0) 
3 10,6 2,88 
tr|F0P6A7|F0P6A7_
STAPE 
Conserved virulence factor C OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1357 PE=4 SV=1 42,6 
5,
1 
1 
121.1 
(M:121.1) 
3 9,7 3,59 
tr|F0P4A6|F0P4A6_
STAPE 
CTP synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=pyrG PE=3 SV=1 60,2 5 2 
533.1 
(M:533.1) 
11 27,2 4,84 
tr|F0P9M7|F0P9M7
_STAPE 
Cystathionine gamma-synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=metB2 PE=3 SV=1 41,6 
4,
9 
2 
327.3 
(M:327.3) 
6 15 4,26 
tr|F0P817|F0P817_S
TAPE 
Cysteine desulfurase OS=Staphylococcus pseudintermedius (strain ED99) GN=sufS PE=3 SV=1 45,9 
5,
1 
2 
370.8 
(M:370.8) 
7 22,3 3,23 
tr|F0P915|F0P915_S
TAPE 
Cysteine synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=cysK PE=4 SV=1 33 
5,
5 
2 
1855.8 
(M:1855.8) 
25 77 2,16 
tr|F0P9M8|F0P9M8
_STAPE 
Cysteine synthase/cystathionine beta-synthase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2356 PE=4 SV=1 32,8 
4,
9 
2 
306.2 
(M:306.2) 
7 26,9 266,52 
tr|F0P8Y6|F0P8Y6_S
TAPE 
Cysteine--tRNA ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=cysS PE=3 SV=1 53,7 5 2 
296.9 
(M:296.9) 
6 13,7 3,44 
tr|F0P8U3|F0P8U3_
STAPE 
Cys-tRNA(Pro)/Cys-tRNA(Cys) deacylase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2046 PE=3 SV=1 17,6 
7,
2 
1 
132.3 
(M:132.3) 
3 10,1 8,14 
tr|F0P4M0|F0P4M0
_STAPE 
Cytidine deaminase OS=Staphylococcus pseudintermedius (strain ED99) GN=cdd PE=4 SV=1 14,8 
4,
9 
1 
390.3 
(M:390.3) 
6 49,6 4,27 
tr|F0P5J6|F0P5J6_S
TAPE 
Cytidylate kinase OS=Staphylococcus pseudintermedius (strain ED99) GN=cmk PE=3 SV=1 24,6 
4,
8 
2 
319.8 
(M:319.8) 
6 32 2,08 
tr|F0P8N3|F0P8N3_
STAPE 
cytosol aminopeptidase 54,4 
5,
8 
1 
89.6 
(M:89.6) 
3 6,1 348,23 
tr|F0P797|F0P797_S
TAPE 
D-3-phosphoglycerate dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=serA PE=4 SV=1 57,7 
5,
3 
1 
215.7 
(M:215.7) 
4 12,1 231,37 
tr|F0P7J3|F0P7J3_S
TAPE 
dak2 domain fusion protein 60,7 
4,
6 
3 
699.1 
(M:699.1) 
13 26,2 3,97 
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tr|F0P773|F0P773_S
TAPE 
D-alanine aminotransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=dat PE=3 SV=1 31,6 
5,
1 
1 
1022.1 
(M:1022.1) 
16 72 2,77 
tr|F0P4F5|F0P4F5_
STAPE 
D-alanine--D-alanine ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=ddl PE=3 SV=1 39,9 5 2 
404.7 
(M:404.7) 
10 31,5 5,13 
tr|E8SER8|E8SER8_
STAPH 
D-alanine--poly(Phosphoribitol) ligase subunit 1 OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0724 PE=3 SV=1 54,4 
5,
5 
2 
286.8 
(M:286.8) 
6 12,6 5,1 
tr|F0P7Z1|F0P7Z1_S
TAPE 
D-alanine--poly(phosphoribitol) ligase subunit 2 OS=Staphylococcus pseudintermedius (strain ED99) GN=dltC PE=3 SV=1 9 
3,
9 
2 
39.7 
(M:39.7) 
1 19,2 4,63 
tr|E8SIE2|E8SIE2_S
TAPH 
dCMP deaminase Late competence protein ComEB OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1357 PE=3 SV=1 17,2 
6,
5 
3 
165.8 
(M:165.8) 
3 18,3 5,29 
tr|F0P4F7|F0P4F7_
STAPE 
dead deah box helicase 56,1 
9,
5 
1 
45.5 
(M:45.5) 
2 5,1 314,5 
tr|E8SGZ9|E8SGZ9_
STAPH 
Deblocking aminopeptidase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1096 PE=4 SV=1 38,1 
5,
4 
2 
95.5 
(M:95.5) 
3 7,3 5,95 
tr|F0P8W1|F0P8W1
_STAPE 
Decarboxylase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2064 PE=4 SV=1 20,9 
5,
2 
3 
123.2 
(M:123.2) 
3 20,1 6,3 
tr|F0P6B1|F0P6B1_
STAPE 
DegV family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1361 PE=4 SV=1 31,2 
6,
2 
2 
525.6 
(M:525.6) 
9 32 3,62 
tr|F0P3N6|F0P3N6_
STAPE 
Delta-aminolevulinic acid dehydratase OS=Staphylococcus pseudintermedius (strain ED99) GN=hemB PE=3 SV=1 36,5 
5,
1 
2 
210.2 
(M:210.2) 
6 22,5 1,43 
tr|F0P5K2|F0P5K2_
STAPE 
Demethylmenaquinone methyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=ubiE PE=3 SV=1 26,9 
8,
6 
2 
215.5 
(M:215.5) 
6 18,1 1,89 
tr|F0P8E8|F0P8E8_
STAPE 
DeoxyadenosIne kinase OS=Staphylococcus pseudintermedius (strain ED99) GN=dak PE=4 SV=1 26,3 
5,
5 
3 
89.4 
(M:89.4) 
2 12,2 369 
tr|F0P447|F0P447_S
TAPE 
Deoxycytidine triphosphate deaminase OS=Staphylococcus pseudintermedius (strain ED99) GN=dcd PE=3 SV=1 20,2 
4,
8 
1 
131.8 
(M:131.8) 
3 23,2 1,66 
tr|F0P3A8|F0P3A8_
STAPE 
Deoxyribose-phosphate aldolase OS=Staphylococcus pseudintermedius (strain ED99) GN=deoC PE=3 SV=1 23,7 
4,
9 
2 
625.2 
(M:625.2) 
11 61,4 128,27 
tr|F0P3L6|F0P3L6_S
TAPE 
Dephospho-CoA kinase OS=Staphylococcus pseudintermedius (strain ED99) GN=coaE PE=3 SV=1 23,1 
4,
9 
1 
461.8 
(M:461.8) 
9 46,9 2,36 
tr|F0P3K2|F0P3K2_
STAPE 
DHH subfamily phosphodiesterase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1098 PE=4 SV=1 34,8 
4,
6 
2 
48.8 
(M:48.8) 
2 6,5 5 
tr|E8SH13|E8SH13_
STAPH 
Diaminopimelate decarboxylase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=lysA PE=3 SV=1 46,7 
5,
3 
2 
150.7 
(M:150.7) 
4 8,6 370,56 
tr|E8SH41|E8SH41_
STAPH 
Dihydrofolate reductase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1138 PE=3 SV=1 18,3 5 2 
142.4 
(M:142.4) 
3 23,3 5,73 
tr|E8SHJ4|E8SHJ4_S
TAPH 
Dihydrolipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex OS=Staphylococcus pseudintermedius (strain HKU10-03) 
GN=SPSINT_1209 PE=3 SV=1 
46,9 
5,
2 
2 
108.1 
(M:108.1) 
3 5,2 4,15 
tr|F0P3V2|F0P3V2_
STAPE 
Dihydrolipoyl dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=pdhD PE=3 SV=1 49,5 
4,
8 
1 
1969.1 
(M:1969.1) 
29 62 4,33 
tr|F0P7L8|F0P7L8_S
TAPE 
Dihydroorotase OS=Staphylococcus pseudintermedius (strain ED99) GN=pyrC PE=3 SV=1 46,1 
5,
1 
3 
460.5 
(M:460.5) 
11 36,3 4,63 
tr|F0P7L5|F0P7L5_S
TAPE 
Dihydroorotate dehydrogenase B (NAD(+)), electron transfer subunit OS=Staphylococcus pseudintermedius (strain ED99) GN=pyrK PE=3 SV=1 27,6 
5,
2 
1 
269.0 
(M:269.0) 
6 24 2,05 
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tr|F0P7L4|F0P7L4_S
TAPE 
Dihydroorotate dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=pyrD PE=3 SV=1 32,7 
5,
6 
1 
105.5 
(M:105.5) 
2 9,8 4,36 
tr|F0P914|F0P914_S
TAPE 
Dihydropteroate synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=folP PE=4 SV=1 29,4 
4,
9 
1 
120.8 
(M:120.8) 
2 6,7 2,24 
tr|F0P402|F0P402_S
TAPE 
Dihydroxyacetone kinase, DhaK subunit OS=Staphylococcus pseudintermedius (strain ED99) GN=dhaK PE=4 SV=1 34,9 
4,
7 
3 
414.5 
(M:414.5) 
8 24,1 5,36 
tr|F0P403|F0P403_S
TAPE 
Dihydroxyacetone kinase, DhaL subunit OS=Staphylococcus pseudintermedius (strain ED99) GN=dhaL PE=4 SV=1 21,1 
4,
5 
1 
659.2 
(M:659.2) 
9 52,8 5,28 
tr|E8SI70|E8SI70_ST
APH 
Dipeptide-binding ABC transporter, periplasmic substrate-binding component OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0079 PE=4 SV=1 59,9 
5,
9 
2 
118.8 
(M:118.8) 
3 6,9 5,37 
tr|E8SDR2|E8SDR2_
STAPH 
D-lactate dehydrogenase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0522 PE=4 SV=1 37 
4,
7 
2 
95.6 
(M:95.6) 
3 6,3 5,09 
tr|B0B0K7|B0B0K7_
9STAP 
DNA gyrase subunit B OS=Staphylococcus pseudintermedius GN=gyrB PE=3 SV=1 68,9 
5,
7 
5 
339.0 
(M:339.0) 
10 13,9 5,45 
tr|F0P621|F0P621_S
TAPE 
DNA ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=ligA PE=3 SV=1 75 
5,
2 
3 
168.5 
(M:168.5) 
4 7,8 5,27 
tr|E8SGK1|E8SGK1_
STAPH 
DNA mismatch repair protein MutL OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=mutL PE=3 SV=1 73,3 
5,
2 
2 
118.2 
(M:118.2) 
4 5,7 667,87 
tr|E8SGK0|E8SGK0_
STAPH 
DNA mismatch repair protein MutS OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=mutS PE=3 SV=1 98,3 5 2 
131.1 
(M:131.1) 
4 5,2 334,4 
tr|E8SHQ8|E8SHQ8
_STAPH 
DNA polymerase III subunit beta OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2450 PE=3 SV=1 41,8 
4,
7 
3 
352.0 
(M:352.0) 
6 16 4,67 
tr|E8SIU8|E8SIU8_S
TAPH 
DNA polymerase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1449 PE=3 SV=1 99,2 5 3 
681.6 
(M:681.6) 
15 18,4 4,04 
tr|F0P7D1|F0P7D1_
STAPE 
DNA-binding protein 11 
9,
5 
1 
26.9 
(M:26.9) 
1 11,6 1,85 
tr|F0P977|F0P977_S
TAPE 
dna-binding protein 23,6 
5,
2 
2 
502.2 
(M:502.2) 
7 44,7 5,69 
tr|F0P5K0|F0P5K0_
STAPE 
DNA-binding protein HU OS=Staphylococcus pseudintermedius (strain ED99) GN=hup PE=3 SV=1 9,6 
9,
5 
2 
989.5 
(M:989.5) 
11 73,3 150,12 
tr|F0P9C0|F0P9C0_
STAPE 
dna-binding regulatory family 26,3 
4,
6 
2 
119.8 
(M:119.8) 
3 11,3 0,69 
tr|F0P3C2|F0P3C2_
STAPE 
DNA-directed RNA polymerase subunit alpha OS=Staphylococcus pseudintermedius (strain ED99) GN=rpoA PE=3 SV=1 35 
4,
7 
2 
566.2 
(M:566.2) 
11 32,2 4,35 
tr|F0P8X3|F0P8X3_
STAPE 
DNA-directed RNA polymerase subunit beta OS=Staphylococcus pseudintermedius (strain ED99) GN=rpoB PE=3 SV=1 133,5 5 10 
1356.7 
(M:1356.7) 
28 24,4 5,32 
tr|E8SDZ9|E8SDZ9_
STAPH 
dna-directed rna polymerase subunit delta 21,2 
3,
6 
3 
209.3 
(M:209.3) 
4 24,6 2,54 
tr|F0P7K8|F0P7K8_
STAPE 
DNA-directed RNA polymerase subunit omega OS=Staphylococcus pseudintermedius (strain ED99) GN=rpoZ PE=3 SV=1 7,9 7 1 
65.5 
(M:65.5) 
1 13 5,41 
tr|E8SJ75|E8SJ75_S
TAPH 
Do-like Serine protease, DegP/HtrA OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1496 PE=4 SV=1 45,1 
5,
8 
2 
754.7 
(M:754.7) 
11 30,5 4,23 
tr|F0P7N4|F0P7N4_
STAPE 
D-ribose pyranase OS=Staphylococcus pseudintermedius (strain ED99) GN=rbsD PE=3 SV=1 15 
5,
7 
3 
85.3 
(M:85.3) 
2 12,7 4,98 
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tr|E8SHG6|E8SHG6
_STAPH 
Elastin binding protein EbpS OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1181 PE=4 SV=1 49 
5,
5 
2 
386.9 
(M:386.9) 
7 19,1 5,26 
tr|F0P4K3|F0P4K3_
STAPE 
Elongation factor 4 OS=Staphylococcus pseudintermedius (strain ED99) GN=lepA PE=3 SV=1 68,1 5 2 
49.5 
(M:49.5) 
2 3,1 2,14 
tr|F0P8W8|F0P8W8
_STAPE 
Elongation factor G OS=Staphylococcus pseudintermedius (strain ED99) GN=fusA PE=3 SV=1 76,7 
4,
8 
2 
1882.5 
(M:1882.5) 
36 52,7 4,21 
tr|F0P5F0|F0P5F0_
STAPE 
Elongation factor P OS=Staphylococcus pseudintermedius (strain ED99) GN=efp PE=3 SV=1 20,6 
4,
9 
2 
361.5 
(M:361.5) 
7 30,3 3,63 
tr|F0P7E3|F0P7E3_
STAPE 
Elongation factor Ts OS=Staphylococcus pseudintermedius (strain ED99) GN=tsf PE=3 SV=1 32,4 
5,
2 
2 
1804.0 
(M:1804.0) 
26 74 2,41 
tr|F0P8W7|F0P8W7
_STAPE 
Elongation factor Tu OS=Staphylococcus pseudintermedius (strain ED99) GN=tuf PE=3 SV=1 43,2 
4,
7 
17 
2612.3 
(M:2612.3) 
34 78,5 3,41 
tr|E8SIA9|E8SIA9_S
TAPH 
endonuclease iv 33,2 
5,
7 
3 
507.7 
(M:507.7) 
9 31,6 3,81 
tr|E8SEL4|E8SEL4_S
TAPH 
Endonuclease/Exonuclease/phosphatase family protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1927 PE=4 SV=1 69,4 
8,
5 
2 
436.7 
(M:436.7) 
11 19,6 5,18 
tr|F0P931|F0P931_S
TAPE 
endoribonuclease L-PSP 14 5 1 
40.3 
(M:40.3) 
1 11,9 1,38 
tr|F0P851|F0P851_S
TAPE 
Enolase OS=Staphylococcus pseudintermedius (strain ED99) GN=eno PE=3 SV=1 47 
4,
5 
2 
2072.1 
(M:2072.1) 
28 75,6 82,35 
tr|F0P8G8|F0P8G8_
STAPE 
Enoyl-[acyl-carrier-protein] reductase [NADPH] OS=Staphylococcus pseudintermedius (strain ED99) GN=fabI PE=3 SV=1 27,8 
5,
9 
2 
610.8 
(M:610.8) 
12 40 151,32 
tr|E8SIK3|E8SIK3_S
TAPH 
Excinuclease ABC OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0130 PE=4 SV=1 83,8 6 2 
156.0 
(M:156.0) 
4 5,7 388,7 
tr|F0P3J0|F0P3J0_S
TAPE 
Exfoliative toxin OS=Staphylococcus pseudintermedius (strain ED99) GN=siet PE=4 SV=1 35,8 
5,
3 
2 
477.6 
(M:477.6) 
7 31,2 173,54 
tr|E8SIY6|E8SIY6_ST
APH 
Extracellular adherence protein of broad specificity Eap/Map OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1487 PE=4 SV=1 27,4 
9,
8 
2 
1587.8 
(M:1587.8) 
23 64 3,34 
tr|E8SHG9|E8SHG9
_STAPH 
Ferredoxin OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1184 PE=4 SV=1 8,9 
3,
5 
2 
93.1 
(M:93.1) 
2 17,1 529,77 
tr|F0P722|F0P722_S
TAPE 
Ferredoxin oxidoreductase subunit beta OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1484 PE=4 SV=1 31,1 5 2 
468.0 
(M:468.0) 
8 37,8 3,52 
tr|E8SEW8|E8SEW8
_STAPH 
Ferrichrome-binding periplasmic protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1951 PE=4 SV=1 34,5 
5,
5 
2 
163.4 
(M:163.4) 
4 20,5 368,45 
tr|F0P640|F0P640_S
TAPE 
Ferritin OS=Staphylococcus pseudintermedius (strain ED99) GN=ftnA PE=4 SV=1 19,9 
4,
6 
2 
223.3 
(M:223.3) 
3 20,4 543,46 
tr|F0P6T3|F0P6T3_S
TAPE 
Ferrochelatase OS=Staphylococcus pseudintermedius (strain ED99) GN=hemH PE=3 SV=1 35,4 
4,
9 
1 
376.2 
(M:376.2) 
7 27,7 1,4 
tr|Q5HHH2|Q5HHH
2_STAAC 
FeS assembly ATPase SufC OS=Staphylococcus aureus (strain COL) GN=SACOL0914 PE=3 SV=1 28,3 
4,
9 
2 
75.1 
(M:75.1) 
2 13,4 277,55 
tr|F0P815|F0P815_S
TAPE 
FeS assembly protein SufB OS=Staphylococcus pseudintermedius (strain ED99) GN=sufB PE=4 SV=1 52,5 
5,
1 
2 
420.2 
(M:420.2) 
11 23,2 5,72 
tr|F0P9S7|F0P9S7_S
TAPE 
flavin reductase 23 
4,
8 
1 
114.2 
(M:114.2) 
2 10,2 1,52 
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tr|F0P3Y8|F0P3Y8_S
TAPE 
Flavohemoprotein OS=Staphylococcus pseudintermedius (strain ED99) GN=hmp PE=3 SV=1 42,3 
5,
4 
1 
472.5 
(M:472.5) 
10 24,1 2,97 
tr|F0P5P5|F0P5P5_
STAPE 
FMN-dependent NADH-azoreductase OS=Staphylococcus pseudintermedius (strain ED99) GN=azoR PE=3 SV=1 23,2 
5,
1 
1 
746.5 
(M:746.5) 
12 55,8 4,88 
tr|F0P6S2|F0P6S2_S
TAPE 
Foldase protein PrsA OS=Staphylococcus pseudintermedius (strain ED99) GN=prsA PE=4 SV=1 36,3 
6,
3 
2 
1053.3 
(M:1053.3) 
21 59,1 3,66 
tr|F0P4Z1|F0P4Z1_S
TAPE 
Formate acetyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=pflB PE=3 SV=1 84,7 
5,
4 
2 
2233.2 
(M:2233.2) 
38 39 4,53 
tr|F8TLV0|F8TLV0_
9STAP 
Formate dehydrogenase OS=Staphylococcus pseudintermedius PE=3 SV=1 110,2 
5,
2 
3 
217.2 
(M:217.2) 
7 7,6 373,93 
tr|F0P791|F0P791_S
TAPE 
Formate--tetrahydrofolate ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=fhs PE=3 SV=1 60,2 
5,
9 
4 
385.9 
(M:385.9) 
8 13,3 5,09 
tr|F0P432|F0P432_S
TAPE 
Fructosamine kinase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0289 PE=4 SV=1 32,4 
4,
4 
2 
224.5 
(M:224.5) 
3 13,9 4,91 
tr|F0P4B0|F0P4B0_
STAPE 
Fructose-1,6-bisphosphate aldolase, class II OS=Staphylococcus pseudintermedius (strain ED99) GN=fba PE=4 SV=1 31,2 
5,
1 
3 
1064.7 
(M:1064.7) 
20 50,3 3,91 
tr|E8SGQ2|E8SGQ2
_STAPH 
Fructose-bisphosphate aldolase class I OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2258 PE=4 SV=1 33 
4,
9 
2 
1963.0 
(M:1963.0) 
33 92,6 125,44 
tr|E8SJR0|E8SJR0_S
TAPH 
Fumarate hydratase class II OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=fumC PE=3 SV=1 50,8 
5,
4 
3 
297.9 
(M:297.9) 
8 20,8 5,29 
tr|F0P8K4|F0P8K4_
STAPE 
Fumarylacetoacetate hydrolase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1868 PE=4 SV=1 33,1 
4,
9 
2 
921.6 
(M:921.6) 
18 68,1 95,61 
tr|F0P3I4|F0P3I4_S
TAPE 
GAF domain protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1080 PE=4 SV=1 16,2 
4,
6 
2 
253.7 
(M:253.7) 
4 31,8 2,19 
tr|E8SEV7|E8SEV7_
STAPH 
Galactose-1-phosphate uridylyltransferase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=galT PE=3 SV=1 57,1 
5,
1 
2 
57.9 
(M:57.9) 
2 3,8 3,83 
tr|F0P5D2|F0P5D2_
STAPE 
Glucokinase OS=Staphylococcus pseudintermedius (strain ED99) GN=glk PE=4 SV=1 35,3 
5,
3 
1 
238.0 
(M:238.0) 
4 15,2 2,74 
tr|F0P8D6|F0P8D6_
STAPE 
Glucosamine-6-phosphate deaminase OS=Staphylococcus pseudintermedius (strain ED99) GN=nagB PE=3 SV=1 27,3 
4,
8 
2 
72.2 
(M:72.2) 
2 8,2 1,96 
tr|F0P6Q5|F0P6Q5_
STAPE 
Glucosamine-6-phosphate isomerase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0945 PE=4 SV=1 22,2 
5,
9 
1 
649.9 
(M:649.9) 
10 41,7 164,33 
tr|F0P5H4|F0P5H4_
STAPE 
Glucose-6-phosphate 1-dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=zwf PE=3 SV=1 57,1 
5,
4 
3 
787.8 
(M:787.8) 
17 40,7 3,1 
tr|F0P8K9|F0P8K9_
STAPE 
Glucose-6-phosphate isomerase OS=Staphylococcus pseudintermedius (strain ED99) GN=pgi PE=3 SV=1 49,2 
4,
9 
2 
1008.9 
(M:1008.9) 
18 62,5 4,05 
tr|F0P8L3|F0P8L3_S
TAPE 
Glutamate dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=gudB PE=3 SV=1 45,5 
5,
1 
2 
399.8 
(M:399.8) 
10 25,1 3,69 
tr|F0P3N7|F0P3N7_
STAPE 
Glutamate-1-semialdehyde 2,1-aminomutase OS=Staphylococcus pseudintermedius (strain ED99) GN=hemL PE=3 SV=1 46,7 
4,
8 
2 
630.8 
(M:630.8) 
11 35,3 2,07 
tr|E8SJ07|E8SJ07_S
TAPH 
Glutamate--tRNA ligase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=gltX PE=3 SV=1 56,2 5 2 
337.8 
(M:337.8) 
7 15,7 276,86 
tr|F0P642|F0P642_S
TAPE 
glutamine amidotransferase 27 
5,
6 
1 
62.0 
(M:62.0) 
2 7,5 976,53 
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tr|F0P906|F0P906_S
TAPE 
Glutamine amidotransferase subunit PdxT OS=Staphylococcus pseudintermedius (strain ED99) GN=pdxT PE=3 SV=1 20,6 
5,
2 
2 
244.0 
(M:244.0) 
6 44,9 197,45 
tr|F0P701|F0P701_S
TAPE 
Glutamine synthetase OS=Staphylococcus pseudintermedius (strain ED99) GN=glnA PE=3 SV=1 51 
5,
1 
2 
965.0 
(M:965.0) 
18 51,1 4,02 
tr|F0P3I0|F0P3I0_S
TAPE 
Glutamine--fructose-6-phosphate aminotransferase [isomerizing] OS=Staphylococcus pseudintermedius (strain ED99) GN=glmS PE=3 SV=1 66,1 5 3 
1358.8 
(M:1358.8) 
25 37 5,57 
tr|F0P778|F0P778_S
TAPE 
Glutamyl aminopeptidase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1048 PE=4 SV=1 39,3 
5,
3 
2 
116.7 
(M:116.7) 
2 6,5 2,88 
tr|F0P625|F0P625_S
TAPE 
Glutamyl-tRNA(Gln) amidotransferase subunit A OS=Staphylococcus pseudintermedius (strain ED99) GN=gatA PE=3 SV=1 53 5 2 
633.4 
(M:633.4) 
11 25,7 3,1 
tr|F0P705|F0P705_S
TAPE 
Glutathione peroxidase OS=Staphylococcus pseudintermedius (strain ED99) GN=bsaA PE=3 SV=1 17,8 
6,
5 
3 
493.0 
(M:493.0) 
13 71,3 4,4 
tr|F0P855|F0P855_S
TAPE 
Glyceraldehyde-3-phosphate dehydrogenase 1 OS=Staphylococcus pseudintermedius (strain ED99) GN=gapA PE=3 SV=1 36,4 
4,
8 
24 
1495.1 
(M:1495.1) 
22 54,9 5,3 
tr|F0P3L7|F0P3L7_S
TAPE 
Glyceraldehyde-3-phosphate dehydrogenase 2 OS=Staphylococcus pseudintermedius (strain ED99) GN=gapB PE=3 SV=1 36,8 
5,
4 
1 
64.1 
(M:64.1) 
2 7,1 3,08 
tr|F0P712|F0P712_S
TAPE 
Glycerol kinase OS=Staphylococcus pseudintermedius (strain ED99) GN=glpK PE=3 SV=1 55,8 
4,
9 
2 
692.0 
(M:692.0) 
12 24,8 4,45 
tr|F0P8S4|F0P8S4_S
TAPE 
Glycerol phosphate lipoteichoic acid synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=ltaS PE=4 SV=1 74,3 
6,
3 
3 
366.5 
(M:366.5) 
9 17,4 3,15 
tr|F0P715|F0P715_S
TAPE 
Glycerol uptake operon antiterminator regulatory protein OS=Staphylococcus pseudintermedius (strain ED99) GN=glpP PE=4 SV=1 19,9 
7,
1 
2 
158.2 
(M:158.2) 
3 24,3 3,2 
tr|F0P9F3|F0P9F3_
STAPE 
Glycerol-3-phosphate cytidylyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=tagD PE=4 SV=1 15,8 
5,
4 
2 
416.5 
(M:416.5) 
10 47,7 4,1 
tr|F0P5J9|F0P5J9_S
TAPE 
Glycerol-3-phosphate dehydrogenase [NAD(P)+] OS=Staphylococcus pseudintermedius (strain ED99) GN=gpsA PE=3 SV=1 35,9 
5,
7 
1 
152.8 
(M:152.8) 
4 13,9 280,43 
tr|F0P3S6|F0P3S6_S
TAPE 
glycerophosphoryl diester phosphodiesterase 34,9 8 2 
161.0 
(M:161.0) 
4 14,5 3,02 
tr|B1GVE4|B1GVE4
_9STAP 
Glycerophosphoryl diester phosphodiesterase OS=Staphylococcus pseudintermedius GN=ugpQ PE=4 SV=1 27,9 
4,
9 
1 
232.3 
(M:232.3) 
6 28,3 3,89 
tr|F0P828|F0P828_S
TAPE 
Glycine cleavage system H protein OS=Staphylococcus pseudintermedius (strain ED99) GN=gcvH PE=3 SV=1 13,8 4 2 
254.9 
(M:254.9) 
4 50 282,08 
tr|F0P5E4|F0P5E4_
STAPE 
glycine dehydrogenase subunit 2 54,9 
5,
4 
2 
47.9 
(M:47.9) 
2 4,3 488,6 
tr|E8SIB8|E8SIB8_S
TAPH 
Glycine--tRNA ligase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=glyQS PE=3 SV=1 53,5 5 3 
1155.7 
(M:1155.7) 
20 54,1 4,83 
tr|F0P856|F0P856_S
TAPE 
Glycolytic operon regulator OS=Staphylococcus pseudintermedius (strain ED99) GN=gapR PE=4 SV=1 38,7 
8,
4 
1 
180.5 
(M:180.5) 
5 19,1 490,04 
tr|F0P687|F0P687_S
TAPE 
Glycosyl transferase, group 1 family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1335 PE=4 SV=1 42,2 
5,
4 
3 
102.4 
(M:102.4) 
3 8 6,92 
tr|F0P9S6|F0P9S6_S
TAPE 
Glyoxylase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2492 PE=4 SV=1 36,5 
4,
8 
2 
604.1 
(M:604.1) 
10 37,2 4,02 
tr|F0P802|F0P802_S
TAPE 
Glyoxylate reductase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1904 PE=4 SV=1 36,1 
5,
3 
1 
356.8 
(M:356.8) 
7 22,1 5,07 
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tr|F0P6X4|F0P6X4_
STAPE 
GMP reductase OS=Staphylococcus pseudintermedius (strain ED99) GN=guaC PE=3 SV=1 35,9 
6,
5 
4 
398.4 
(M:398.4) 
10 31,4 3,9 
tr|F0P971|F0P971_S
TAPE 
GMP synthase [glutamine-hydrolyzing] OS=Staphylococcus pseudintermedius (strain ED99) GN=guaA PE=3 SV=1 58,4 
4,
9 
2 
526.4 
(M:526.4) 
13 24,8 136,41 
tr|E8SJ47|E8SJ47_S
TAPH 
GTP cyclohydrolase FolE2 OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=folE2 PE=3 SV=1 33,4 
5,
3 
3 
191.7 
(M:191.7) 
4 13,7 4,22 
tr|F0P5J8|F0P5J8_S
TAPE 
GTPase Der OS=Staphylococcus pseudintermedius (strain ED99) GN=engA PE=3 SV=1 49 
5,
7 
2 
527.7 
(M:527.7) 
10 24,8 4,94 
tr|F0P4M1|F0P4M1
_STAPE 
GTPase Era OS=Staphylococcus pseudintermedius (strain ED99) GN=era PE=3 SV=1 34,1 
6,
4 
1 
61.2 
(M:61.2) 
2 8,7 2,29 
tr|F0P3P9|F0P3P9_
STAPE 
GTPase obg OS=Staphylococcus pseudintermedius (strain ED99) GN=obgE PE=3 SV=1 47,4 
5,
2 
1 
214.5 
(M:214.5) 
5 14,2 4,1 
tr|F0P9A5|F0P9A5_
STAPE 
GTP-binding protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2477 PE=4 SV=1 40,5 
4,
7 
2 
447.1 
(M:447.1) 
9 32,1 132,82 
tr|F0P7E5|F0P7E5_
STAPE 
GTP-sensing transcriptional pleiotropic repressor CodY OS=Staphylococcus pseudintermedius (strain ED99) GN=codY PE=3 SV=1 28,6 
5,
6 
1 
840.7 
(M:840.7) 
15 48,6 2,91 
tr|F0P7K9|F0P7K9_
STAPE 
Guanylate kinase OS=Staphylococcus pseudintermedius (strain ED99) GN=gmk PE=3 SV=1 24 
5,
4 
1 
107.5 
(M:107.5) 
2 10,6 1,53 
tr|F0P4J5|F0P4J5_S
TAPE 
HAD family hydrolase 22,4 
5,
7 
1 
94.7 
(M:94.7) 
2 8,8 6,62 
tr|F0P803|F0P803_S
TAPE 
HAD-superfamily subfamily IIA hydrolase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1905 PE=4 SV=1 28,3 
4,
4 
2 
56.0 
(M:56.0) 
2 7,7 508,43 
tr|F0P608|F0P608_S
TAPE 
haloacid dehalogenase-like family hydrolase 23,8 
5,
1 
2 
86.1 
(M:86.1) 
2 12,1 367,17 
tr|F0P4K5|F0P4K5_
STAPE 
Heat-inducible transcription repressor hrcA OS=Staphylococcus pseudintermedius (strain ED99) GN=hrcA PE=3 SV=1 37,3 
6,
1 
2 
322.7 
(M:322.7) 
7 26,1 3,87 
tr|E8SGW7|E8SGW7
_STAPH 
heat-shock protein 16,8 
5,
3 
2 
377.0 
(M:377.0) 
7 62,5 154,08 
tr|F0P4E9|F0P4E9_
STAPE 
heavy metal-associated domain protein 8,1 
4,
6 
1 
24.2 
(M:24.2) 
1 21,9 8,46 
tr|E8SGB4|E8SGB4_
STAPH 
Heme-degrading cytoplasmic oxygenase IsdI OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2202 PE=4 SV=1 12,8 8 2 
21.7 
(M:21.7) 
1 11 2,78 
tr|F0P6S7|F0P6S7_S
TAPE 
Histidine triad (HIT) protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0967 PE=4 SV=1 15,9 5 3 
399.8 
(M:399.8) 
8 51,8 2,68 
tr|F0P4G1|F0P4G1_
STAPE 
Histidine--tRNA ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=hisS PE=3 SV=1 48,4 
5,
4 
3 
321.2 
(M:321.2) 
8 20,1 3,48 
tr|F0P8R8|F0P8R8_
STAPE 
Histidinol-phosphate aminotransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=hisC PE=3 SV=1 39 
5,
1 
2 
237.6 
(M:237.6) 
6 20,3 4,88 
tr|F0P3Q2|F0P3Q2_
STAPE 
Holliday junction ATP-dependent DNA helicase RuvB OS=Staphylococcus pseudintermedius (strain ED99) GN=ruvB PE=3 SV=1 37,7 
5,
1 
2 
50.0 
(M:50.0) 
2 4,5 5,74 
tr|F0P4H5|F0P4H5_
STAPE 
Holliday junction resolvase 15,7 
5,
1 
2 
89.9 
(M:89.9) 
2 12,7 3,28 
tr|F0P548|F0P548_S
TAPE 
Holo-[acyl-carrier-protein] synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=acpS PE=3 SV=1 13,4 7 2 
123.7 
(M:123.7) 
3 20,7 5,85 
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tr|F0P6Y2|F0P6Y2_S
TAPE 
Homoserine dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=hom PE=3 SV=1 46,5 
4,
9 
2 
115.7 
(M:115.7) 
4 7 5,84 
sp|Q5HHQ8|HPRK_
STAAC 
HPr kinase/phosphorylase OS=Staphylococcus aureus (strain COL) GN=hprK PE=3 SV=1 34,5 6 2 
70.9 
(M:70.9) 
2 5,8 3,57 
tr|F0P8V5|F0P8V5_
STAPE 
HTH-type transcriptional regulator MgrA OS=Staphylococcus pseudintermedius (strain ED99) GN=mgrA PE=4 SV=1 16,8 
5,
8 
1 
335.2 
(M:335.2) 
6 52,4 144,82 
tr|F0P5W3|F0P5W3
_STAPE 
HTH-type transcriptional regulator TcaR OS=Staphylococcus pseudintermedius (strain ED99) GN=tcaR PE=4 SV=1 17,5 8 1 
78.1 
(M:78.1) 
2 11,7 2,65 
tr|F0P588|F0P588_S
TAPE 
Hydrolase, carbon-nitrogen family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0797 PE=4 SV=1 30,3 
4,
9 
1 
226.8 
(M:226.8) 
5 21,7 288,11 
tr|F0P9J7|F0P9J7_S
TAPE 
Hydrolase, TatD family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2320 PE=4 SV=1 29 
5,
4 
2 
140.3 
(M:140.3) 
4 16,9 3,13 
tr|F0P918|F0P918_S
TAPE 
Hypoxanthine phosphoribosyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=hpt PE=4 SV=1 20,2 
4,
9 
2 
307.0 
(M:307.0) 
5 31,3 1,31 
tr|E8SHU1|E8SHU1
_STAPH 
IgG-binding protein SBI OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0032 PE=4 SV=1 56,5 
5,
4 
2 
467.7 
(M:467.7) 
10 20,1 3,66 
tr|E8SF10|E8SF10_S
TAPH 
Imidazolonepropionase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=hutI PE=3 SV=1 45,6 
5,
2 
2 
167.8 
(M:167.8) 
4 11,4 3,85 
tr|F0P9M2|F0P9M2
_STAPE 
Immunodominant staphylococcal antigen B, putative OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2350 PE=4 SV=1 19 
8,
6 
1 
512.7 
(M:512.7) 
8 36,3 3,25 
tr|F0P5B5|F0P5B5_
STAPE 
inorganic pyrophosphatase 34 
4,
6 
1 
493.4 
(M:493.4) 
7 31,6 1,82 
tr|F0P972|F0P972_S
TAPE 
Inosine-5'-monophosphate dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=guaB PE=3 SV=1 52,4 
5,
3 
3 
1909.5 
(M:1909.5) 
33 70,7 4,83 
tr|F0P3U2|F0P3U2_
STAPE 
Inositol monophosphatase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1685 PE=4 SV=1 30,2 
5,
2 
1 
130.9 
(M:130.9) 
2 11,8 311,02 
tr|F0P658|F0P658_S
TAPE 
Intracellular protease, PfpI family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0878 PE=4 SV=1 18,5 
4,
5 
2 
916.2 
(M:916.2) 
11 55,3 157,86 
tr|F0P876|F0P876_S
TAPE 
Iron compound ABC transporter periplasmic component OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2150 PE=4 SV=1 32,8 
6,
4 
2 
176.3 
(M:176.3) 
3 11,9 2,74 
tr|F0P9G9|F0P9G9_
STAPE 
Iron compound ABC transporter, iron compound-binding protein OS=Staphylococcus pseudintermedius (strain ED99) GN=sirA PE=4 SV=1 36,2 
6,
1 
3 
549.8 
(M:549.8) 
11 35,5 4,3 
tr|E8SDS7|E8SDS7_
STAPH 
Iron-sulfur cluster assembly protein SufD OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0537 PE=4 SV=1 48,4 
4,
9 
3 
459.3 
(M:459.3) 
10 27,1 4,58 
tr|E8SJR5|E8SJR5_S
TAPH 
Iron-sulfur cluster-binding protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1604 PE=4 SV=1 41,9 
6,
4 
3 
90.2 
(M:90.2) 
3 7,4 2,92 
tr|E8SEG2|E8SEG2_
STAPH 
Isochorismatase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1875 PE=4 SV=1 20,3 
5,
2 
1 
71.5 
(M:71.5) 
1 10,5 0,5 
tr|F0P3L0|F0P3L0_S
TAPE 
Isocitrate dehydrogenase [NADP] OS=Staphylococcus pseudintermedius (strain ED99) GN=icd PE=3 SV=1 46,3 5 2 
562.8 
(M:562.8) 
12 30,5 3,81 
tr|F0P7M4|F0P7M4
_STAPE 
Isoleucine--tRNA ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=ileS PE=3 SV=1 104,3 
5,
2 
6 
322.5 
(M:322.5) 
8 7,3 6,21 
tr|E8SG76|E8SG76_
STAPH 
Isoprenyl transferase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0986 PE=3 SV=1 29,4 
6,
6 
3 
120.5 
(M:120.5) 
3 15,8 292,05 
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tr|E8SE98|E8SE98_S
TAPH 
kinase-associated protein b 14,6 
5,
8 
2 
80.1 
(M:80.1) 
2 13,5 8,85 
tr|F0P5T4|F0P5T4_S
TAPE 
lactate dehydrogenase 35,3 
5,
4 
1 
415.8 
(M:415.8) 
10 30,5 152,02 
tr|F0P4Y9|F0P4Y9_S
TAPE 
Leucine dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=dhlE PE=3 SV=1 39,4 5 2 
401.2 
(M:401.2) 
7 19,5 3,54 
tr|F0P765|F0P765_S
TAPE 
Leucine--tRNA ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=leuS PE=3 SV=1 92,2 5 3 
600.4 
(M:600.4) 
15 13,2 6,15 
tr|F0P6X2|F0P6X2_
STAPE 
LexA repressor OS=Staphylococcus pseudintermedius (strain ED99) GN=lexA PE=3 SV=1 23,3 
5,
2 
1 
68.8 
(M:68.8) 
2 13 298,65 
tr|E8SI63|E8SI63_ST
APH 
Lipase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0072 PE=4 SV=1 75,8 
7,
8 
2 
144.1 
(M:144.1) 
4 7,7 6,11 
tr|E8SFE0|E8SFE0_
STAPH 
Lipoprotein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2041 PE=4 SV=1 25,7 
5,
4 
2 
348.8 
(M:348.8) 
5 27,4 207,23 
tr|F0P807|F0P807_S
TAPE 
Lipoyl synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=lipA PE=3 SV=1 34,8 
8,
6 
2 
132.3 
(M:132.3) 
4 15,7 4,8 
tr|F0P760|F0P760_S
TAPE 
L-lactate dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=ldh PE=3 SV=1 33,9 
5,
1 
1 
1195.1 
(M:1195.1) 
16 45,6 1,44 
tr|F0P652|F0P652_S
TAPE 
Low molecular weight protein-tyrosine-phosphatase PtpA OS=Staphylococcus pseudintermedius (strain ED99) GN=ptpA PE=4 SV=1 17,5 
4,
7 
1 
108.8 
(M:108.8) 
2 15,1 2,4 
tr|F0P4C1|F0P4C1_
STAPE 
Low molecular weight protein-tyrosine-phosphatase PtpB OS=Staphylococcus pseudintermedius (strain ED99) GN=ptpB PE=4 SV=1 15,9 
4,
7 
1 
100.1 
(M:100.1) 
2 15,6 434,8 
tr|E8SIQ4|E8SIQ4_S
TAPH 
Lysine--tRNA ligase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=lysS PE=3 SV=1 56,8 
5,
3 
3 
350.3 
(M:350.3) 
9 15,4 3,85 
tr|F0P380|F0P380_S
TAPE 
lysophospholipase 31,9 
4,
5 
1 
227.6 
(M:227.6) 
5 25,7 2,17 
tr|F0P8U9|F0P8U9_
STAPE 
Malate dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=mdh PE=3 SV=1 33,6 
5,
2 
1 
91.4 
(M:91.4) 
2 8 2,82 
tr|F0P5V6|F0P5V6_
STAPE 
malate:quinone oxidoreductase 55,6 
7,
7 
1 
89.2 
(M:89.2) 
3 6 4,77 
tr|F0P7I7|F0P7I7_S
TAPE 
Malonyl CoA-acyl carrier protein transacylase OS=Staphylococcus pseudintermedius (strain ED99) GN=fabD PE=3 SV=1 33,8 
4,
8 
1 
251.1 
(M:251.1) 
5 24 3,48 
tr|F0P9H5|F0P9H5_
STAPE 
manganese abc transporter substrate-binding protein 34,5 
6,
1 
2 
980.1 
(M:980.1) 
17 49 154,21 
tr|F0P5Q4|F0P5Q4_
STAPE 
Metalloregulation DNA-binding stress protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0144 PE=3 SV=1 16,9 
4,
6 
1 
476.8 
(M:476.8) 
8 56,1 3,05 
tr|F0P644|F0P644_S
TAPE 
Methionine aminopeptidase OS=Staphylococcus pseudintermedius (strain ED99) GN=map PE=3 SV=1 27,6 
5,
2 
1 
475.2 
(M:475.2) 
11 42,3 185,12 
tr|F0P9J8|F0P9J8_S
TAPE 
Methionine--tRNA ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=metG PE=3 SV=1 74,8 
5,
2 
2 
704.9 
(M:704.9) 
15 19,8 5,54 
tr|F0P7K4|F0P7K4_
STAPE 
Methionyl-tRNA formyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=fmt PE=3 SV=1 34 
5,
3 
2 
113.5 
(M:113.5) 
4 9,7 2,69 
tr|E8SG67|E8SG67_
STAPH 
Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=trmFO PE=3 SV=1 48,2 
6,
1 
3 
313.4 
(M:313.4) 
6 18 4,68 
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tr|F0P5Z2|F0P5Z2_S
TAPE 
molybdenum cofactor biosysynthesis protein 25,3 
6,
8 
2 
159.7 
(M:159.7) 
2 15,5 311,44 
tr|F0P6K0|F0P6K0_
STAPE 
Molybdopterin converting factor, subunit 2 OS=Staphylococcus pseudintermedius (strain ED99) GN=moaE PE=4 SV=1 17,3 
5,
8 
1 
103.2 
(M:103.2) 
2 13,8 2,71 
tr|F0P660|F0P660_S
TAPE 
monofunctional glycosyltransferase 30,8 
9,
5 
1 
162.1 
(M:162.1) 
4 20,4 2,64 
tr|F0P551|F0P551_S
TAPE 
mRNA interferase OS=Staphylococcus pseudintermedius (strain ED99) GN=mazF PE=3 SV=1 13,1 
9,
8 
2 
162.9 
(M:162.9) 
3 17,9 595,58 
tr|F0P390|F0P390_S
TAPE 
MutT/nudix family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0234 PE=4 SV=1 14,9 
4,
7 
1 
97.6 
(M:97.6) 
2 22,3 4,16 
tr|F0P5F4|F0P5F4_
STAPE 
N utilization substance protein B homolog OS=Staphylococcus pseudintermedius (strain ED99) GN=nusB PE=3 SV=1 15,2 
5,
6 
1 
113.2 
(M:113.2) 
3 24,6 342,72 
tr|F0P3Y6|F0P3Y6_S
TAPE 
N5-carboxyaminoimidazole ribonucleotide mutase OS=Staphylococcus pseudintermedius (strain ED99) GN=purE PE=3 SV=1 17 
5,
5 
2 
113.6 
(M:113.6) 
3 23,1 5,22 
tr|E8SH51|E8SH51_
STAPH 
n6-adenine-specific dna methylase 42,1 
5,
2 
3 
116.5 
(M:116.5) 
3 8 749,37 
tr|E8SE38|E8SE38_S
TAPH 
N-acetylglucosamine-1-phosphate uridyltransferase eukaryotic OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1833 PE=4 SV=1 45,4 
5,
2 
2 
119.1 
(M:119.1) 
3 7,1 4,94 
tr|E8SEW4|E8SEW4
_STAPH 
N-acetylmannosamine kinase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1947 PE=4 SV=1 32,3 5 2 
153.6 
(M:153.6) 
3 12,2 1,33 
tr|F0P9M4|F0P9M4
_STAPE 
N-acetylmuramoyl-L-alanine amidase Sle1 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2352 PE=4 SV=1 36,7 
9,
8 
1 
514.1 
(M:514.1) 
7 29 2,98 
tr|F0P859|F0P859_S
TAPE 
NAD dependent epimerase/dehydratase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1965 PE=4 SV=1 34,3 
9,
3 
3 
271.9 
(M:271.9) 
6 19,7 2,37 
tr|F0P8W3|F0P8W3
_STAPE 
NAD dependent epimerase/dehydratase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2233 PE=4 SV=1 35,7 
4,
7 
2 
75.9 
(M:75.9) 
2 6,9 3,94 
tr|F0P8H2|F0P8H2_
STAPE 
nad(+) nadh kinase 30,3 
6,
8 
2 
57.9 
(M:57.9) 
2 7,4 3,96 
tr|F0P6H0|F0P6H0_
STAPE 
NAD/NADP octopine/nopaline dehydrogenase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0521 PE=4 SV=1 40,3 
5,
1 
2 
242.4 
(M:242.4) 
7 24,6 176,01 
tr|F0P3K4|F0P3K4_
STAPE 
NAD-dependent malic enzyme OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1100 PE=3 SV=1 44,5 
5,
1 
2 
558.0 
(M:558.0) 
12 41 147,4 
tr|F0P7Z6|F0P7Z6_S
TAPE 
nadh dehydrogenase 44,1 
6,
2 
1 
495.1 
(M:495.1) 
10 23,5 4,36 
tr|F0P3T9|F0P3T9_S
TAPE 
NADH-dependent flavin oxidoreductase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1682 PE=4 SV=1 42,1 
5,
1 
2 
725.5 
(M:725.5) 
14 42,4 1,88 
tr|F0P4U6|F0P4U6_
STAPE 
nadph:quinone oxidoreductase 20,5 
6,
1 
1 
730.1 
(M:730.1) 
9 74,6 1,67 
sp|Q5HHU4|QUEF_
STAAC 
NADPH-dependent 7-cyano-7-deazaguanine reductase OS=Staphylococcus aureus (strain COL) GN=queF PE=3 SV=1 19,6 
5,
3 
3 
69.7 
(M:69.7) 
2 14,5 380,23 
tr|F0P7U9|F0P7U9_
STAPE 
Naphthoate synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=menB PE=4 SV=1 30,3 
5,
4 
2 
614.4 
(M:614.4) 
10 44,1 2,15 
tr|F0P5C1|F0P5C1_
STAPE 
NH(3)-dependent NAD(+) synthetase OS=Staphylococcus pseudintermedius (strain ED99) GN=nadE PE=3 SV=1 30,8 
5,
4 
2 
477.7 
(M:477.7) 
9 36,7 4,36 
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tr|F0P5C0|F0P5C0_
STAPE 
Nicotinate phosphoribosyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=pncB PE=3 SV=1 56,3 6 1 
321.5 
(M:321.5) 
6 14,9 238,64 
tr|F0P534|F0P534_S
TAPE 
Nitrate reductase, beta subunit OS=Staphylococcus pseudintermedius (strain ED99) GN=narH PE=4 SV=1 59,1 
5,
8 
2 
281.6 
(M:281.6) 
8 17,4 5,18 
tr|F0P6C7|F0P6C7_
STAPE 
Nitric-oxide reductase, putative OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1377 PE=4 SV=1 29,5 
4,
7 
1 
125.2 
(M:125.2) 
3 18,1 274,91 
tr|F0P523|F0P523_S
TAPE 
Nitrite reductase [NAD(P)H], large subunit OS=Staphylococcus pseudintermedius (strain ED99) GN=nirB PE=4 SV=1 89 
5,
3 
3 
724.7 
(M:724.7) 
15 19,1 4,55 
tr|F0P524|F0P524_S
TAPE 
Nitrite reductase [NAD(P)H], small subunit OS=Staphylococcus pseudintermedius (strain ED99) GN=nirD PE=4 SV=1 11,4 
4,
5 
1 
203.9 
(M:203.9) 
3 28,8 1,07 
tr|F0P801|F0P801_S
TAPE 
Nitrogen fixation protein NifU OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1903 PE=4 SV=1 8,6 
4,
2 
1 
73.9 
(M:73.9) 
2 42,5 2,4 
tr|F0P461|F0P461_S
TAPE 
Nitroreductase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0318 PE=4 SV=1 23,7 
4,
8 
2 
477.9 
(M:477.9) 
10 47,4 2,33 
tr|F0P7R0|F0P7R0_
STAPE 
Non-canonical purine NTP pyrophosphatase OS=Staphylococcus pseudintermedius (strain ED99) GN=rdgB PE=3 SV=1 21,2 
4,
5 
1 
50.9 
(M:50.9) 
2 10,3 4,69 
tr|F0P9L0|F0P9L0_S
TAPE 
Nucleoid-associated protein SPSE_2336 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2336 PE=3 SV=1 11,6 
5,
2 
1 
127.6 
(M:127.6) 
2 15,1 6,35 
tr|F0P678|F0P678_S
TAPE 
Nucleoside diphosphate kinase OS=Staphylococcus pseudintermedius (strain ED99) GN=ndk PE=3 SV=1 16,5 
5,
4 
2 
333.5 
(M:333.5) 
7 48,7 3,56 
tr|F0P923|F0P923_S
TAPE 
nucleotide pyrophosphohydrolase 45,1 
4,
6 
1 
117.1 
(M:117.1) 
2 5,8 1,59 
tr|E8SHK3|E8SHK3_
STAPH 
Octaprenyl-diphosphate synthase / Dimethylallyltransferase / Geranyltranstransferase (Farnesyldiphosphate synthase) / Geranylgeranyl pyrophosphate synthetase 
OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1218 PE=3 SV=1 
32,6 
5,
4 
2 
115.3 
(M:115.3) 
2 8,5 5,29 
tr|F0P6E7|F0P6E7_
STAPE 
oligoendopeptidase f 68,6 
4,
7 
2 
484.8 
(M:484.8) 
11 20,7 5,36 
tr|F0P8H9|F0P8H9_
STAPE 
Oligoendopeptidase F OS=Staphylococcus pseudintermedius (strain ED99) GN=pepF PE=4 SV=1 69,6 5 3 
1201.6 
(M:1201.6) 
22 33,9 3,95 
tr|F0P8I6|F0P8I6_S
TAPE 
Oligopeptide ABC transporter, periplasmic oligopeptide-binding protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1850 PE=4 SV=1 62 
8,
6 
2 
525.3 
(M:525.3) 
12 25,5 130,24 
tr|E8SEL6|E8SEL6_S
TAPH 
Oligopeptide transport ATP-binding protein OppF OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0671 PE=3 SV=1 35,6 
8,
7 
3 
99.1 
(M:99.1) 
3 10,5 5,73 
tr|F0P8I8|F0P8I8_S
TAPE 
Oligopeptide transport ATP-binding protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1852 PE=3 SV=1 40 
5,
8 
1 
118.5 
(M:118.5) 
3 7,2 2,31 
tr|B1GVI3|B1GVI3_9
STAP 
Open reading frame X OS=Staphylococcus pseudintermedius PE=3 SV=1 12,9 
9,
3 
4 
35.6 
(M:35.6) 
1 12,4 7,34 
tr|F0P834|F0P834_S
TAPE 
Organic hydroperoxide resistance protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1939 PE=4 SV=1 15,5 
4,
6 
1 
635.6 
(M:635.6) 
9 46,4 3,27 
tr|E8SEA7|E8SEA7_
STAPH 
Ornithine aminotransferase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=rocD PE=3 SV=1 43,7 
5,
2 
3 
102.9 
(M:102.9) 
2 7 6,48 
tr|F0P7A1|F0P7A1_
STAPE 
Ornithine cyclodeaminase/mu-crystallin family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1071 PE=4 SV=1 34,9 
4,
8 
2 
218.2 
(M:218.2) 
5 14,5 3,74 
tr|F0P7L3|F0P7L3_S
TAPE 
Orotidine 5'-phosphate decarboxylase OS=Staphylococcus pseudintermedius (strain ED99) GN=pyrF PE=3 SV=1 25,8 
5,
4 
2 
84.8 
(M:84.8) 
3 10,7 5,08 
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tr|E8SIH5|E8SIH5_S
TAPH 
Oxidoreductase of aldo/keto reductase family, subgroup 1 OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1390 PE=4 SV=1 31,7 
5,
7 
2 
563.5 
(M:563.5) 
12 42,4 144,41 
tr|E8SJC7|E8SJC7_S
TAPH 
Oxidoreductase of aldo/keto reductase family, subgroup 1 OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1548 PE=4 SV=1 31,8 
5,
1 
3 
622.8 
(M:622.8) 
12 39,9 2,23 
tr|F0P6H4|F0P6H4_
STAPE 
Oxidoreductase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0525 PE=4 SV=1 38,6 
5,
5 
1 
287.0 
(M:287.0) 
5 22 2,68 
tr|F0P470|F0P470_S
TAPE 
Oxidoreductase, short chain dehydrogenase/reductase family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0327 PE=4 SV=1 31,4 
4,
6 
1 
458.8 
(M:458.8) 
9 44,7 3,48 
tr|F0P397|F0P397_S
TAPE 
Oxygen-dependent choline dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=betA PE=3 SV=1 62,9 
6,
9 
3 
616.6 
(M:616.6) 
15 33,3 93,85 
tr|E8SI88|E8SI88_ST
APH 
Pantothenate synthetase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=panC PE=3 SV=1 32,2 5 2 
168.0 
(M:168.0) 
4 14,7 4,51 
tr|F0P9E9|F0P9E9_
STAPE 
Penicillin binding protein 4 OS=Staphylococcus pseudintermedius (strain ED99) GN=pbp4 PE=3 SV=1 47,9 
9,
1 
2 
196.3 
(M:196.3) 
5 13,9 224,45 
tr|F0P695|F0P695_S
TAPE 
Penicillin-binding protein 2 OS=Staphylococcus pseudintermedius (strain ED99) GN=pbp2 PE=4 SV=1 82,2 6 2 
1445.4 
(M:1445.4) 
27 39,3 4,91 
tr|F0P4N9|F0P4N9_
STAPE 
Penicillin-binding protein 3 OS=Staphylococcus pseudintermedius (strain ED99) GN=pbp3 PE=4 SV=1 76,3 
8,
3 
3 
62.0 
(M:62.0) 
2 3,7 3,68 
tr|E8SKB8|E8SKB8_
STAPH 
Peptidase T OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=pepT PE=3 SV=1 45,4 
4,
8 
2 
286.2 
(M:286.2) 
6 17,7 3,37 
tr|F0P5G9|F0P5G9_
STAPE 
Peptidase T-like protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1288 PE=4 SV=1 40,3 
5,
1 
1 
50.8 
(M:50.8) 
2 6,7 8,42 
tr|F0P4H9|F0P4H9_
STAPE 
Peptidase, U32 family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1180 PE=4 SV=1 35,9 
4,
7 
2 
136.7 
(M:136.7) 
3 12,3 4,94 
tr|E8SDY5|E8SDY5_
STAPH 
Peptide chain release factor 1 OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=prfA PE=3 SV=1 40,5 
4,
8 
3 
234.3 
(M:234.3) 
6 17,3 3,54 
tr|F0P8N6|F0P8N6_
STAPE 
Peptide chain release factor 2 OS=Staphylococcus pseudintermedius (strain ED99) GN=prfB PE=3 SV=1 37,6 
4,
8 
2 
198.0 
(M:198.0) 
5 16,4 4,59 
tr|F0P8F3|F0P8F3_
STAPE 
Peptide chain release factor 3 OS=Staphylococcus pseudintermedius (strain ED99) GN=prfC PE=3 SV=1 59,4 
5,
1 
3 
249.1 
(M:249.1) 
7 13,5 4,94 
tr|F0P3V7|F0P3V7_
STAPE 
Peptide deformylase OS=Staphylococcus pseudintermedius (strain ED99) GN=defB PE=3 SV=1 20,8 
5,
3 
1 
502.9 
(M:502.9) 
9 34,4 2,6 
tr|F0P6B2|F0P6B2_
STAPE 
Peptide methionine sulfoxide reductase MsrA OS=Staphylococcus pseudintermedius (strain ED99) GN=msrA1 PE=3 SV=1 19,9 
4,
9 
2 
263.5 
(M:263.5) 
6 27 5,14 
tr|F0P6B3|F0P6B3_
STAPE 
Peptide methionine sulfoxide reductase MsrB OS=Staphylococcus pseudintermedius (strain ED99) GN=msrB PE=3 SV=1 16,2 
4,
9 
1 
400.3 
(M:400.3) 
5 43,7 1,52 
tr|F0P6U8|F0P6U8_
STAPE 
Peptide methionine sulfoxide reductase regulator MsrR OS=Staphylococcus pseudintermedius (strain ED99) GN=msrR PE=4 SV=1 36 
9,
7 
2 
392.3 
(M:392.3) 
10 34,4 3,87 
tr|F0P8M2|F0P8M2
_STAPE 
Peptidyl-prolyl cis-trans isomerase, cyclophilin-type OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1886 PE=3 SV=1 21,8 
4,
4 
2 
547.9 
(M:547.9) 
11 53,8 218,66 
tr|E8SFJ6|E8SFJ6_S
TAPH 
Phenylalanine--tRNA ligase alpha subunit OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=pheS PE=3 SV=1 40,2 
5,
3 
3 
177.3 
(M:177.3) 
5 13,2 353,79 
tr|E8SFJ7|E8SFJ7_S
TAPH 
Phenylalanine--tRNA ligase beta subunit OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=pheT PE=3 SV=1 88,5 
4,
9 
2 
379.2 
(M:379.2) 
7 11 3,89 
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tr|F0P622|F0P622_S
TAPE 
Pheromone lipoprotein CamS OS=Staphylococcus pseudintermedius (strain ED99) GN=camS PE=4 SV=1 45,8 
5,
2 
1 
98.9 
(M:98.9) 
3 7,7 319,02 
tr|F0P7I8|F0P7I8_S
TAPE 
Phosphate acyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=plsX PE=3 SV=1 35,4 
5,
7 
3 
440.5 
(M:440.5) 
10 27,4 4,93 
tr|F0P4L7|F0P4L7_S
TAPE 
Phosphate starvation-inducible protein PhoH OS=Staphylococcus pseudintermedius (strain ED99) GN=phoH PE=4 SV=1 34,5 
5,
7 
2 
161.8 
(M:161.8) 
3 12,4 3,57 
tr|E8SF65|E8SF65_S
TAPH 
Phosphocarrier protein of PTS system OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0789 PE=3 SV=1 9,5 
4,
7 
3 
244.5 
(M:244.5) 
4 43,2 332,33 
tr|F0P7Q9|F0P7Q9_
STAPE 
phosphodiesterase 19,3 
5,
3 
1 
100.0 
(M:100.0) 
2 17,8 328,61 
tr|E8SF66|E8SF66_S
TAPH 
Phosphoenolpyruvate-protein phosphotransferase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0790 PE=3 SV=1 63,5 
4,
7 
3 
527.5 
(M:527.5) 
12 23 5,54 
tr|E8SHP6|E8SHP6_
STAPH 
Phosphoesterase, DHH family protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2438 PE=4 SV=1 74,4 
5,
2 
3 
137.3 
(M:137.3) 
4 6,6 5,66 
tr|F0P7U0|F0P7U0_
STAPE 
Phosphoglucomutase OS=Staphylococcus pseudintermedius (strain ED99) GN=pgcA PE=3 SV=1 60,6 
4,
8 
2 
669.3 
(M:669.3) 
14 37,8 68,8 
tr|F0P3H5|F0P3H5_
STAPE 
Phosphoglucosamine mutase OS=Staphylococcus pseudintermedius (strain ED99) GN=glmM PE=3 SV=1 48,8 
4,
8 
2 
602.8 
(M:602.8) 
14 33,9 5,52 
tr|E8SJS2|E8SJS2_S
TAPH 
Phosphoglycerate dehydrogenase-like protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1611 PE=4 SV=1 36,3 
5,
8 
2 
375.8 
(M:375.8) 
8 27,8 2,82 
tr|F0P854|F0P854_S
TAPE 
Phosphoglycerate kinase OS=Staphylococcus pseudintermedius (strain ED99) GN=pgk PE=3 SV=1 42,6 
4,
7 
2 
968.9 
(M:968.9) 
20 47,2 4,48 
tr|F0P9S8|F0P9S8_S
TAPE 
Phospholipase/carboxylesterase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2494 PE=4 SV=1 21,8 
4,
8 
1 
274.6 
(M:274.6) 
6 33,3 4,17 
tr|F0P8B8|F0P8B8_
STAPE 
phosphomethylpyrimidine kinase 29,6 5 2 
301.1 
(M:301.1) 
8 34,4 3,46 
tr|F0P3S2|F0P3S2_S
TAPE 
Phosphopantetheine adenylyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=coaD PE=3 SV=1 18,5 
5,
6 
2 
158.9 
(M:158.9) 
4 22,1 410,35 
tr|F0P7K7|F0P7K7_
STAPE 
Phosphopantothenoylcysteine decarboxylase/phosphopantothenate--cysteine ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=coaBC PE=4 SV=1 44,3 
6,
5 
1 
274.6 
(M:274.6) 
5 14,7 3,45 
tr|F0P3A9|F0P3A9_
STAPE 
Phosphopentomutase OS=Staphylococcus pseudintermedius (strain ED99) GN=deoB PE=3 SV=1 43,7 
4,
8 
2 
483.2 
(M:483.2) 
11 33,2 3,72 
tr|E8SF57|E8SF57_S
TAPH 
Phosphoribosylamine--glycine ligase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=purD PE=3 SV=1 45,2 
4,
8 
3 
399.9 
(M:399.9) 
7 18 3,4 
tr|F0P3Y5|F0P3Y5_S
TAPE 
Phosphoribosylaminoimidazole carboxylase, ATPase subunit OS=Staphylococcus pseudintermedius (strain ED99) GN=purK PE=4 SV=1 42,7 
5,
3 
2 
155.5 
(M:155.5) 
2 6,4 3,02 
tr|F0P3Y4|F0P3Y4_S
TAPE 
Phosphoribosylaminoimidazole-succinocarboxamide synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=purC PE=3 SV=1 26,4 
4,
7 
1 
363.1 
(M:363.1) 
8 35,2 4,06 
tr|F0P3X9|F0P3X9_
STAPE 
Phosphoribosylformylglycinamidine cyclo-ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=purM PE=3 SV=1 36,9 
4,
6 
2 
109.5 
(M:109.5) 
2 8,7 0,99 
tr|F0P3Y2|F0P3Y2_S
TAPE 
Phosphoribosylformylglycinamidine synthase 1 OS=Staphylococcus pseudintermedius (strain ED99) GN=purQ PE=3 SV=1 24,4 
4,
9 
1 
303.4 
(M:303.4) 
7 26,9 2,89 
tr|F0P3Y1|F0P3Y1_S
TAPE 
Phosphoribosylformylglycinamidine synthase 2 OS=Staphylococcus pseudintermedius (strain ED99) GN=purL PE=3 SV=1 79,1 
4,
8 
2 
731.6 
(M:731.6) 
17 24,7 5,3 
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tr|F0P3Y3|F0P3Y3_S
TAPE 
Phosphoribosylformylglycinamidine synthase, PurS protein OS=Staphylococcus pseudintermedius (strain ED99) GN=purS PE=4 SV=1 9,8 
4,
6 
2 
157.7 
(M:157.7) 
2 31,4 0,84 
tr|E8SF55|E8SF55_S
TAPH 
Phosphoribosylglycinamide formyltransferase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0779 PE=4 SV=1 21,1 
5,
4 
2 
120.5 
(M:120.5) 
2 14,9 495,27 
tr|F0P4M5|F0P4M5
_STAPE 
phosphotransferase 31,1 
5,
6 
1 
213.9 
(M:213.9) 
6 25,8 5,9 
tr|F0P7C3|F0P7C3_
STAPE 
Polyribonucleotide nucleotidyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=pnp PE=3 SV=1 76,9 5 2 
1549.8 
(M:1549.8) 
32 42,6 5,29 
tr|F0P3N4|F0P3N4_
STAPE 
Porphobilinogen deaminase OS=Staphylococcus pseudintermedius (strain ED99) GN=hemC PE=3 SV=1 34,2 
4,
9 
3 
104.2 
(M:104.2) 
3 9,1 452,09 
tr|F0P3W3|F0P3W3
_STAPE 
Potassium uptake protein TrkA OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1706 PE=4 SV=1 24,2 5 2 
100.5 
(M:100.5) 
2 12,3 4,92 
tr|E8SK61|E8SK61_S
TAPH 
Prephenate dehydratase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1668 PE=4 SV=1 30 5 2 
98.4 
(M:98.4) 
3 10,1 4,62 
tr|F0P3Q5|F0P3Q5_
STAPE 
Preprotein translocase, YajC subunit OS=Staphylococcus pseudintermedius (strain ED99) GN=yajC PE=4 SV=1 9,7 10 1 
325.9 
(M:325.9) 
6 51,7 5,86 
tr|F0P5E9|F0P5E9_
STAPE 
Proline dipeptidase OS=Staphylococcus pseudintermedius (strain ED99) GN=pepP PE=3 SV=1 39,3 
5,
3 
1 
601.2 
(M:601.2) 
12 35,1 3,51 
tr|E8SG80|E8SG80_
STAPH 
Proline--tRNA ligase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=proS PE=3 SV=1 63,9 
5,
1 
3 
818.3 
(M:818.3) 
16 30,3 3,81 
tr|F0P6S5|F0P6S5_S
TAPE 
Protease production regulatory protein Hpr OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0965 PE=4 SV=1 20,6 
6,
2 
1 
159.0 
(M:159.0) 
4 18,8 5,35 
tr|E8SID5|E8SID5_S
TAPH 
Protein GrpE OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=grpE PE=3 SV=1 24,6 
4,
4 
3 
378.7 
(M:378.7) 
7 29,6 1,43 
tr|F0P7P8|F0P7P8_
STAPE 
Protein MraZ OS=Staphylococcus pseudintermedius (strain ED99) GN=mraZ PE=3 SV=1 17,1 
4,
8 
2 
58.2 
(M:58.2) 
2 7,7 3,6 
tr|F0P7B1|F0P7B1_
STAPE 
Protein RecA OS=Staphylococcus pseudintermedius (strain ED99) GN=recA PE=3 SV=1 37,9 
5,
3 
2 
569.6 
(M:569.6) 
12 28,5 199,51 
tr|F0P8N7|F0P8N7_
STAPE 
Protein translocase subunit SecA OS=Staphylococcus pseudintermedius (strain ED99) GN=secA PE=3 SV=1 96,5 
5,
5 
2 
182.0 
(M:182.0) 
4 6,2 3,1 
tr|F0P3Z3|F0P3Z3_S
TAPE 
protein-disulfide isomerase 26,2 
5,
7 
2 
644.2 
(M:644.2) 
14 51,5 160,41 
tr|E8SJN5|E8SJN5_S
TAPH 
Protoporphyrinogen IX oxidase, aerobic OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1574 PE=4 SV=1 52,3 
5,
7 
2 
105.4 
(M:105.4) 
3 10,7 291,33 
tr|F0P5I6|F0P5I6_S
TAPE 
Pseudouridine synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=rluB PE=3 SV=1 28,2 
9,
5 
1 
78.2 
(M:78.2) 
2 8,5 0,73 
tr|F0P6B4|F0P6B4_
STAPE 
PTS system glucose-specific IIA component OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1364 PE=4 SV=1 18 
4,
6 
2 
439.0 
(M:439.0) 
8 54,8 2,04 
tr|F0P5L7|F0P5L7_S
TAPE 
PTS system, mannose/fructose/N-acetylgalactosamine-specific component IIA OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0107 PE=4 SV=1 17,6 
6,
6 
1 
308.2 
(M:308.2) 
7 54,1 189,18 
tr|F0P9J2|F0P9J2_S
TAPE 
Pur operon repressor OS=Staphylococcus pseudintermedius (strain ED99) GN=purR PE=4 SV=1 30,4 
8,
5 
2 
187.7 
(M:187.7) 
4 19,4 3,26 
tr|E8SE11|E8SE11_S
TAPH 
Purine nucleoside phosphorylase DeoD-type OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=deoD PE=3 SV=1 26 
4,
7 
3 
156.5 
(M:156.5) 
3 17,8 238,41 
 103 
 
tr|F0P466|F0P466_S
TAPE 
Putative esterase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0323 PE=4 SV=1 33 
5,
2 
1 
62.1 
(M:62.1) 
2 6,9 1,89 
tr|F0P7T0|F0P7T0_S
TAPE 
Putative lipoprotein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1747 PE=4 SV=1 23,9 
4,
4 
1 
485.2 
(M:485.2) 
9 28,4 158,42 
tr|F0P674|F0P674_S
TAPE 
Putative peroxiredoxin OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0894 PE=4 SV=1 17,4 
5,
1 
2 
261.0 
(M:261.0) 
7 35,5 6,2 
tr|F0P4B2|F0P4B2_
STAPE 
Putative transcriptional regulator OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0702 PE=4 SV=1 12,4 
5,
7 
1 
88.1 
(M:88.1) 
2 18,3 6,38 
tr|B1GVI2|B1GVI2_9
STAP 
Putative uncharacterized protein OS=Staphylococcus pseudintermedius PE=4 SV=1 48,6 
5,
5 
2 
76.5 
(M:76.5) 
2 5,7 719,98 
tr|F0P7Z9|F0P7Z9_S
TAPE 
Pyridine nucleotide-disulfide oxidoreductase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1901 PE=4 SV=1 39,7 
6,
1 
2 
271.4 
(M:271.4) 
5 13,6 4,84 
tr|F0P907|F0P907_S
TAPE 
Pyridoxal biosynthesis lyase PdxS OS=Staphylococcus pseudintermedius (strain ED99) GN=pdxS PE=3 SV=1 31,9 
5,
5 
2 
871.8 
(M:871.8) 
16 49,2 2,59 
tr|E8SGW9|E8SGW9
_STAPH 
pyridoxal-dependent decarboxylase domain protein 53,8 
6,
3 
2 
105.8 
(M:105.8) 
3 7,2 4,65 
tr|F0P4Y0|F0P4Y0_S
TAPE 
pyridoxamine 5 -phosphate oxidase family protein 16,4 
4,
6 
1 
283.8 
(M:283.8) 
4 28,9 5,89 
tr|F0P492|F0P492_S
TAPE 
Pyrimidine-nucleoside phosphorylase OS=Staphylococcus pseudintermedius (strain ED99) GN=pdp PE=4 SV=1 46,6 
4,
6 
3 
621.6 
(M:621.6) 
12 36 246,66 
tr|E8SEY8|E8SEY8_S
TAPH 
Pyrrolidone-carboxylate peptidase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=pcp PE=3 SV=1 23,5 
5,
1 
2 
91.1 
(M:91.1) 
2 10,8 2,32 
tr|F0P5H6|F0P5H6_
STAPE 
Pyrroline-5-carboxylate reductase OS=Staphylococcus pseudintermedius (strain ED99) GN=proC PE=4 SV=1 29,9 
4,
8 
1 
122.5 
(M:122.5) 
3 12,2 3,95 
tr|F0P3T2|F0P3T2_S
TAPE 
Pyruvate carboxylase OS=Staphylococcus pseudintermedius (strain ED99) GN=pyc PE=3 SV=1 128,7 
5,
3 
2 
397.6 
(M:397.6) 
11 10,4 282,59 
tr|E8SFW9|E8SFW9
_STAPH 
Pyruvate decarboxylase Alpha-keto-acid decarboxylase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2139 PE=3 SV=1 60,3 
4,
7 
2 
362.5 
(M:362.5) 
8 17,7 4,94 
tr|F0P3V3|F0P3V3_
STAPE 
Pyruvate dehydrogenase complex E2 component, dihydrolipoamide acetyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=pdhC PE=3 SV=1 46,6 
4,
8 
2 
1494.6 
(M:1494.6) 
23 64,4 4,12 
tr|F0P3V5|F0P3V5_
STAPE 
Pyruvate dehydrogenase E1 component alpha subunit OS=Staphylococcus pseudintermedius (strain ED99) GN=pdhA PE=4 SV=1 41,5 5 2 
970.3 
(M:970.3) 
15 37 4,35 
tr|F0P3V4|F0P3V4_
STAPE 
Pyruvate dehydrogenase E1 component subunit beta OS=Staphylococcus pseudintermedius (strain ED99) GN=pdhB PE=4 SV=1 35,4 
4,
8 
2 
1096.8 
(M:1096.8) 
15 55,7 3,5 
tr|F0P723|F0P723_S
TAPE 
Pyruvate ferredoxin oxidoreductase alpha chain OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1485 PE=4 SV=1 64,5 
5,
2 
2 
383.8 
(M:383.8) 
10 20,5 5,72 
tr|F0P4Z2|F0P4Z2_S
TAPE 
Pyruvate formate-lyase-activating enzyme OS=Staphylococcus pseudintermedius (strain ED99) GN=pflA PE=4 SV=1 28,3 
5,
3 
1 
66.3 
(M:66.3) 
2 12,3 3,66 
tr|F0P3K8|F0P3K8_
STAPE 
Pyruvate kinase OS=Staphylococcus pseudintermedius (strain ED99) GN=pyk PE=3 SV=1 62,9 
4,
9 
1 
2018.1 
(M:2018.1) 
33 43,7 4,63 
tr|E8SK18|E8SK18_S
TAPH 
Pyruvate oxidase, CidC / Pyruvate oxidase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1625 PE=3 SV=1 64,2 
5,
2 
2 
1391.1 
(M:1391.1) 
25 50,8 63,52 
tr|F0P9N9|F0P9N9_
STAPE 
Pyruvate, phosphate dikinase OS=Staphylococcus pseudintermedius (strain ED99) GN=ppdK PE=4 SV=1 96,7 
4,
9 
2 
277.5 
(M:277.5) 
8 10,1 5,75 
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tr|F0P3Q4|F0P3Q4_
STAPE 
Queuine tRNA-ribosyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=tgt PE=3 SV=1 43,3 
5,
9 
2 
94.5 
(M:94.5) 
2 5 2,73 
tr|F0P7R8|F0P7R8_
STAPE 
Quinol oxidase subunit II OS=Staphylococcus pseudintermedius (strain ED99) GN=qoxA PE=4 SV=1 42 
6,
1 
2 
992.6 
(M:992.6) 
19 38,8 4,71 
tr|E8SIH7|E8SIH7_S
TAPH 
recombinase RarA 46,9 
6,
3 
2 
100.9 
(M:100.9) 
2 4,5 2,15 
tr|F0P575|F0P575_S
TAPE 
Redox-sensing transcriptional repressor rex OS=Staphylococcus pseudintermedius (strain ED99) GN=rex PE=3 SV=1 23,7 
5,
3 
2 
88.6 
(M:88.6) 
3 13 1,48 
tr|F0P8I4|F0P8I4_S
TAPE 
Regulatory protein spx OS=Staphylococcus pseudintermedius (strain ED99) GN=spxA PE=3 SV=1 15,4 
5,
7 
2 
177.6 
(M:177.6) 
4 33,6 5,28 
tr|Q5HJZ8|Q5HJZ8_
STAAC 
Replication initiation protein OS=Staphylococcus aureus (strain COL) GN=repC PE=4 SV=1 37,6 
6,
8 
3 
170.3 
(M:170.3) 
6 12,7 4,12 
tr|E8SFG7|E8SFG7_
STAPH 
Respiratory nitrate reductase alpha chain OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2068 PE=3 SV=1 138,5 
5,
8 
2 
150.0 
(M:150.0) 
4 3,4 470,45 
tr|F0P5E5|F0P5E5_
STAPE 
Rhodanese-like domain protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1264 PE=4 SV=1 14,9 
10
,1 
1 
481.5 
(M:481.5) 
7 41,4 3,08 
tr|F0P7C5|F0P7C5_
STAPE 
Riboflavin biosynthesis protein RibF OS=Staphylococcus pseudintermedius (strain ED99) GN=ribF PE=4 SV=1 36,7 
5,
3 
2 
83.3 
(M:83.3) 
3 12,1 4,84 
tr|E8SH47|E8SH47_
STAPH 
Ribonuclease HI OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1144 PE=4 SV=1 14,9 
5,
3 
2 
77.8 
(M:77.8) 
2 15,9 416,08 
tr|F0P3W1|F0P3W1
_STAPE 
Ribonuclease J OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1704 PE=3 SV=1 62 
6,
1 
2 
323.3 
(M:323.3) 
9 17,7 162,17 
tr|F0P5H5|F0P5H5_
STAPE 
Ribonuclease Z OS=Staphylococcus pseudintermedius (strain ED99) GN=rnz PE=3 SV=1 34,3 
5,
9 
1 
210.8 
(M:210.8) 
5 22 297,16 
tr|F0P8Q5|F0P8Q5_
STAPE 
Ribonucleoside-diphosphate reductase OS=Staphylococcus pseudintermedius (strain ED99) GN=nrdE PE=3 SV=1 80,2 
5,
5 
2 
516.3 
(M:516.3) 
11 17,5 5,66 
tr|F0P8Q4|F0P8Q4_
STAPE 
Ribonucleoside-diphosphate reductase, beta subunit OS=Staphylococcus pseudintermedius (strain ED99) GN=nrdF PE=4 SV=1 37 
4,
8 
2 
319.5 
(M:319.5) 
7 23,4 4,23 
tr|F0P5Z3|F0P5Z3_S
TAPE 
Ribose-5-phosphate isomerase A OS=Staphylococcus pseudintermedius (strain ED99) GN=rpiA PE=3 SV=1 25,8 
4,
9 
2 
147.0 
(M:147.0) 
4 14,7 3,51 
tr|F0P928|F0P928_S
TAPE 
Ribose-phosphate pyrophosphokinase OS=Staphylococcus pseudintermedius (strain ED99) GN=prs PE=3 SV=1 35,3 
5,
3 
2 
407.5 
(M:407.5) 
9 36,1 157,57 
tr|E8SJQ7|E8SJQ7_S
TAPH 
Ribosomal large subunit pseudouridine synthase D, YhcT OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1596 PE=4 SV=1 31,7 
6,
7 
3 
85.6 
(M:85.6) 
2 7,6 1,8 
tr|F0P4K9|F0P4K9_
STAPE 
Ribosomal protein L11 methyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=prmA PE=3 SV=1 35 
4,
4 
1 
120.0 
(M:120.0) 
3 13,5 410,56 
tr|F0P5J7|F0P5J7_S
TAPE 
Ribosomal protein S1 OS=Staphylococcus pseudintermedius (strain ED99) GN=rpsA PE=4 SV=1 43,5 
4,
6 
2 
1323.7 
(M:1323.7) 
22 62,4 3,4 
tr|E8SHN5|E8SHN5_
STAPH 
Ribosomal RNA large subunit methyltransferase H OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=rlmH PE=3 SV=1 18,1 
9,
5 
2 
25.6 
(M:25.6) 
1 11,3 0,46 
tr|F0P4L0|F0P4L0_S
TAPE 
Ribosomal RNA small subunit methyltransferase E OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1211 PE=3 SV=1 28,6 
6,
1 
1 
87.6 
(M:87.6) 
2 8 4,41 
tr|F0P7P7|F0P7P7_
STAPE 
Ribosomal RNA small subunit methyltransferase H OS=Staphylococcus pseudintermedius (strain ED99) GN=mraW PE=3 SV=1 35,4 
6,
8 
1 
71.6 
(M:71.6) 
2 8,7 3,31 
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tr|F0P4J6|F0P4J6_S
TAPE 
Ribosomal silencing factor RsfS OS=Staphylococcus pseudintermedius (strain ED99) GN=rsfS PE=3 SV=1 13,5 
4,
9 
1 
124.3 
(M:124.3) 
3 18,6 8,25 
tr|F0P8N8|F0P8N8_
STAPE 
Ribosomal subunit interface protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1985 PE=4 SV=1 21,7 
5,
3 
2 
415.9 
(M:415.9) 
8 31,2 151,74 
tr|F0P7D3|F0P7D3_
STAPE 
Ribosome maturation factor RimP OS=Staphylococcus pseudintermedius (strain ED99) GN=rimP PE=3 SV=1 17,4 
4,
9 
1 
78.3 
(M:78.3) 
2 11,6 2,95 
tr|F0P7C7|F0P7C7_
STAPE 
Ribosome-binding factor A OS=Staphylococcus pseudintermedius (strain ED99) GN=rbfA PE=3 SV=1 13,3 
5,
9 
2 
271.3 
(M:271.3) 
5 43 4,79 
tr|F0P7E1|F0P7E1_
STAPE 
Ribosome-recycling factor OS=Staphylococcus pseudintermedius (strain ED99) GN=frr PE=3 SV=1 20,4 
5,
3 
1 
853.0 
(M:853.0) 
14 52,7 136,22 
tr|F0P7J7|F0P7J7_S
TAPE 
Ribulose-phosphate 3-epimerase OS=Staphylococcus pseudintermedius (strain ED99) GN=rpe PE=3 SV=1 23,7 
4,
9 
1 
86.2 
(M:86.2) 
2 12 5,97 
tr|F0P4W7|F0P4W7
_STAPE 
ring-cleaving dioxygenase mhqO 34,2 
5,
5 
1 
421.4 
(M:421.4) 
9 27 4,52 
tr|F0P8Y4|F0P8Y4_S
TAPE 
RNA methyltransferase, TrmH family, group 3 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2255 PE=4 SV=1 27,1 
8,
9 
2 
320.2 
(M:320.2) 
8 39 4,6 
tr|F0P4M7|F0P4M7
_STAPE 
RNA polymerase sigma factor OS=Staphylococcus pseudintermedius (strain ED99) GN=sigA PE=3 SV=1 42,3 
4,
9 
2 
341.2 
(M:341.2) 
8 22,8 4,9 
tr|F0P922|F0P922_S
TAPE 
RNA-binding S4 domain protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2305 PE=4 SV=1 9,5 
9,
8 
1 
76.1 
(M:76.1) 
2 20 6,75 
tr|F0P7Y0|F0P7Y0_S
TAPE 
rRNA adenine N-6-methyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=ermA PE=4 SV=1 28,8 
9,
8 
2 
62.9 
(M:62.9) 
2 6,5 2,87 
tr|F0P920|F0P920_S
TAPE 
S1 RNA binding domain protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2303 PE=4 SV=1 13,9 
9,
5 
2 
309.7 
(M:309.7) 
8 43,2 4,92 
tr|F0P739|F0P739_S
TAPE 
S-adenosylmethionine synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=metK PE=3 SV=1 44,1 
4,
9 
3 
387.2 
(M:387.2) 
7 20,6 2,78 
tr|E8SII9|E8SII9_ST
APH 
S-adenosylmethionine:tRNA ribosyltransferase-isomerase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=queA PE=3 SV=1 38,8 
5,
5 
2 
52.4 
(M:52.4) 
2 5,9 433,64 
tr|F0P7X7|F0P7X7_
STAPE 
SAM-dependent methyltransferase 28,2 
5,
9 
1 
118.3 
(M:118.3) 
2 9 2,7 
tr|E8SEX5|E8SEX5_
STAPH 
Secretory antigen SsaA OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1958 PE=4 SV=1 25,5 
6,
5 
3 
808.4 
(M:808.4) 
7 46,3 0,34 
tr|F0P3I5|F0P3I5_S
TAPE 
Septation ring formation regulator EzrA OS=Staphylococcus pseudintermedius (strain ED99) GN=ezrA PE=4 SV=1 66,7 
4,
8 
3 
796.5 
(M:796.5) 
15 27,9 173,34 
tr|F0P4C3|F0P4C3_
STAPE 
Serine hydroxymethyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=glyA PE=3 SV=1 45,3 6 3 
1260.0 
(M:1260.0) 
25 58,7 5,54 
tr|F0P6B6|F0P6B6_
STAPE 
serine protease 56,9 
8,
2 
3 
74.9 
(M:74.9) 
2 4,9 6,47 
tr|E8SHQ1|E8SHQ1
_STAPH 
Serine--tRNA ligase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=serS PE=3 SV=1 48,4 
5,
1 
3 
668.1 
(M:668.1) 
14 42,7 116,52 
tr|F0P4J2|F0P4J2_S
TAPE 
Shikimate dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=aroE PE=3 SV=1 30,1 
5,
5 
2 
89.0 
(M:89.0) 
2 7 5,41 
tr|F0P3F5|F0P3F5_
STAPE 
Siderophore biosynthesis protein, IucA/IucC family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0632 PE=4 SV=1 74,5 
5,
4 
2 
61.5 
(M:61.5) 
2 2,8 4,98 
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tr|F0P8K7|F0P8K7_
STAPE 
Signal peptidase IB OS=Staphylococcus pseudintermedius (strain ED99) GN=sipB PE=3 SV=1 21,9 
6,
5 
2 
302.0 
(M:302.0) 
5 29,7 3,09 
tr|F0P7I0|F0P7I0_S
TAPE 
Signal recognition particle protein OS=Staphylococcus pseudintermedius (strain ED99) GN=ffh PE=3 SV=1 50,3 
8,
9 
3 
80.3 
(M:80.3) 
2 5,5 3,19 
tr|F0P7I2|F0P7I2_S
TAPE 
Signal recognition particle receptor FtsY OS=Staphylococcus pseudintermedius (strain ED99) GN=ftsY PE=3 SV=1 44,7 
4,
6 
1 
172.6 
(M:172.6) 
5 12 308,51 
tr|E8SJN8|E8SJN8_S
TAPH 
Signal transduction protein TRAP (Target of RNAIII-activating protein) OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1577 PE=4 SV=1 19,7 
5,
4 
2 
101.2 
(M:101.2) 
2 11,3 3,67 
tr|F0P3Q7|F0P3Q7_
STAPE 
Single-strand DNA-specific exonuclease RecJ OS=Staphylococcus pseudintermedius (strain ED99) GN=recJ PE=4 SV=1 85,8 5 2 
60.9 
(M:60.9) 
2 2,8 6,77 
tr|F0P995|F0P995_S
TAPE 
Single-stranded DNA-binding protein OS=Staphylococcus pseudintermedius (strain ED99) GN=ssb PE=4 SV=1 18,7 
5,
3 
5 
435.3 
(M:435.3) 
7 37,5 3,1 
tr|F0P4Y5|F0P4Y5_S
TAPE 
Sortase A OS=Staphylococcus pseudintermedius (strain ED99) GN=srtA PE=4 SV=1 22,4 
5,
6 
1 
97.6 
(M:97.6) 
3 15,2 4,05 
tr|E8SE08|E8SE08_S
TAPH 
S-ribosylhomocysteine lyase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=luxS PE=3 SV=1 17,6 
5,
2 
2 
265.5 
(M:265.5) 
5 26,9 264,84 
tr|F0P930|F0P930_S
TAPE 
stage V sporulation protein G 11,8 
4,
6 
2 
366.4 
(M:366.4) 
7 41,3 4,27 
tr|F0P9I8|F0P9I8_S
TAPE 
Staphylococcal accessory regulator A OS=Staphylococcus pseudintermedius (strain ED99) GN=sarA PE=3 SV=1 14,7 
7,
8 
1 
368.4 
(M:368.4) 
7 39 1,24 
tr|F0P6Y6|F0P6Y6_S
TAPE 
Staphylococcal accessory regulator family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1447 PE=3 SV=1 14,2 7 2 
307.7 
(M:307.7) 
7 38,3 6,21 
tr|F0P7X6|F0P7X6_
STAPE 
Streptomycin aminoglycoside 6-adenylyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=aadE PE=4 SV=1 36,1 
4,
9 
1 
102.8 
(M:102.8) 
3 10,6 2,35 
tr|F0P7R3|F0P7R3_
STAPE 
Succinate dehydrogenase flavoprotein subunit OS=Staphylococcus pseudintermedius (strain ED99) GN=sdhA PE=4 SV=1 65,3 
5,
6 
2 
697.1 
(M:697.1) 
16 32,1 5,5 
tr|F0P7R2|F0P7R2_
STAPE 
Succinate dehydrogenase iron-sulfur subunit OS=Staphylococcus pseudintermedius (strain ED99) GN=sdhB PE=4 SV=1 30,5 
7,
5 
2 
754.5 
(M:754.5) 
15 54,6 155,96 
tr|F0P406|F0P406_S
TAPE 
Succinate-semialdehyde dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=gabD PE=3 SV=1 51,1 
5,
3 
2 
336.5 
(M:336.5) 
7 18,2 4,46 
tr|F0P7F2|F0P7F2_
STAPE 
Succinyl-CoA ligase [ADP-forming] subunit alpha OS=Staphylococcus pseudintermedius (strain ED99) GN=sucD PE=3 SV=1 31,4 
5,
3 
2 
477.2 
(M:477.2) 
7 30,6 2,18 
tr|E8SG63|E8SG63_
STAPH 
Succinyl-CoA ligase [ADP-forming] subunit beta OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=sucC PE=3 SV=1 42,2 
4,
9 
3 
483.1 
(M:483.1) 
11 34 4,27 
tr|F0P4T3|F0P4T3_S
TAPE 
succinyl-diaminopimelate desuccinylase 43,2 5 1 
189.0 
(M:189.0) 
4 9,8 2,46 
sp|Q5HFK7|SODM1
_STAAC 
Superoxide dismutase [Mn/Fe] 1 OS=Staphylococcus aureus (strain COL) GN=sodA PE=3 SV=1 22,7 
5,
1 
1 
81.1 
(M:81.1) 
2 8 0,18 
tr|F0P4N8|F0P4N8_
STAPE 
Superoxide dismutase OS=Staphylococcus pseudintermedius (strain ED99) GN=sodA PE=3 SV=1 22,7 
5,
2 
13 
375.7 
(M:375.7) 
7 30,2 1,94 
tr|F0P6U2|F0P6U2_
STAPE 
Synergohymenotropic toxin OS=Staphylococcus pseudintermedius (strain ED99) GN=lukS-I PE=4 SV=1 35,1 
9,
4 
1 
87.3 
(M:87.3) 
2 7,4 2,93 
tr|F0P5L3|F0P5L3_S
TAPE 
tagatose-6-phosphate ketose isomerase 41,6 
5,
2 
1 
133.9 
(M:133.9) 
4 14,8 4,9 
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tr|F0P9F6|F0P9F6_
STAPE 
Teichoic acids export ATP-binding protein TagH OS=Staphylococcus pseudintermedius (strain ED99) GN=tagH PE=3 SV=1 29,8 
8,
9 
1 
69.8 
(M:69.8) 
3 9,8 503,52 
tr|F0P6D0|F0P6D0_
STAPE 
Tellurite resistance protein, putative OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1382 PE=4 SV=1 44,8 
5,
3 
3 
466.3 
(M:466.3) 
11 27,1 5,78 
tr|F0P682|F0P682_S
TAPE 
tetratricopeptide repeat protein 48,1 
4,
1 
2 
261.7 
(M:261.7) 
6 24,7 4,94 
tr|F0P4E4|F0P4E4_
STAPE 
Thiamine-phosphate synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=thiE PE=3 SV=1 23,6 5 1 
141.9 
(M:141.9) 
4 21,2 3,61 
tr|F0P9C2|F0P9C2_
STAPE 
Thiazole synthase OS=Staphylococcus pseudintermedius (strain ED99) GN=thiG PE=3 SV=1 27,4 
4,
9 
2 
56.8 
(M:56.8) 
2 7,1 6,55 
tr|F0P4G3|F0P4G3_
STAPE 
ThiF family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1164 PE=4 SV=1 28,2 7 2 
128.9 
(M:128.9) 
2 10,2 6,67 
tr|F0P365|F0P365_S
TAPE 
ThiJ/PfpI family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0208 PE=4 SV=1 27,3 
5,
9 
2 
138.2 
(M:138.2) 
3 16,3 2,51 
tr|F0P6W0|F0P6W0
_STAPE 
Thioesterase family protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1421 PE=4 SV=1 17,9 
5,
2 
2 
72.0 
(M:72.0) 
2 16,9 0,45 
tr|F0P3J2|F0P3J2_S
TAPE 
thiol peroxidase 18,3 
4,
3 
2 
383.4 
(M:383.4) 
5 40,9 200,69 
tr|F0P7R6|F0P7R6_
STAPE 
Thioredoxin OS=Staphylococcus pseudintermedius (strain ED99) GN=trxA PE=3 SV=1 11,5 
4,
5 
2 
832.0 
(M:832.0) 
13 99 2,55 
tr|F0P866|F0P866_S
TAPE 
Thioredoxin reductase OS=Staphylococcus pseudintermedius (strain ED99) GN=trxB PE=3 SV=1 33,4 5 2 
368.6 
(M:368.6) 
6 22,9 3,03 
tr|F0P4R3|F0P4R3_
STAPE 
Threonine dehydratase, catabolic OS=Staphylococcus pseudintermedius (strain ED99) GN=ilvA-1 PE=3 SV=1 37,2 
5,
2 
1 
1383.8 
(M:1383.8) 
22 60,1 3,57 
tr|E8SGN2|E8SGN2_
STAPH 
Threonine synthase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1060 PE=3 SV=1 38,1 5 3 
158.7 
(M:158.7) 
4 13,3 254,27 
tr|F0P3M1|F0P3M1
_STAPE 
Threonine--tRNA ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=thrS PE=3 SV=1 74,6 
5,
4 
2 
933.2 
(M:933.2) 
20 30,1 5,22 
tr|F0P9K6|F0P9K6_
STAPE 
Thymidylate kinase OS=Staphylococcus pseudintermedius (strain ED99) GN=tmk PE=3 SV=1 22,8 
5,
5 
1 
126.0 
(M:126.0) 
3 18,5 2,98 
tr|E8SH42|E8SH42_
STAPH 
Thymidylate synthase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=thyA PE=3 SV=1 36,6 
5,
5 
3 
141.7 
(M:141.7) 
4 12 5,09 
tr|F0P745|F0P745_S
TAPE 
transaldolase 25,7 
4,
6 
2 
938.2 
(M:938.2) 
16 58,1 2,04 
tr|F0P4I2|F0P4I2_S
TAPE 
Transcription elongation factor GreA OS=Staphylococcus pseudintermedius (strain ED99) GN=greA PE=3 SV=1 17,8 
4,
5 
2 
186.6 
(M:186.6) 
4 38 439,46 
tr|F0P8T9|F0P8T9_S
TAPE 
Transcription repressor of fructose operon OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2042 PE=4 SV=1 27,9 
6,
3 
1 
252.6 
(M:252.6) 
5 25,6 208,3 
tr|F0P4B5|F0P4B5_
STAPE 
Transcription termination factor Rho OS=Staphylococcus pseudintermedius (strain ED99) GN=rho PE=3 SV=1 49,7 
8,
3 
1 
54.0 
(M:54.0) 
2 5,5 492,71 
tr|E8SG84|E8SG84_
STAPH 
Transcription termination protein NusA OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0994 PE=4 SV=1 43,8 
4,
6 
3 
582.5 
(M:582.5) 
11 30,4 237,79 
tr|E8SJ15|E8SJ15_S
TAPH 
Transcription termination/antitermination protein nusG OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0210 PE=3 SV=1 20,6 
5,
1 
3 
255.1 
(M:255.1) 
5 34,6 1,64 
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tr|F0P5W6|F0P5W6
_STAPE 
Transcriptional activator, TenA/Thi-4 family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0455 PE=4 SV=1 26 
4,
6 
2 
89.0 
(M:89.0) 
2 9,8 4,08 
tr|F0P902|F0P902_S
TAPE 
Transcriptional regulator CtsR OS=Staphylococcus pseudintermedius (strain ED99) GN=ctsR PE=4 SV=1 17,8 
6,
1 
2 
387.2 
(M:387.2) 
8 51 4,49 
tr|F0P6F8|F0P6F8_
STAPE 
Transcriptional regulator OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0507 PE=4 SV=1 34,9 
6,
1 
2 
438.0 
(M:438.0) 
10 44,5 3,94 
tr|F0P5H3|F0P5H3_
STAPE 
Transcriptional regulator, AraC family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1294 PE=4 SV=1 33 
4,
9 
1 
73.6 
(M:73.6) 
2 6,3 491,49 
tr|F0P6R6|F0P6R6_
STAPE 
Transcriptional regulator, Cro/CI family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0956 PE=4 SV=1 17,7 
7,
6 
2 
103.5 
(M:103.5) 
3 20,8 370,06 
tr|F0P5I0|F0P5I0_S
TAPE 
Transcriptional regulator, Fur family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1301 PE=4 SV=1 17,5 
5,
7 
2 
346.7 
(M:346.7) 
7 38,4 3,8 
tr|F0P7U2|F0P7U2_
STAPE 
Transcriptional regulator, LytR family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1759 PE=4 SV=1 44,4 6 1 
212.8 
(M:212.8) 
4 14,5 238,25 
tr|F0P6K5|F0P6K5_
STAPE 
Transcriptional regulator, MarR family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0556 PE=4 SV=1 17,2 
6,
5 
1 
29.4 
(M:29.4) 
1 10,8 3,58 
tr|F0P4G5|F0P4G5_
STAPE 
Transcriptional regulator, putative OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1166 PE=4 SV=1 15,5 
6,
6 
1 
473.4 
(M:473.4) 
8 61,9 162,54 
tr|F0P5I7|F0P5I7_S
TAPE 
Transcriptional regulatory protein SrrA OS=Staphylococcus pseudintermedius (strain ED99) GN=srrA PE=4 SV=1 27,8 
5,
3 
2 
275.7 
(M:275.7) 
6 25,3 3,98 
tr|F0P464|F0P464_S
TAPE 
transglycosylase 24,6 
5,
7 
1 
532.8 
(M:532.8) 
5 30,6 151,58 
tr|F0P6W9|F0P6W9
_STAPE 
Transketolase OS=Staphylococcus pseudintermedius (strain ED99) GN=tkt PE=4 SV=1 72,2 
5,
1 
4 
2797.4 
(M:2797.4) 
44 64,8 4,88 
tr|F0P3B8|F0P3B8_
STAPE 
Translation initiation factor IF-1 OS=Staphylococcus pseudintermedius (strain ED99) GN=infA PE=3 SV=1 8,3 
6,
7 
1 
158.4 
(M:158.4) 
3 47,2 1,69 
tr|E8SGG9|E8SGG9
_STAPH 
Translation initiation factor IF-2 OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=infB PE=3 SV=1 78,1 
5,
2 
3 
176.7 
(M:176.7) 
4 7,9 3,99 
tr|F0P3M4|F0P3M4
_STAPE 
Translation initiation factor IF-3 OS=Staphylococcus pseudintermedius (strain ED99) GN=infC PE=3 SV=1 20,1 
9,
9 
2 
363.2 
(M:363.2) 
7 41,1 2,86 
tr|E8SG89|E8SG89_
STAPH 
Triacylglycerol lipase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2177 PE=4 SV=1 76,7 
5,
4 
6 
681.8 
(M:681.8) 
13 24,2 4,9 
tr|F0P3M9|F0P3M9
_STAPE 
Trigger factor OS=Staphylococcus pseudintermedius (strain ED99) GN=tig PE=3 SV=1 49,2 
4,
2 
1 
760.2 
(M:760.2) 
14 21,9 136,28 
tr|F0P853|F0P853_S
TAPE 
Triosephosphate isomerase OS=Staphylococcus pseudintermedius (strain ED99) GN=tpiA PE=3 SV=1 27,3 
4,
9 
1 
924.1 
(M:924.1) 
15 54,2 2,88 
tr|F0P6Q4|F0P6Q4_
STAPE 
trna (cytidine -2 -o)-methyltransferase 18,1 
5,
5 
2 
108.2 
(M:108.2) 
3 16,7 4,76 
tr|F0P9T5|F0P9T5_S
TAPE 
tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG OS=Staphylococcus pseudintermedius (strain ED99) GN=mnmG PE=3 SV=1 69,9 
5,
5 
3 
188.8 
(M:188.8) 
6 9,3 2,88 
tr|F0P781|F0P781_S
TAPE 
tRNA-binding protein 21,9 
4,
7 
1 
199.6 
(M:199.6) 
3 16,1 2,28 
tr|F0P4H0|F0P4H0_
STAPE 
tRNA-specific 2-thiouridylase MnmA OS=Staphylococcus pseudintermedius (strain ED99) GN=trmU PE=3 SV=1 41,4 5 2 
94.6 
(M:94.6) 
3 8,9 4,59 
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tr|E8SEL8|E8SEL8_S
TAPH 
Tryptophan--tRNA ligase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=trpS PE=3 SV=1 37 
5,
8 
3 
265.1 
(M:265.1) 
6 17,3 3,48 
tr|F0P539|F0P539_S
TAPE 
Two-component response regulator NreC OS=Staphylococcus pseudintermedius (strain ED99) GN=nreC PE=4 SV=1 24,3 
5,
2 
2 
220.9 
(M:220.9) 
5 27,3 227,27 
tr|E8SHB9|E8SHB9_
STAPH 
Two-component response regulator OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2393 PE=4 SV=1 22,4 
5,
3 
2 
80.0 
(M:80.0) 
2 11 4,97 
tr|F0P4Q2|F0P4Q2_
STAPE 
Two-component response regulator VicR OS=Staphylococcus pseudintermedius (strain ED99) GN=vicR PE=4 SV=1 27,3 
5,
2 
2 
125.8 
(M:125.8) 
3 16,3 412,38 
tr|F0P648|F0P648_S
TAPE 
Two-component response regulator VraR OS=Staphylococcus pseudintermedius (strain ED99) GN=vraR PE=4 SV=1 23,5 
5,
3 
1 
161.6 
(M:161.6) 
3 21,5 527,27 
tr|F0P3Z9|F0P3Z9_S
TAPE 
Two-component response regulator, LytR OS=Staphylococcus pseudintermedius (strain ED99) GN=lytR PE=4 SV=1 27,9 
5,
4 
1 
90.7 
(M:90.7) 
3 12,7 581,37 
tr|F0P793|F0P793_S
TAPE 
Tyrosine--tRNA ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=tyrS PE=3 SV=1 47,6 
5,
1 
2 
547.7 
(M:547.7) 
13 31 4,28 
tr|F0P6J0|F0P6J0_S
TAPE 
UDP-glucose 4-epimerase OS=Staphylococcus pseudintermedius (strain ED99) GN=galE PE=3 SV=1 36,9 
5,
1 
2 
101.7 
(M:101.7) 
3 8,2 4,8 
tr|E8SKB3|E8SKB3_
STAPH 
UDP-N-acetylenolpyruvoylglucosamine reductase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=murB PE=3 SV=1 34,3 
5,
2 
3 
382.0 
(M:382.0) 
8 25,2 4,42 
tr|F0P4D6|F0P4D6_
STAPE 
UDP-N-acetylglucosamine 1-carboxyvinyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=murA PE=3 SV=1 45 
5,
5 
2 
519.5 
(M:519.5) 
11 30,9 4,38 
tr|F0P4C5|F0P4C5_
STAPE 
UDP-N-acetylglucosamine 2-epimerase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0715 PE=3 SV=1 42,7 
5,
2 
3 
530.6 
(M:530.6) 
11 31,4 3,46 
tr|F0P6B8|F0P6B8_
STAPE 
UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase OS=Staphylococcus pseudintermedius (strain ED99) 
GN=murG PE=3 SV=1 
40,2 
6,
4 
2 
130.2 
(M:130.2) 
4 15,2 231,36 
tr|F0P641|F0P641_S
TAPE 
UDP-N-acetylmuramate--alanine ligase 48,8 
5,
8 
1 
341.2 
(M:341.2) 
9 16,3 6,18 
tr|E8SJ86|E8SJ86_S
TAPH 
UDP-N-acetylmuramate--L-alanine ligase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=murC PE=3 SV=1 49,2 
4,
9 
2 
259.0 
(M:259.0) 
7 18,8 4,54 
tr|E8SFP0|E8SFP0_
STAPH 
UDP-N-acetylmuramoylalanine--D-glutamate ligase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=murD PE=3 SV=1 49,9 6 2 
332.5 
(M:332.5) 
7 18,5 4,26 
tr|F0P8F5|F0P8F5_
STAPE 
UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--L-lysine ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=murE PE=3 SV=1 54 
5,
4 
3 
368.0 
(M:368.0) 
10 25,1 4,7 
tr|F0P4F6|F0P4F6_
STAPE 
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase OS=Staphylococcus pseudintermedius (strain ED99) GN=murF PE=3 SV=1 50 5 2 
84.8 
(M:84.8) 
2 9,7 251,59 
tr|F0P7Q0|F0P7Q0_
STAPE 
Uncharacterized N-acetyltransferase SPSE_1633 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1633 PE=3 SV=1 17,4 5 2 
320.4 
(M:320.4) 
6 38,9 1,58 
tr|Q5HJ42|Q5HJ42_
STAAC 
Uncharacterized protein OS=Staphylococcus aureus (strain COL) GN=SACOL0323 PE=4 SV=1 11,9 
7,
9 
1 
24.1 
(M:24.1) 
1 12,7 0,18 
tr|Q5HFW4|Q5HFW
4_STAAC 
Uncharacterized protein OS=Staphylococcus aureus (strain COL) GN=SACOL1499 PE=4 SV=1 12,2 
5,
1 
2 
63.1 
(M:63.1) 
2 21 1,69 
tr|F0P4W5|F0P4W5
_STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0088 PE=4 SV=1 18 
4,
7 
1 
63.0 
(M:63.0) 
2 9,3 3,85 
tr|F0P4W6|F0P4W6
_STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0089 PE=4 SV=1 16,8 
4,
7 
1 
368.4 
(M:368.4) 
6 51,7 5,59 
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tr|F0P5M2|F0P5M2
_STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0112 PE=4 SV=1 18,9 5 1 
326.4 
(M:326.4) 
4 28,1 1,47 
tr|F0P5Q1|F0P5Q1_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0141 PE=4 SV=1 19,9 
5,
5 
1 
458.6 
(M:458.6) 
8 40,3 4,87 
tr|F0P5Q3|F0P5Q3_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0143 PE=4 SV=1 12,5 
4,
6 
1 
67.5 
(M:67.5) 
1 11,2 1,7 
tr|F0P341|F0P341_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0182 PE=4 SV=1 19,4 
4,
4 
2 
288.1 
(M:288.1) 
6 40,6 3,39 
tr|F0P459|F0P459_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0316 PE=4 SV=1 31,8 
9,
5 
1 
133.0 
(M:133.0) 
3 10,6 1,89 
tr|F0P4Z4|F0P4Z4_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0365 PE=4 SV=1 23,6 
5,
1 
2 
417.7 
(M:417.7) 
7 43,8 2,16 
tr|F0P546|F0P546_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0422 PE=4 SV=1 13,9 
9,
3 
1 
171.9 
(M:171.9) 
4 39 4,52 
tr|F0P5T7|F0P5T7_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0426 PE=4 SV=1 12,5 
6,
2 
1 
218.1 
(M:218.1) 
4 32,4 7,06 
tr|F0P6H5|F0P6H5_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0526 PE=4 SV=1 12,5 
9,
4 
1 
265.3 
(M:265.3) 
6 31,6 3,56 
tr|F0P3F1|F0P3F1_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0628 PE=4 SV=1 21,3 
9,
4 
2 
427.1 
(M:427.1) 
6 28,6 4,3 
tr|F0P3F2|F0P3F2_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0629 PE=4 SV=1 9,5 
9,
4 
2 
21.9 
(M:21.9) 
1 12,3 6,94 
tr|F0P3G3|F0P3G3_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0640 PE=4 SV=1 10,1 
5,
9 
2 
528.4 
(M:528.4) 
10 86 6,21 
tr|F0P3H3|F0P3H3_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0659 PE=4 SV=1 29,7 
6,
3 
2 
116.9 
(M:116.9) 
3 12,3 5,63 
tr|F0P490|F0P490_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0679 PE=4 SV=1 15,7 9 1 
116.5 
(M:116.5) 
3 21,6 3,03 
tr|F0P497|F0P497_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0687 PE=4 SV=1 26,3 
4,
5 
1 
90.0 
(M:90.0) 
2 13 4,71 
tr|F0P5B0|F0P5B0_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0819 PE=4 SV=1 15,1 
5,
5 
2 
164.1 
(M:164.1) 
3 30,2 0,69 
tr|F0P5B1|F0P5B1_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0820 PE=4 SV=1 6,4 
5,
1 
1 
90.7 
(M:90.7) 
1 22,8 4,92 
tr|F0P6P8|F0P6P8_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0937 PE=4 SV=1 8,3 
5,
2 
1 
71.1 
(M:71.1) 
2 48,1 258,95 
tr|F0P6S6|F0P6S6_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0966 PE=4 SV=1 13 
9,
3 
2 
312.8 
(M:312.8) 
5 45,8 6,72 
tr|F0P740|F0P740_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1009 PE=4 SV=1 35,2 
5,
9 
3 
791.9 
(M:791.9) 
16 56,4 5,16 
tr|F0P777|F0P777_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1047 PE=4 SV=1 12,2 9 2 
77.8 
(M:77.8) 
2 22,9 0,8 
tr|F0P784|F0P784_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1054 PE=4 SV=1 22,1 
5,
9 
2 
895.4 
(M:895.4) 
11 63,9 4,24 
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tr|F0P785|F0P785_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1055 PE=4 SV=1 39,3 
9,
1 
2 
923.4 
(M:923.4) 
14 45,5 200,26 
tr|F0P4L4|F0P4L4_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1215 PE=4 SV=1 24 
5,
7 
2 
83.4 
(M:83.4) 
2 8,8 1,53 
tr|F0P5F3|F0P5F3_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1272 PE=4 SV=1 13,7 
6,
4 
1 
120.9 
(M:120.9) 
2 16,1 6,82 
tr|F0P5G7|F0P5G7_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1286 PE=4 SV=1 16,3 
4,
9 
2 
254.3 
(M:254.3) 
5 35,2 289,62 
tr|F0P6A8|F0P6A8_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1358 PE=4 SV=1 16,2 
4,
7 
1 
139.2 
(M:139.2) 
3 23,3 4,51 
tr|F0P6Y7|F0P6Y7_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1448 PE=4 SV=1 34 6 1 
94.0 
(M:94.0) 
2 6,6 0,7 
tr|F0P719|F0P719_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1481 PE=4 SV=1 14,5 5 1 
37.4 
(M:37.4) 
1 12 0,98 
tr|F0P724|F0P724_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1486 PE=4 SV=1 29,7 
6,
1 
2 
316.6 
(M:316.6) 
7 25 2,82 
tr|F0P7J4|F0P7J4_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1577 PE=4 SV=1 13,5 
5,
1 
2 
192.2 
(M:192.2) 
4 37,9 5,17 
tr|F0P7N7|F0P7N7_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1620 PE=3 SV=1 25,5 
5,
8 
3 
74.0 
(M:74.0) 
2 8 3,8 
tr|F0P7N8|F0P7N8_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1621 PE=4 SV=1 30,8 
4,
8 
2 
71.3 
(M:71.3) 
2 8,9 5,74 
tr|F0P3S4|F0P3S4_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1667 PE=4 SV=1 15,3 
5,
8 
1 
68.9 
(M:68.9) 
2 14 4,01 
tr|F0P3S5|F0P3S5_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1668 PE=4 SV=1 9,9 
9,
5 
1 
36.1 
(M:36.1) 
1 14,8 6,65 
tr|F0P3S7|F0P3S7_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1670 PE=4 SV=1 16,8 
5,
1 
1 
67.8 
(M:67.8) 
2 14,4 0,83 
tr|F0P3S8|F0P3S8_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1671 PE=4 SV=1 41,2 
5,
2 
1 
48.5 
(M:48.5) 
2 10,1 305,64 
tr|F0P3U4|F0P3U4_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1687 PE=4 SV=1 26 
5,
7 
1 
111.6 
(M:111.6) 
2 13,5 0,34 
tr|F0P3W9|F0P3W9
_STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1712 PE=4 SV=1 19,7 
9,
9 
1 
206.9 
(M:206.9) 
4 24,4 2,97 
tr|F0P805|F0P805_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1907 PE=4 SV=1 10,2 
4,
3 
2 
176.2 
(M:176.2) 
4 43,2 4,16 
tr|F0P871|F0P871_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1978 PE=4 SV=1 13,2 
5,
3 
1 
114.2 
(M:114.2) 
2 13,8 4,28 
tr|F0P9B1|F0P9B1_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2066 PE=4 SV=1 11,5 
5,
1 
1 
141.0 
(M:141.0) 
3 44,4 1,84 
tr|F0P9C8|F0P9C8_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2084 PE=4 SV=1 23,9 
4,
7 
1 
48.3 
(M:48.3) 
2 11,7 3,27 
tr|F0P9I6|F0P9I6_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2142 PE=4 SV=1 9,5 
8,
7 
2 
33.2 
(M:33.2) 
1 11,2 6,96 
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tr|F0P9J0|F0P9J0_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2146 PE=4 SV=1 18,4 
9,
4 
1 
238.8 
(M:238.8) 
4 29,3 6,76 
tr|F0P8B6|F0P8B6_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2192 PE=4 SV=1 11,6 
4,
8 
2 
64.8 
(M:64.8) 
1 14 6,02 
tr|F0P8E0|F0P8E0_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2218 PE=4 SV=1 13,5 
5,
7 
2 
128.3 
(M:128.3) 
2 17,6 1,63 
tr|F0P9K5|F0P9K5_
STAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2328 PE=4 SV=1 11,8 
4,
3 
1 
21.3 
(M:21.3) 
1 15,6 1,28 
tr|F0P975|F0P975_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2443 PE=4 SV=1 16,2 
4,
9 
1 
723.4 
(M:723.4) 
13 82,1 4,84 
tr|F0P986|F0P986_S
TAPE 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2455 PE=4 SV=1 35 
5,
1 
2 
169.3 
(M:169.3) 
4 23,3 230,42 
tr|E8SJ37|E8SJ37_S
TAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0232 PE=4 SV=1 4,6 9 1 
29.9 
(M:29.9) 
1 18,4 4,48 
tr|E8SJW1|E8SJW1_
STAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0380 PE=4 SV=1 18,6 5 2 
97.9 
(M:97.9) 
3 23,3 277,44 
tr|E8SE90|E8SE90_S
TAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0627 PE=4 SV=1 13,6 
6,
4 
2 
120.4 
(M:120.4) 
3 23,2 6,64 
tr|E8SG62|E8SG62_
STAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0972 PE=4 SV=1 10,8 
4,
3 
2 
78.1 
(M:78.1) 
1 15,4 2,8 
tr|E8SGJ6|E8SGJ6_S
TAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1024 PE=4 SV=1 11,1 
4,
3 
2 
50.1 
(M:50.1) 
1 10,1 3,06 
tr|E8SGP0|E8SGP0_
STAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1068 PE=4 SV=1 31,2 
6,
1 
2 
83.0 
(M:83.0) 
2 9,2 4,76 
tr|E8SHV0|E8SHV0_
STAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1247 PE=4 SV=1 13,5 
4,
6 
1 
52.8 
(M:52.8) 
2 16,5 5,96 
tr|E8SIC8|E8SIC8_S
TAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1343 PE=4 SV=1 18 
5,
5 
2 
123.7 
(M:123.7) 
3 20,4 357,69 
tr|E8SIT4|E8SIT4_ST
APH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1435 PE=4 SV=1 23,2 
4,
8 
2 
168.5 
(M:168.5) 
3 14,8 5,02 
tr|E8SJ89|E8SJ89_S
TAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1510 PE=4 SV=1 33,5 
5,
8 
2 
123.7 
(M:123.7) 
4 12,2 5,44 
tr|E8SJN4|E8SJN4_S
TAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1573 PE=4 SV=1 21,1 5 2 
117.8 
(M:117.8) 
3 20,1 2,66 
tr|E8SEY6|E8SEY6_S
TAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1969 PE=4 SV=1 17,3 
9,
4 
2 
147.6 
(M:147.6) 
3 15,5 2,8 
tr|E8SG92|E8SG92_
STAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2180 PE=4 SV=1 38,1 
6,
6 
2 
353.8 
(M:353.8) 
8 28,3 188,07 
tr|E8SGS5|E8SGS5_
STAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2281 PE=4 SV=1 20,1 
4,
8 
2 
59.5 
(M:59.5) 
2 13,5 5,1 
tr|E8SH95|E8SH95_
STAPH 
Uncharacterized protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2369 PE=4 SV=1 16,8 
4,
7 
1 
328.8 
(M:328.8) 
6 55,8 5,59 
tr|F0P3J5|F0P3J5_S
TAPE 
Universal stress protein family OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1091 PE=4 SV=1 18,6 
4,
9 
2 
1010.8 
(M:1010.8) 
12 72,5 1,87 
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tr|F0P865|F0P865_S
TAPE 
UPF0042 nucleotide-binding protein SPSE_1972 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1972 PE=3 SV=1 34,8 6 2 
156.1 
(M:156.1) 
2 9,6 2,99 
tr|F0P7I1|F0P7I1_S
TAPE 
UPF0122 protein SPSE_1564 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1564 PE=3 SV=1 13,8 
5,
1 
1 
81.9 
(M:81.9) 
2 14,4 6,96 
tr|F0P6X0|F0P6X0_
STAPE 
UPF0291 protein SPSE_1431 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1431 PE=3 SV=1 9 
7,
9 
1 
46.5 
(M:46.5) 
2 26,9 506,48 
tr|F0P6R8|F0P6R8_
STAPE 
UPF0342 protein SPSE_0958 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0958 PE=3 SV=1 13,3 
4,
3 
1 
632.0 
(M:632.0) 
14 74,6 3,79 
tr|F0P3W0|F0P3W0
_STAPE 
UPF0356 protein SPSE_1703 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1703 PE=3 SV=1 8,8 
5,
4 
2 
196.4 
(M:196.4) 
4 66,2 4,88 
sp|Q5HFI7|Y1630_S
TAAC 
UPF0365 protein SACOL1630 OS=Staphylococcus aureus (strain COL) GN=SACOL1630 PE=3 SV=1 35,2 
5,
5 
1 
369.2 
(M:369.2) 
6 17,3 2,88 
tr|F0P4L5|F0P4L5_S
TAPE 
UPF0365 protein SPSE_1216 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1216 PE=3 SV=1 35,2 
6,
1 
1 
860.6 
(M:860.6) 
17 56,2 4,68 
tr|F0P8A0|F0P8A0_
STAPE 
UPF0447 protein SPSE_2174 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_2174 PE=3 SV=1 29,6 
5,
1 
2 
168.3 
(M:168.3) 
4 14,3 4,32 
tr|F0P4H6|F0P4H6_
STAPE 
UPF0473 protein SPSE_1177 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1177 PE=3 SV=1 12,4 
3,
9 
1 
120.6 
(M:120.6) 
2 21,7 3,57 
tr|F0P3U3|F0P3U3_
STAPE 
UPF0637 protein SPSE_1686 OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_1686 PE=3 SV=1 23,8 
6,
4 
2 
198.3 
(M:198.3) 
5 26,1 3,54 
tr|F0P4C4|F0P4C4_
STAPE 
Uracil phosphoribosyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=upp PE=3 SV=1 23 
5,
4 
2 
744.5 
(M:744.5) 
14 69,4 3,32 
tr|F0P8B7|F0P8B7_
STAPE 
Uracil-DNA glycosylase OS=Staphylococcus pseudintermedius (strain ED99) GN=ung PE=3 SV=1 25,6 
6,
2 
1 
94.4 
(M:94.4) 
2 11,3 5,3 
tr|E8SHS5|E8SHS5_
STAPH 
Urease accessory protein UreE OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=ureE PE=3 SV=1 17,5 
5,
1 
2 
312.5 
(M:312.5) 
4 29,8 3,11 
tr|F0P9S0|F0P9S0_S
TAPE 
Urease accessory protein UreG OS=Staphylococcus pseudintermedius (strain ED99) GN=ureG PE=3 SV=1 22,4 
4,
9 
1 
110.8 
(M:110.8) 
2 12,3 3,91 
tr|E8SFZ9|E8SFZ9_S
TAPH 
Urease subunit alpha OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=ureC PE=3 SV=1 61,5 
5,
2 
3 
360.2 
(M:360.2) 
9 18,2 4,21 
tr|F0P445|F0P445_S
TAPE 
Urease subunit beta OS=Staphylococcus pseudintermedius (strain ED99) GN=ureB PE=3 SV=1 13,2 
5,
9 
3 
130.4 
(M:130.4) 
2 20,3 6,27 
tr|F0P7E2|F0P7E2_
STAPE 
Uridylate kinase OS=Staphylococcus pseudintermedius (strain ED99) GN=pyrH PE=3 SV=1 26,2 
5,
4 
2 
455.4 
(M:455.4) 
7 31,2 2,96 
tr|F0P6T2|F0P6T2_S
TAPE 
Uroporphyrinogen decarboxylase OS=Staphylococcus pseudintermedius (strain ED99) GN=hemE PE=3 SV=1 38,4 
5,
9 
2 
203.0 
(M:203.0) 
4 11,9 5,36 
tr|E8SFH0|E8SFH0_
STAPH 
Uroporphyrinogen-III methyltransferase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_2071 PE=3 SV=1 34,4 
5,
9 
3 
178.8 
(M:178.8) 
4 15,6 1,07 
tr|F0P374|F0P374_S
TAPE 
UTP-glucose-1-phosphate uridylyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=galU PE=4 SV=1 32,5 
4,
9 
2 
174.3 
(M:174.3) 
4 13,9 1,95 
tr|E8SJ97|E8SJ97_S
TAPH 
Xaa-His dipeptidase OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1518 PE=4 SV=1 52,6 
4,
6 
2 
646.2 
(M:646.2) 
15 37,1 3,47 
tr|F0P974|F0P974_S
TAPE 
Xanthine phosphoribosyltransferase OS=Staphylococcus pseudintermedius (strain ED99) GN=xpt PE=3 SV=1 21 
4,
9 
1 
109.6 
(M:109.6) 
3 23,7 265,32 
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tr|E8SEP3|E8SEP3_
STAPH 
YjcG, 2H phosphoesterase superfamily protein OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_0698 PE=4 SV=1 19,5 
4,
8 
2 
296.8 
(M:296.8) 
6 34,5 1,51 
tr|F0P366|F0P366_S
TAPE 
zinc ABC transporter substrate-binding protein 62 
5,
4 
2 
131.3 
(M:131.3) 
3 5,5 6,36 
tr|F0P685|F0P685_S
TAPE 
zinc metallopeptidase 25,7 
9,
2 
1 
129.4 
(M:129.4) 
3 12,5 5,79 
tr|F0P469|F0P469_S
TAPE 
Zinc metalloproteinase aureolysin OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0326 PE=4 SV=1 55,1 
4,
7 
7 
624.3 
(M:624.3) 
10 25,1 2,98 
tr|E8SGI0|E8SGI0_S
TAPH 
Zinc protease OS=Staphylococcus pseudintermedius (strain HKU10-03) GN=SPSINT_1008 PE=3 SV=1 49 
5,
2 
2 
240.1 
(M:240.1) 
8 17,9 6,72 
tr|F0P5M9|F0P5M9
_STAPE 
Zinc-binding alcohol dehydrogenase OS=Staphylococcus pseudintermedius (strain ED99) GN=SPSE_0119 PE=3 SV=1 37,2 
5,
1 
1 
488.0 
(M:488.0) 
10 28,5 5,59 
 
 
 
 
 
 
